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Abstract 
In ophthalmology, accurate measurement of intraocular pressure (IOP) and in vivo 
measurement of corneal material stiffness have been long-standing problems. Access to 
this information would transform the diagnosis and therapy of diseases and conditions 
such as glaucoma, refractive errors and keratoconus that are currently affecting over 50% 
of the world population. The aim of this study is to develop new methods for the 
accurate measurement of IOP and corneal material stiffness in vivo. 
 
To achieve this goal, a mathematical method was developed to analyse tomography data 
of keratoconic corneas, to estimate the area, height and location of the keratoconic cone. 
This information was utilised in the development of representative numerical models of 
the ocular globe. A large parametric study was then conducted, and with the aid of 
custom-built programming tools, high-performance computing and optimisation 
techniques, new methods were developed. These methods enabled the use of 
information obtained from a non-contact tonometry device to estimate biomechanically 
corrected IOP and corneal material stiffness.  
 
Methods developed in this study were validated on data collected from experimental 
tests as well as a large clinical database obtained from four continents. The results 
showed that the newly developed methods for measuring IOP are more accurate than 
those currently available in the market. IOP measurements were stable when compared 
in pre and post-surgical procedures such as refractive correction or corneal crosslinking. 
IOP values showed a weak/no correlation with geometrical or biomechanical 
parameters. Further methods for measuring corneal biomechanics in-vivo showed 
notable advancements compared to the existing method. Biomechanical values were 
weakly/not correlated with IOP and geometrical features while strongly correlated with 
age as an indication of changes in material stiffness. The experimental validation showed 
excellent agreement between the in-vivo measurements in comparison to ex-vivo 
findings.  
 
The outcome of this research will have an impact on the better diagnosis of glaucoma 
by eliminating misdiagnosis due to IOP measurement inaccuracies. Further, it enables 
personalised disease management and treatment through in-vivo measurement of 
corneal biomechanics that leads to optimisation of surgical procedures, most notably 
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A1        First Aplanation  
A1L A1 Length  
A1T Applanation 1 Time  
A1V A1 Velocity  
ACG Angle-closure Glaucoma  
ACH Anterior Cone apex 
Height  
AO  American Optical 
AP1 Applanation Pressure 1  
AsphQFront Anterior 
Surface Asphericity  
B 
BAD-D Total Deviation of the 
Belin-Ambrosio Display  
BFS Best Fit Sphere 
BioEG Biomechanical 
Engineering Group  
bIOP Biomechanically Corrected 
Intraocular Pressure   
bPar Base Parameters  
C 
C Cylinder 
CBI Corneal Biomechanical 
Index  
CCT  Central Corneal Thickness  
CH Corneal Hysteresis 
CKI Centre keratoconus index  
CRF Corneal Resistant Factor  
Cu D Total Diameter of the 
Ablated Tissue 
CVS  Corvis ST 
CVSIOP  Corvis uncorrected IOP 
CXL corneal crosslinking  
D 
D Diopter  
DCR Dynamic Corneal 
Response  
DCT Dynamic Contour 
Tonometry  
DeflAmpA1 A1 Deflection 
Amp.  
DeflAmpMax Deflection 
Amplitude Maximum  
E 
E Yong’s Modulus  
 
EleFBFS8mm Best Fit Sphere 
within 8mm Diameter  
Et Tangent Modulus  
F 
FFKC Forme Frust Keratoconus  
fIOP Fluid Structure Interaction 
IOP  
GAT  Goldman Applanation 
Tonometry 
G 
GATAdj GAT Adjusted 
H 
HC          Highest Concavity 
HCR Radius at HC  
HCT Highest Concavity Time  
I 
ICRS Intrastromal Corneal Ring 
Segments  
IHA Index of Height Asymmetry  
IHD Index of Height 
Decentration  
IOP Intraocular Pressure  
IOPcc Corneal Compensated IOP  
IOPt True Intraocular Pressure  
ISV Index of Surface Variance  
IVA Index of Vertical Asymmetry  
K 
KC Keratoconus  
KCI Keratoconus Index known as 
Klyce-Maeda  
KI Keratoconus index  
KMax Maximum Front Surface 
Curvature  
KSI Keratoconus Severity Index  
KSS  Keraotoconous Severity Score 
L 
LASIK Laser-Assisted in Situ 
Keratomileuses  
LVC Laser Vision Correction  
M 
M/F  Male Over Female Ratio 
MD Mean Deviation  
mmHg Millimetre of Mercury 
N 
NCT Non-Contact Tonometer  
NTG Normal-Tension Glaucoma  
 
O 
OAG Open-Angle Glaucoma  
OCT Optical Coherence 
Tomography 
OHT Ocular Hypertension  
ONH Optic Nerves Head  
Op D Optical Zone Diameter 
ORA Ocular Response 
Analyser 
P 
PBS Phosphate Buffered 
Saline  
PCHM  Posterior Cone Apex 
Height Movement  
PCT Peripheral Corneal 
Thickness  






QS Quality Score 
R 
Rmin Minimum Radius of 
Curvature  
S 
S Sphericity  
SD standard deviations  
SE Spherical Equivalent  
SMILE Small Incision Lenticule 
Extraction  
SP Stiffness Parameter  
SPA1 Stiffness Parameter at 
A1  
SPHC Stiffness Parameter at 
HC  




Keratoconus Classification  
U 
UV Ultraviolet 
UVA  Ultraviolet A 
W 
WEM Whole Eye Movement 
 




Ablation - surgical removal of tissue, typically using a cool beam laser 
Ablation zone - the area of tissue that is removed during laser surgery 
Anterior chamber - the fluid-filled space between the cornea and iris 
Aqueous humor - the clear, watery fluid between the cornea and the front of the vitreous  
Astigmatism - results from an irregularly-shaped or American football-shaped cornea which 
causes light to refract ineffectively 
Ciliary body - the ring of muscle fibres that holds the lens of the eye. It also helps control 
intraocular pressure 
Ciliary muscle - the smooth muscle portion of the ciliary body that is responsible for controlling 
the lens’ shape as it narrows or thickens to focus on images at different distances 
Cone - the irregular bulge on the surface of the cornea 
Cornea - the dome-shaped window of the eye that provides most of the eye’s optical power 
Corneal transplantation - a surgical procedure to remove a diseased or scarred cornea and 
replace it with a healthy cornea from a deceased donor 
Corneal cross-linking (CXL) - is a treatment for an eye problem called keratoconus 
Diopter - a unit of measurement. It measures the degree to which light converges or diverges 
Glaucoma - a group of diseases that result from increased intraocular pressure, which can result 
in damage to the optic nerve. A common cause of preventable vision loss 
Hyperopia (farsightedness) - results when the eyeball is too short. Light rays hit the retina 
before they come into focus. Distant objects are clearer than near objects; however, even distant 
objects may appear blurry 
Intracorneal ring - a tiny, transparent ring that can be inserted into the periphery of the cornea 
to change its shape and correct nearsightedness 
Intraocular pressure (IOP) - is the fluid pressure inside the eye 
Keratoconus - a hereditary, degenerative condition that causes the cornea to thin and protrude 
into a cone-like shape 
LASIK - laser in situ keratomileusis. A surgical procedure during which the top layer of the cornea 
is pulled back and the middle layer is sculpted to eliminate refractive errors such as nearsightedness, 
farsightedness and astigmatism. The top layer of the cornea is then replaced to serve as a protective 
flap 
Lens - the almond-shaped, elastic structure within the eye that focuses images onto the retina. It 
is curved on both its front and back surfaces; the lens narrows or thickens to focus on images at 
different distances 
Myopia (nearsightedness) - a condition in which the visual images come to a focus in front of 
the retina of the eye because of defects in the refractive media of the eye or because of abnormal 
length of the eyeball, resulting especially in defective vision of distant objects 
Optic nerve - the largest nerve of the eye, comprised of retinal nerve fibres (but no rods and cones), 
the optic nerve connects the retina to the primary visual cortex of the brain. Visual input from the 
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retina travels along the nerve fibres of the optic nerve to the brain. The brain interprets images sent 
by the optic nerve of each eye, reverses the images, and integrates them into the one three-
dimensional image that you see 
PRK - Photorefractive keratectomy (PRK) is a type of laser eye surgery. It's used to improve vision 
by correcting refractive errors in the eye 
Retina - the innermost layer of blood vessels and nerves that serves as the “film” of the eye. The 
retina receives visual images and transmits signals to the optic nerve through its nerve endings, the 
rods and cones 
Sclera - the tough outermost layer of the eye joining the cornea; the visible part is the white of the 
eye. The sclera has a transparent covering, the conjunctiva. The sclera helps maintain the eyeball’s 
shape, which is about one inch (25mm) in diameter 
Trabecular meshwork – a porpous medium created by beam-like structures behind the iris that 
filters the aqueous humour and allows it to drain into the bloodstream 
SMILE - Small incision lenticule extraction (SMILE) is a newer type of laser refractive surgery. 
This kind of surgery uses a laser to treat myopia (nearsightedness) and astigmatism (irregularly 
shaped cornea) 
Uvea - the blood vessel-rich pigmented layers of the eye. It includes the iris, ciliary body and 
choroid. It contains the majority of the eye’s blood vessels 
Vitrectomy - surgical removal of the vitreous, blood, and/or membranes from the eye. 
Vitreous or vitreous humour - the clear jelly that fills the eyeball behind the lens. It helps support 
the shape of the eye and transmits light to the retina 
Visual field - field of vision, the entire area that can be seen when the eye is directed forward, 










These terminologies were obtained from the Dictionary of Eye Terminology, Second Edition, 
(1990), Barbara Cassin and Sheila A.B. Solomon, Melvin L. Rubin, M.D., Editor (Triad 
Publishing Company, Gainesville, Florida). EyeCenter 1,2 
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1. Introduction  
 
1.1 Preface 
The eye has served as a topic of contradictory interpretations since ancient times. With 
the belief of philosophers and physicians in the eye as an active organ, Plato wrote in 
the 4th century B.C. that the emanated light rays from the eye capture the object and 
enable humans to see. With little knowledge of the eye anatomy, Aristotle rejected this 
theory, Figure 1-1. He believed it is unreasonable that seeing could occur by issuing 
something from the eye and advocated that the eye should be receiving rays.3 Beyond 
the philosophical discussions, Aristotle started to explore eye conditions. In his book, 
De Generatione Animalium, he discussed changes in eye colours which are believed to be 
related to glaucoma and more specifically acute angular-closure. This work was 
continued in the 1st century by Demosthenes Philalethes who described glaucoma in 
his book, Ophthalmicus, as the colouration of crystalline humour (lens) which he thought 
to be incurable. There seems to have been confusion between glaucoma and cataract in 
the literature during these early days. However, interestingly they were both believed to 
be due to thickening or hardening of intraocular humour. 4  
 
 
Figure 1-1 The eye structure conceived by Aristotle. At this time philosophers only recognised transparent 
cornea and sclera, and everything else was aligned with a hole which meant to be the pupil 5 
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In the 1st century,  interest in exploring light rays led to the book of Optics by the Greek 
philosopher Ptolemy who described convex lenses to aid with magnifying the image. 6 
Despite Aristotle’s view, 2nd century Galen hypothesised that light flows from the brain 
passing through an empty tube of optic nerves and leaves the eye. By taking advantage 
of the knowledge of Alexandria’s anatomists, Galen defined fundamental features of 
physiology and anatomy of the eye that served until the 7th century, Figure 1-2. Among 
those anatomists, Rufus of Ephesus described the eyelids, iris, cornea, retina, tear ducts, 
uvea and the two internal fluids, which he called the aqueous humour and vitreous. 
This knowledge enabled Galen to focus on the crystalline lens, which he described as 
the principal instrument of vision. Influenced by Galen, ophthalmology as a separate 
science started to appear from the 9th century and remained dominated by the emission 
theory and the significance of the crystalline lens. In the 10th century, the study of the 
dilation and contraction of the pupil and damage to the eye by intense light adhered to 
Aristotelian theory.3  
 
 
Figure 1-2 The anatomy of the eye as described by Galen. Many more components were identified at that 
time, including the crystalline lens, conjunctiva, choroid, retina, optic nerves, ciliary body, limbus and iris. 
5 
During this time, Ibn Sina described examination of glaucoma through ocular palpation 
and suggested cataract surgery was less suitable for those with hardening in the cornea.4 
Ibn Sina and later 12th century Alhazen improved the description of the convex lenses, 
used for magnifying images from the 1st century, and explored in detail the light 
refraction and image formation. 7 Ibn Sina’s and Alhazen’s work was followed by 
Nicolaus who described how the light passed through the cornea and crystalline lens 
and was transmitted by the optic nerve to the brain. 3 Building on the resulting 
improvements in understanding of refraction, the use of reading stones became 
gradually more common in reading small texts. 8 The first eyeglasses seem to have been 
produced in northern Italy during the 13th century.9 Important developments followed 
in the 16th century with Alessandro Achillini questioning the significance of the 
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crystalline lens, Vesalius denying the hollow structure of optic nerves and Felix Platter 
suggesting the optic nerve be the primary organ enabling vision and giving importance 
to the retina. 3 During that time, Willebrord Snellius discovered the law of refraction.10  
 
In the early 17th century, with more anatomical knowledge, Figure 1-3, Kepler theorised 
for the first time that the image is formed on the retina. 3 In the 18th century, a German 
professor of anatomy and ophthalmologist surgeon, Burchard David Mauchart, 
documented for the first time keratoconus as a corneal disorder. This work was explored 
in more depth by British physician John Nottingham in the 19th century and 
keratoconus was distinguished from other corneal diseases. 11 In the latter part of that 
century, the first tonometer to measure the pressure inside the eye was developed by von 
Graefe. This was followed by Maklakoff who developed the earliest, relatively accurate 
applanation tonometer. During the 20th century, it became known that glaucoma was 
associated with elevated intraocular pressure, which became routinely monitored in 
clinical practice using the newly developed tonometers.12 Later on, Joseph Dallos, 
William Feinbloom and Otto Wichterle developed contact lenses. 13 This was followed 
by corneal reshaping techniques that were implemented manually by Jose Barraquer and 
later using laser following its invention in the 1950s 14-16.  
 
 
Figure 1-3 Anatomy of the eye in the 17th century  5 
Until the 20th century, and even with the detailed anatomical understanding depicted 
in Figure 1-4, the eye was known as an organ that transduces light into an image but 
never thought of as a biomechanical structure. It was considered a musculature thick 
shell that was pressurised to form its curved shape and provided with nutrition through 
fluid secretion and drainage along with a complex system of vascular as well as a variety 
of solute and fluid transport networks.17 The 9th edition of the veritable bible of 
ophthalmology, Alde’s Physiology of the Eye, published in 1992, did not have any reference 
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to biomechanics, while the 11th edition, published in 2011, had only two relevant index 
entries. 18  
 
Figure 1-4 Eye structure as it is currently known 19 
From the late 20th century onwards, particular attention has been given to the field of 
ocular biomechanics, and the knowledge gained has transformed the diagnosis and 
therapies in ophthalmology. 18 This research is part of efforts to improve understanding 
of ocular biomechanics and develop new technologies to improve clinical practice.  
 
1.2 Background  
Glaucoma management relies on lowering the eye’s pressure (intraocular pressure or 
IOP) which is the only modifiable risk factor. The current inaccuracies in IOP 
measurement are reported to have contributed to 15% of patients with this condition 
are losing their eyesight while under treatment.20,21 This outcome is serious considering 
that glaucoma currently affects 66m people worldwide (11.2m of which suffer bilateral 
blindness as a result) and is expected to become more prevalent with an increasingly 
ageing population.22 
 
Most IOP measurement devices (tonometers) deform a central area of the cornea and 
assume that the resistance to deformation is related to the IOP. 12 While this operating 
principle makes device development simple, it leads to inaccuracies as the IOP 
measurements become affected by the natural variations in corneal thickness, curvature, 
astigmatism, tissue stiffness and corneal medical history.23,24 This had been a long-
standing problem, and several attempts have been made, to varying degrees of success, 
to quantify the inaccuracies in various devices and produce reliable correction methods. 
25-28 
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Goldmann applanation tonometer has served as the gold standard since 1954. 29 This 
tonometer makes contact with the cornea and requires the application of fluorescein 
and a local anaesthetic. This makes it time-consuming and uncomfortable to use. Also 
due to the contact, the device requires disinfection before it can be used on another 
patient. From 1972, with developments in non-contact tonometers such as non-contact 
tonometer (NCT), Keeler Pulsair, Ocular Response Analyser and Corvis ST, clinicians 
were able to monitor IOP as part of clinical routines. The advantages of non-contact 
tonometers are that they are quick, do not require disinfection and more importantly, 
are able to provide information on corneal movement under the puff of air. 30-32 
 
The ability to determine corneal biomechanical properties in-vivo – possibly using non-
contact tonometers – is of great clinical importance as it can help optimise several 
treatments and management procedures that interact or interfere mechanically with the 
eye. Examples include measurement of intraocular pressure (IOP) for effective glaucoma 
management 33,34, refractive surgery planning 35,36, keratoconus risk profiling 37,38, 
optimisation and evaluation of different protocols of collagen crosslinking treatments 
39, selection of intracorneal ring implants and even design of soft contact lenses where 
the mechanical interaction between the lens and the anterior eye is currently not 
considered. 
 
There are two main challenges in estimating in vivo mechanical behaviour. First, the 
deformation of the cornea under an external load is dependant on the IOP and corneal 
stiffness. Both IOP and material stiffness are unknown factors and the inter-related link 
between them and deformation makes accurate measurements more challenging in-vivo. 
40 Second, biological tissues and specifically the cornea and sclera behave in a nonlinear 
manner. 17,41 This means the material stiffness (tangent modulus) changes with variation 
in strain or stress and therefore IOP affects the measured corneal stiffness value. This 
study aims to address these challenges through the development of methods to estimate 
IOP that is free of the effects of corneal stiffness, and in-vivo stress-strain estimates that 
are independent of the IOP and geometrical changes.  
 
1.2.1 Human Eye 
The main components of the eye relevant to this study are the cornea, limbus and sclera, 
Figure 1-5. The transparent cornea and the opaque sclera form the outer tunic of the 
ocular globe protect the eye’s internal components.42 The border between the cornea 
and the sclera is the limbus, which contains the trabecular meshwork that allows outflow 
of the aqueous humour.43 
 
The cornea provides more than 60% of the eye’s optical power through its unique 
microstructure, which results in tissue transparency, geometry and refractive index.44 
Anomalies in corneal shape, like those observed in keratoconus, can affect light 
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refraction and cause deterioration in visual acuity. The chamber between the cornea and 
iris (anterior chamber) and the space from the iris to the lens are filled with aqueous 
humour. This water-like fluid nourishes the lens and cornea while providing stability to 
the shape of the cornea.45 The iris adjusts the amount of light that can enter the eye and 
reach the crystalline lens. The lens focuses the light that passes through the cornea onto 
the retina, and the retina detects light and transfers it to the brain through the optic 
nerve by creating electrical impulses.46,47 Ciliary muscle is responsible for changing the 
shape of the lens, and the ciliary epithelium produces aqueous humour. The part of the 
retina that provides visual clarity is called the macula and has a high density of light-
sensitive cells. The sclera is filled with a colourless and transparent jelly-like substance, 
the vitreous humour, that helps the eye hold its shape and takes up around 80% of its 
internal volume. 10,44,48 
 
 
Figure 1-5 The eye cross-section with some important components 49 
 
The non-regenerating governing layer (about 90% of corneal thickness) of the human 
cornea is the stroma which includes lamellae of organised collagen fibrils.50 The anterior 
epithelium and posterior endothelium are cellular outer layers composed of 
keratinocytes. The epithelium with roughly 10% of corneal thickness, protects the eye 
from froing bodies such as bacteria and water and absorbs cell nutrients and oxygen to 
transfer to the cornea.51 The thin endothelium’s primary function is to pump fluid out 
of the stroma and prevent it from swelling while keeping it clear. If endothelium cells 
are lost, they cannot be regenerated.52 The function of non-regenerating acellular 
Bowman’s layer with a thickness of 8-12 um is not clear. The Descemet's membrane, 
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with roughly the same thickness as the Bowman’s layer, is made of collagen, provides 
protection and can be regenerated after injury. Mechanical behaviour of the cornea is 
controlled by the stroma, and earlier studies showed that the epithelium’s contribution 
to corneal biomechanics was negligible. 53,54  
 
Figure 1-6 Corneal cross-section showing its main layers 53 
 
1.2.2 IOP 
The aqueous humour in the cornea is produced by the ciliary body and drained through 
the trabecular meshwork and uveoscleral outflow, Figure 1-7. The trabecular meshwork, 
made of a triangular porous tissue structure, is located in the angular base of the cornea. 
Through particular canals, it controls the outflow of aqueous humour and regulates 
IOP.55-57 Another drainage of aqueous humour is through an anatomical route called 
uveoscleral outflow.58 IOP is adjusted by the balance between the production and 
drainage of aqueous humour that flows at an estimated rate of 2.75 μl/min. 59 This 
pressure is uniformly distributed across the eye as a hydraulic unit.60 The pressure in the 
eye can be measured by applying a known pressure on the cornea and measuring the 
resulting deformation. The higher the pressure, the smaller the deformation and vice 
versa. The healthy range of the IOP is between 10 and 21 mmHg, and it varies 
throughout the day. 61 In the past, the IOP was examined by gentle pressure on the 
closed eyelids, and later using contact and non-contact tonometry devices. There are a 
number of inaccuracies associated with the majority of measurement methods as the 
corneal deformation is also influenced by the mechanical stiffness of the eye. 61-63 
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Figure 1-7 Aqueous humour production and drainage 64 
1.2.3 Glaucoma  
Glaucoma, the second leading cause of blindness after cataract, is a gradual degeneration 
of the optic nerve that is irreversible and can lead to complete blindness. Most patients 
with glaucoma have elevated Intraocular Pressure (IOP) and around one-third maintain 
a normal pressure while developing optic nerve degeneration, Figure 1-8. Glaucoma is 
an umbrella term used to describe conditions that result in optic nerve degeneration. 
Currently, IOP is the only modifiable risk factor for most types of glaucoma. Due to 
inaccuracies associated with the measurement of IOP and the slow progression of 
glaucoma, in most cases, vision loss and damage to the optic nerve occur before being 
recognised by the clinicians or the patients.21 The main types of glaucoma include 
primary open-angle glaucoma (OAG), primary Angle-closure Glaucoma (ACG), 
secondary glaucoma and congenital glaucoma. 65 
 
Figure 1-8 The eye anatomy comparison for healthy and glaucoma. 66 
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The most common type of glaucoma in the west is OAG, in which the anterior chamber 
appears to be normal, but IOP is elevated. If there is any other identifiable factor for the 
change in IOP, it is then known as secondary glaucoma. If the IOP is in the normal 
range, but the vision is being affected, the condition is known as normal-tension 
glaucoma (NTG), which is a subset of OAG. 67 On the other hand, in ACG the problem 
is in the issue with the drainage of the aqueous humour. If there is any other trigger 
related to other conditions, then it is known as secondary glaucoma. ACG can be acute 
or chronic. In acute ACG, the blockage is due to the iris being moved forward and 
blocking the drainage channels, resulting in IOP increases. Some studies reported that 
secondary acute ACG resulted in greenish or bluish colour in a mid-dilated pupil.4 In 
the chronic type of ACG, the reason for elevated IOP remains the same and the only 
difference is that the condition develops very slowly. Finally, congenital glaucoma is a 
rare condition that develops in babies as a result of problems with the formation of the 
drainage systems before birth. 65 It is also important to learn about Ocular Hypertension 
(OHT) as it refers to a condition where the eye is healthy, but the IOP is higher than 
the normal range. Patients with OHT do not have glaucoma but should be monitored 
closely for the possible side effects of high IOP. 68 
 
1.2.4 Keratoconus 
Keratoconus (KC) is a condition that causes alterations in the curvature of the cornea 
and localised thinning, Figure 1-9 69-72. It commonly begins in early adolescence, 
progresses over the next two decades 73 and can significantly reduce visual acuity and 
vision-related quality of life 74,75. While the characteristic topographic patterns of 
keratoconus can be identified on corneal topographic and tomographic maps, it is still 
difficult to precisely locate the centre of the cone and the transition zone between the 
pathology area and the rest of the corneal tissue 76-80. Classifying and managing 
keratoconus can be more efficient when the affected corneal region is located, especially 
in the case of customised corneal crosslinking 81-84. Hence techniques were developed to 
address this challenge 85-87. However, some of the available techniques to detect the 
keratoconus cone are based on methods that analyse corneal tangential or axial 
curvature maps 85-87. Tangential curvature at a point is defined as the curvature of the 
best fit sphere in the immediate local area surrounding this point. The standard 
management technique for keratoconus is corneal crosslinking (CXL), which is a 
surgical procedure that increases the stiffness of the cornea to prevent further distortion. 
In addition, there are several other methods used for improving the vision in KC eyes 
that includes the use of contact lenses, corneal implants or corneal transplants. 88 
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Figure 1-9 The comparison between health cornea (left) and keratoconic cornea (right) that led to 
thinning and deformation 89 
1.2.5 Biomechanics 
Application of mechanics to biology for a better understanding of living systems’ 
mechanics is defined as biomechanics. Thus the chemical and physical variations in 
tissue properties are being explored in biomechanics. The exponential progress in 
medicine that is mainly brought by advancements in the field of biomechanics made 
clinicians including ophthalmologists to become increasingly interested in the field.17 
Understanding material behaviour such as elasticity is fundamental to the field of 
biomechanics. Elasticity refers to the ability of a material to recover its original shape 
after the applied force is removed. Stress and strain are the components used to define 
tissue behaviour.90 The strain is the amount of stretch in comparison to its original 
dimensions and stress is the force pre-unit area.  
 
When an external force is being applied, the structure deforms until the internal load 
cancel out the opposing force. Both forces and deformations can be decomposed into 
perpendicular and parallel tensor components, respectively defining normal and shear 
strain and stresses.91 If the energy density function defines the relationship between the 
stress-strain, it is termed hyperelastic.92 If the material behaviour is the same across the 
tissue, it is called isotropic. Otherwise, it is anisotropic, and there is no symmetry in 
mechanical properties. When the material is isotropic, elastic properties are the same 
regardless of the direction of the force and position of the tissue. 93,94 If elastic material 
behaviour is linear, it is defined by Young’s modulus and when nonlinear, it is described 
by tangent modulus. The word tangent is being used to indicate the stiffness is changing 
as the stress or strain values change. 
 
When the cornea is subject to a fixed strain value, the stress will drop over time, and 
this behaviour is defined as relaxation, Figure 1-10-A. Similarly, when the tissue is 
subject to fixed stress value, it will stretch over time, and this is known as creep, Figure 
1-10-B. The creep and relaxation in tissue were found to continue for a long time. 95,96 
These are viscoelasticity features and are mainly due to the hydration level of corneal 
tissue and collagen structures. One studies showed a strong correlation between 
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hydration and creep. 97 In that study, the corneal thickness was changed by controlling 
the hydration level, and the amount of strain under the applied load was found to be 
smaller in thinner corneas. Other viscoelastic features include hysteresis and time 
dependence deformation. 98-100 If the loading and unloading of tissue do not follow the 
same path, it is described as hysteresis. Hysteresis is the amount of energy stored in the 
tissue that is equal to the area between the loading and unloading curves, Figure 1-10 
(C). Time dependant strain means the faster the load is being applied, the stiffer the 
cornea becomes and the amount of deformation for a given stress value reduces, Figure 
1-10 (D).  
 
Figure 1-10 The four features of viscoelasticity including (A) relaxation, (B) creep, (C) hysteresis and (D) 
time dependant strain 
 
1.3 Scope of the Study 
Eye conditions such as glaucoma, refractive errors and keratoconus are currently 
affecting over 50% of the world population. Despite research and investment in this 
area over the past 30 years, the diagnosis and therapy of these conditions are made with 
inaccuracies, and largely relies on ophthalmologists’ experience.  
 
This study attempts to reduce inaccuracies and improve the process of diagnosis and 
treatment. It required knowledge in eye anatomy and vision, and involved mathematical 
and engineering analysis, programming, data management and high-performance 
computing. It relied on parametric studies conducted using representative numerical 
modelling of ocular behaviour of human eyes subjected to ocular pressure and a 
tonometry air puff. CorVis ST, developed by OCULUS Optikgeräte, Inc. (Wetzlar, 
Germany),  was the chosen tonometer in this study as it provides more information on 
corneal behaviour compared to other devices such as Ocular Response Analyser (ORA). 
Corvis ST offers 140 images of corneal deformation during the 32 milliseconds of 
application of air puff.  
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The results of parametric studies were statistically analysed in order to develop methods 
to estimate biomechanically corrected IOP and Stress-Strain behaviour. These methods 
were subsequently validated with an experimental study on ex-vivo human eyes and a 
large clinical database.  The new Stress-Strain Index (SSI) was developed in order to 
enable the customisation of surgical and therapeutic procedures, including early-stage 
diagnosis of corneal abnormalities, refractive surgeries and corneal crosslinking.  
 
1.4 Aim and Objectives  
The aim of this study is to develop new methods for the accurate measurement of IOP 
and corneal material stiffness in vivo. This aim is achieved through the fulfilment of the 
following objectives:  
 
• Development of a mathematical method to analyse the tomography data of 
keratoconic corneas in order to estimate the area, height and location of the 
keratoconic cone 
• Building representative numerical models of healthy and keratoconic corneas 
and simulation of Corvis ST air-puff application on the cornea  
• Performing a parametric study with wide variations of important geometrical 
and biomechanical parameters exceeding the reported ranges 
• Development of methods to predict IOP and corneal stiffness for the healthy 
and keratoconic eyes and those subjected to Laser-Assisted in Situ 
Keratomileuses (LASIK) and Small Incision Lenticule Extraction (SMILE) 
surgeries 
• Validation of the IOP and corneal stiffness methods experimentally and using a 
large clinical database  
 
1.5 Thesis Structure  
The thesis includes five chapters providing a detailed description of the study’s 
methodology and findings. It starts by providing an overview of how knowledge in 
ophthalmology has developed over the years, highlights the gaps and describes the 
contribution of this research. In Chapter 2, a literature review is provided to explore 
earlier studies and the lessons learnt in connection to the present research. The 
methodology that is followed to achieve the study aim and objectives is described in 
Chapter 3. The results obtained from numerical simulations are presented in Chapter 
4. In addition, methods developed for IOP and corneal stiffness measurements were 
applied to clinical and experimental data and presented in this chapter. In the end, 
chapter 5 provides a thorough discussion of the main findings in comparison to earlier 
efforts. The conclusions and limitations of this study are also presented in the final 
chapter. 
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1.6 Thesis Contribution  
The contributions of this thesis are:  
 
• Development of a new method for estimating keratoconic cone properties 
including cone area, cone height and cone centre location 
• Development of representative numerical models of keratoconic corneas that 
incorporated realistic cone shapes and distinctive material properties  
• Thorough validation of the new IOP and corneal stiffness methods using 
thousands of clinical cases involving patients with various diseases and 
conditions collected from different clinical centres in four continents  
• Evidence to show the new bIOP is able to compensate better for variations in 
corneal biomechanics in healthy and keratoconic eyes compared to previously 
developed equations 
• Evidence to show that the new SSI parameter is independent of IOP and corneal 
biomechanics and can be applied to keratoconic eyes and those undergoing 
refractive or crosslinking surgeries 
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2. Literature Review  
 
2.1 Introduction  
The following chapter presents a relevant review of literature on the biomechanics of 
the eye, keratoconus, intraocular pressure and tonometry devices. It starts with an 
overview of research carried out to characterise biomechanics of cornea and sclera. The 
chapter then proceeds to a review of keratoconus, and underlying research demonstrates 
how this disease influences corneal biomechanics and geometry, which makes it 
challenging to measure both Intraocular pressure (IOP) and mechanical behaviour in 
vivo. Finally, it presents a literature study conducted on IOP and tonometry devices and 
errors associated with each one. The key lessons learned from earlier studies are 
presented at the end of this chapter.   
 
2.2 Corneal Biomechanics 
The cornea is responsible for 2/3 of the refractive power of the eye. The shape of the 
eye and especially the cornea is dependent on the equilibrium between the intraocular 
pressure and biomechanics of the tissue. 17,101-103 Corneal stiffness has an effect on most 
tonometry systems used to estimate IOP. The natural variation in corneal stiffness can 
lead to over or underestimation of IOP, which in results lead to deficiencies in glaucoma 
management. In diseases such as keratoconus, corneal stiffness reduces, which causes 
excessive deformation, and the cornea starts to change. The current management 
technique is based on corneal crosslinking (CXL), which is intended to restore the 
stiffness in the tissue. Stiffness is also affected by refractive surgery, which is intended to 
change the shape of the cornea to improve vision.104 However, it leads to increased 
corneal deformation under IOP due to loss of stiffness caused by the surgeries which 
contribute to the deficiencies in the outcome of these surgeries. 105 For these reasons, it 
is important to understand corneal biomechanics and to be able to quantify corneal 
stiffness in particular in vivo, which was one of the main aims of this research.  
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2.2.1 Elasticity 
Several types of hyperelastic constitutive models were presented in the literature, among 
which Neo-Hooke and Ogden were most commonly used for corneal modelling. The 
stress and strain relationship is defined using these models with constants that shape 
material properties.106 It is reported that most biological tissues, including the cornea, 
are nonlinear and have different degrees of anisotropy.107 The anisotropy is found to be 
mainly due to the constituent of collagen fibril microstructures in lamellae that are 
almost parallel to the corneal surface. 108 While anisotropic models are more accurate in 
representing tissue behaviour, they are computationally expensive.108 Hence, the use of 
isotropic material models became essential for large size simulation-based studies. 
Research showed that the corneal mechanical response could be presented accurately 
using the Ogden material model. 109-112  
 
2.2.2 Ex-vivo Measurement of elasticity 
The experimental studies on the cornea are mainly dominated by uniaxial and inflation 
tests.113-117 Experiments using uniaxial test relied on excised strips of tissue being clamped 
on a device that applied axial forces to the tissues. Studies that performed these 
experiments started by applying some initial loading and unloading cycles to ensure the 
tissue behaviour is repeatable, and this process is known as preconditioning.118 Upon 
completion of the test, force and deformation data are converted to stress and strain 
curves that its slope enables the calculation of the tangent modulus. It is highlighted 
that uniaxial experiments are useful for quick studies or relative comparisons of 
biomechanics. It is noted that this method of testing is unable to provide accurate 
material behaviour for the cornea. This is first because the corneal tissue is naturally 
curved, and during the uniaxial test, it has to lose its natural shape and become flat. 
Second, by cutting a strip of tissue, fibres are unable to interact in a natural way, and 
only the remaining fibres are aligned towards the direction of the force and contribute 
to overall tissue deformation. As a result of these inaccuracies, the experimental studies 
obtained from the uniaxial test significantly vary from one another, mainly due to these 
limitations. 119,120 
 
Attention gradually moved to test the tissue in its natural shape to overcome these 
problems. For this reason, inflation test rigs were developed that enable intact in vitro 
testing of cornea, sclera or whole eye. 121,122  In these experiments, fluid pressure is 
applied to cause tissue deformation. This deformation is monitored using laser or digital 
cameras, and the pressure is measured and recorded. The analysis is more complex and 
computationally expensive; however, this method of characterising tissue biomechanics 
is used more and more. A study conducted on 57 human corneas between 30 to 99 years 
old using inflation provided reliable biomechanical properties. In this study, the cornea 
was loaded up to 60 mmHg while being clamped close to the limbus.123 The tissue 
exhibited hyperelastic behaviour, and a nonlinear stiffening was reported with age. The 
relationship between stress and strain could be described accurately using exponential 
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Equation 2-1. This led to the development of a relationship between stress and strain 
in correspondence to age, Equation 2-2. 
 
σ = A[𝑒𝐵ε-1] 
Equation 2-1 
 
In Equation 2-1, constants A and B are obtained based on Equation 2-2  to enable 
obtaining the stresses (σ) in accordance with strain (ε) values. 
 
A=35×10-9age2+1.4×10-6age+1.03×10-3,     B=0.0013×age2+0.013×age+99  
Equation 2-2 
 
where age is provided in “year” and stress is obtained in “MPa”. By using Equation 2-2, 
the stress and strain relationship can be presented, as shown in Figure 2-1. The outcome 
of these equations showed a good match with experimental findings and has been used 
in numerical simulations. 123-125 The effect of corneal hydration relationship with age is 
not clearly reported in the literature. One study reported that corneal thickness does 
not change with age and this indicates the hydration level stays more or less the same. 
126 In contrast, another study found that corneal hydration is reduced with age. 127 
Contradictory to both of these studies, Sharifipour, et al. 128 concluded that since 
Corneal Hysteresis (CH) and Corneal Resistance Factor (CRF) measured by Ocular 
Response Analyser are reduced with age, corneal hydration should increase with age to 
balance this relationship.  
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2.2.3 In-plane Shear  
It is found that deformation of the cornea due to shear force is methodologically 
challenging to measure. Although its value is estimated to be small 129, its actual 
resistance is not known. Studies measured the shear modulus in the human eye to be 
between 2kPa to 20kPa 130,131 and another study showed this value is depth dependant 
and is higher in the anterior part 132. Since the value for shear modulus is relatively small, 
it is not considered in the majority of studies that used numerical simulations. There is 
a need to conduct more studies in this area to identify the shear modulus value 
accurately. This could have an impact on the improvement of accuracy in numerical 
simulations when the cornea is subjected to a bending force. 133-135 
 
2.2.4 Morphology and Ultrastructure  
The cornea and sclera have complex material behaviour including hyperelasticity 
(nonlinear stress-strain relationship), viscoelasticity (dependence on strain rate of 
deformation), regional variation of stiffness and dependence on age and medical history. 
In addition, the tissue is known to possess a high degree of anisotropy as its mechanical 
behaviour is dependent on the distribution of collagen fibres, the main load-carrying 
components of the tissue. With the collagen fibres showing significant regional 
variations in density and orientation, the biomechanical behaviour of the tissue changes 
accordingly, experiencing stiffness values that vary with location and direction, and 
making ocular biomechanics a highly complex topic. 
 
Soft tissues generally consist of two main constituents: cells and extracellular matrix. 
According to Humphrey 136, the extracellular matrix (ECM) – made of proteins, 
glycosaminoglycan and water – contributes to the eyes’ material properties in a number 
of ways; one such contribution is the provision of tissue stiffness and, as such, the ECM 
may be regarded as the main source of mechanical properties which affect tissue 
behaviour. Proteins included within the ECM include the collagen fibrils (one of the 
most abundant proteins), elastin and proteoglycan (which together form the tissues’ 
unique microstructure). 
 
A total of 28 categories of collagen types have been identified 137, among which collagen 
type one (fibrillar collagen) is the most common and abundant 138. In addition, types II, 
III, V, VI and XI are all regarded as fibrillar collagens, differentiated by their individual 
self-assembly processes 139. These collagens contribute to the formation of bands of fibrils 
in a staggered arrangement, organised into fibres, which provide mechanical support 137 
and whose production has been described thoroughly in the literature 139,140, Figure 2-2. 
As such, the detailed synthesis of fibrillar collagen from cell to ECM will not be given 
herein, although the hierarchical structure of fibrils will be briefly outlined for its 
important role in biomechanics. 
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Collagen fibrils may be treated as the fundamental building blocks in collagen-rich 
tissues and, as such, may be used to understand the tissues’ mechanical characteristics. 
The collagen molecules, which form the fibrils, can be observed via x-ray scattering, to 
allow the analysis of the tissues’ regional microstructure. On the other hand, the ground 
substance matrix around the fibrils is used to describe all other components including, 
but not limited to, proteoglycans, water and elastin, Figure 2-2 138,141.  
 
 
Figure 2-2 Hierarchical structure of fibrils within tissue. (a) Collagen molecules are combined to form fibrils, 
fascicles and tendon fibres; the interaction between fibrils and molecules is shown in (b) and (c), respectively. 
C-L, cross-links between collagen molecules; PG, proteoglycan-rich matrix between fibrils. Adapted from 138. 
 
Individual collagen fibrils are cross-linked via proteoglycans and packed together, in a 
parallel form, in lamellae, which in turn are organised – layered in varying orientations 
– to form a composite material, providing the tissue with the general architecture shown 
in Figure 2-3. The parallel organisation of fibrils within individual lamellae leads to 
higher stiffness in the direction of the fibrils and reduced stiffness in other directions, 
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Figure 2-3 Lamellae structure within the cornea 142 
 
In the human eye, the number of lamellae within the stroma varies from approximately 
300 at the centre of the cornea to 500 at the limbus 142. According to Meek, et al. 143, 
two preferred meridional orientations of collagen fibrils have been found in the central 
human cornea by synchrotron X-ray diffraction – inferior-superior and temporal-nasal. 
This arrangement continues from the corneal apex to 1-2 mm from the limbus, where 
it becomes circumferential. Indeed, Aghamohammadzadeh, et al. 144 demonstrated 
maintenance of the vertical and horizontal directions of fibrils to 1 mm from the limbus, 
which, in contrast, has a circular disposition of fibrils (Figure 2-4-a). Among all fibrils in 
the central cornea, one third are orientated within 45 degrees of the superior-inferior 
meridian and a similar quantity around the temporal-nasal direction (Figure 2-4-b); 
leaving one third in the diagonal directions in between 145. This observation is concluded 
based on studies on healthy corneas and may not necessarily apply in other cases, for 
example, in keratoconic cases where the collagen fibrils do not seem to have clear 







Figure 2-4 (a) The general arrangement of fibrils in the central cornea with preferred orientation in the 
vertical and horizontal directions145; (b) The 45-degree sectors of the central cornea where two-thirds of 
collagen fibrils have been observed to have a preferential orientation 145 
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2.2.5 In-vivo Measurements of Biomechanics  
In this section, three commonly used methods for measuring in vivo corneal 
biomechanics are reviewed. These include Brillouin Microscopy, Elastography and 
Tonometry based systems.  
 
2.2.5.1 Brillouin Microscopy  
Research showed that acoustic waves in the cornea are the result of thermal variations 
of molecules that produce volatility of pressure which propagates at around 1620 m/s, 
close to the speed of sound in the water. An effect known as Doppler frequency shift 
occurs as a result of the interaction between the reflection of the light with the 
modulation of the refractive index. Doppler effect is when the relative movement of the 
observer in regard to the wave source causes a change in the frequency of a wave. This 
shift in the cornea was found to be proportional to the speed of sound, which is equal 
to the square of longitudinal modulus. Brillion microscopy is a low power laser, in 
addition to a high res confocal spectrometer to measure frequency. The longitudinal 
modulus obtained from this device is believed to be correlated to shear modulus and 
reported to map the localised properties. The rationale behind this is that the 
polarisation of scattered light from shear phonons assumed orthogonal to the 
longitudinal Brillouin scattering that enabled the separation of shear from longitudinal 
signals. When experimentally tested on Amorphous Polycarbonate (Lexan), Kim et al. 
showed an ability to measure the shear modulus.147 However, in contrast, Wu et al. 
proved that Brillouin measurements are influenced by the level of hydration in the tissue 
as it influences acoustic waves and not tissue stiffness.148,149 The measurement value is 
useful for comparative studies, for instance, evaluation of changes in the same tissue 
before and after CXL or identifying localised changes in keratoconic eyes.150-153 Although 
this technology offers easy measurement and is a non-contact painless method, so far, it 
has not been able to gather enough information to measure tissue mechanical behaviour 
on its own. The method described here is called the spontaneous Brillouin scattering. It 
is believed that advancements in the second method, stimulated Brillouin, can address 
some of the shortfalls. 154 
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Figure 2-5S The methodology used in Brillouin microscopy 148 
 
2.2.5.2 Elastography 
Elastography has been used commonly to diagnose diseases such as fibrosis or steatosis 
in the liver, breast, prostate and thyroid cancers.155-157 It is based on a concept that creates 
some distortion in the tissue and then observes and analyses the response. The 
distortion is produced through three different methods of pushing or vibrating, acoustic 
radiation force impulse and ultimately, physiological distortions such as heartbeat or 
pulses. They are mostly based on ultrasound or magnetic resonance systems. By 
observing the response of the tissue, this method enables the detection of abnormal 
stiffness in the tissue. It was shown that if the tissue is deforming less or the wave travels 
more slowly than expected, the tissue can be identified as stiffer than normal. The 
ophthalmic application of this device requires ultrafast imaging to capture high-
resolution images with a shear wave of around 15MHz. 158-160 The elastic modulus 
obtained from the healthy corneas in the literature ranges from 50 to 190 kPa using this 
method.161,162 The drawback with this technique is reported to be the requirement of 
contact with the tissue, which causes patient discomfort. Studies noted that the new 
versions of OCT-based (Optical Coherence Tomography) imaging are likely to 
overcome this problem, Figure 2-6. However, the accuracy of estimating corneal 
biomechanics using these devices is not yet known. 163-165  
 
In vivo Measurement of Corneal Stiffness and Intraocular Pressure to Enable Personalised Disease Management and Treatment | 22 
 
 
22 | P a g e  
 
 
Figure 2-6 The structure of Optical Coherence elastography 165 
 
2.2.5.3 Tonometry based systems  
In recent years, there have been many advancements in how intraocular pressure is being 
measured. These devices have the advantage of being non-contact and apply puff of air 
to deform the cornea and monitor its deformation. 166  More information on this is 
provided in section 2.5. Ocular Response Analyser (ORA; Reichert Ophthalmic 
Instruments, Depew, NY) was the first to introduce biomechanical parameters to their 
device.167 The problem with this device is that it only captures the cornea in two 
positions, at first and second applanations. Hence by knowing the pressure and time it 
takes to reach these two positions, two parameters of Corneal Hysteresis (CH) and 
Corneal Resistance Factor (CRF) have been estimated. 168,169 Although the CH 
parameter in ORA is correlated with CCT, it appeared to provide useful insights into 
biomechanics. For instance, a study revealed a correlation between these parameters and 
the progression of open-angle glaucoma.170,171 Another study indicated that ORA could 
identify patients with keratoconus, although the accuracy was not great. 172 
 
Further developments in non-contact tonometry led to the development of Corvis ST 
(Oculus Optikgeräte GmbH, Wetzlar, Germany) that combined air puff with the high-
speed Scheimpflug camera system that monitors the deformation throughout the 
application of pressure, Figure 2-7. This new information enabled the development of 
new biomechanical parameters such as Stiffness Parameter (SP) and Corneal 
Biomechanical Index (CBI). In brief, CBI is a multivariant regression model that can 
separate healthy and KC corneas. SP is the differences between the IOP minus the 
pressure at applanation one divided by the maximum deflection minus applanation one 
deflection 173-175 Both parameters are influenced by IOP and corneal geometrical 
parameters and unable to measure true material stiffness. 176,177  
 
Studies on both ORA and Corvis ST showed some ability (to a varying degree of success) 
to differentiate between KC and healthy or hyperopia and myopia.178-180 A more recent 
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study developed a parameter called Stress-Strain Index (SSI) that is able to measure 
corneal biomechanics in vivo for healthy eyes with little influence from IOP and CCT.181 
This parameter showed a good performance in healthy patients, but when tried on larger 
studies indicated a need for improvements to be less dependant on geometry (CCT) and 
IOP. 182,183 Also, it demands notable improvement for diseased cornea and those after 
surgical procedures as the equation was developed with the intention to be applied only 
to healthy corneas. This thesis will tackle this issue of in vivo biomechanical 
measurements by developing a new biomechanical parameter that can be applied to all 
types of corneas with different diseases while remains independent or weakly correlated 
to IOP and geometrical parameters. This parameter should show a significant 
correlation with age as a measure of stiffness. There is one significant drawback with the 
use of noncontact air-puff tonometry to measure biomechanics which was reported in 
the literature. The drawback is the large deformation caused by air puff, and the small 
monitoring region of deformation, which hides the information requires for 
determining the localised variation of corneal biomechanics. 184 
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Figure 2-7 The deformations of the cornea under air puff application as it is monitored by Corvis-ST. 
Also, the Figure highlights the first and second applanation 185 
2.3 Sclera Biomechanics  
An eye that is able to see far away images sharply is referred to as emmetropia. 
Emmetropization is the process the eye adjusts its axial length to the focal length during 
childhood. 186 Myopic eyes in comparison to the emmetropic ones are known to have 
elongated sclera. This prevents the eye to focus the light on the retina and causes blurry 
vision. Posterior sclera elongation is reported to be the cause of changes in axial length. 
187 Myopia as the most common refractive error roughly affects 23% of the world 
population and estimated to increase to over 50% by 2050. 188 In addition to myopia, 
other diseases such as glaucoma, retinal detachment, and macular degeneration relate 
directly to sclera biomechanics. 189-192 Hence knowledge of sclera biomechanics became 
necessary for tackling these unmet clinical needs.  
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The sclera was found to be the primary load-bearing avascular tissue between the cornea 
and the optic nerve that provides structural stability against intraocular and extraocular 
forces. IOP is an intraocular force, and extraocular forces include saccades, muscle forces 
and blinking. Structural stability should be maintained to allow the retina to receive the 
light rays in the correct locations to enable clear vision.187 Studies showed that the 
thickness of the sclera varies from one location to another, but it is thinnest around the 
equatorial and thickest at the posterior pole.118,193 Majority of the sclera tissue is made 
of water (68%) followed by collagens (29%) proteoglycans, elastin and other proteins. 
194 The distribution of collagen fibres in the sclera does not follow any pattern, and this 
randomness resulted in opaque material. Due to this randomness, simulation of 
microstructure based numerical models of sclera has become more complicated.195,196 
 
It was found that the nature of collagen fibres and their structure results in the tissue 
behaving in a nonlinear manner similar to the cornea. This means the increase in strain 
leads to an increase in stiffness. Understanding sclera biomechanics is essential to 
evaluate the eye globe responses to surgeries, tonometric pressure, IOP, extraocular 
muscles and fat, and better understand diseases and conditions such as retinal 
detachment and glaucoma. An ex vivo experimental study on 36 human scleras obtained 
the material behaviour, thickness variation and correlation of sclera with age. 118 The 
current thesis is relying on the information obtained from this study to simulate sclera 
behaviour. Although the variation in localised stiffness of the sclera has no impact on 
the outcome of this thesis, still sclera is considered age dependant and split into three 
different regions. More on this is explained in chapter three, section 3.3.5.  
 
2.4 Keratoconus  
Keratoconus was first identified by Nottingham in 1854 and was distinguished from 
other ectatic diseases. 197 After more than 160 years of research, the pathogenesis of this 
disease remains uncertain. Today it is diagnosed by the steepening and thinning of the 
cornea through the study of corneal topography and remains the most common ectatic 
disorder. If not diagnosed and controlled, continuous progression of keratoconus can 
lead to visual impairment. In this section, a review of relevant literature is provided.  
 
2.4.1 Epidemiology  
There are many studies conducted on the epidemiology of keratoconus with significant 
variations. These variations may be subjected to geography, time and inhabitants factors. 
Keratoconus with an incidence rate below 1/2000 was classified as a rare disease. 73,198 
The prevalence varies from one country to another and is summarised in Table 2-1. A 
meta-analysis concluded that the rate of 138/100,000 is the global prevalence for 
keratoconus. The data suggest a higher prevalence in Asian backgrounds.199 
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Table 2-1 Prevalence of KC based on the geographical positions 
Country Prevalence (out of 100,000) 
Russia (Gorskova and Sevost'ianov 200) 0.2 
UK (Pearson, et al. 201) 4.5 
Macedonia (Ljubic 202) 6.8 
Japan (Tanabe, et al. 203) 17.3 
Finland (Ihalainen 204) 30 
UK Asians (Pearson, et al. 201) 32.3 
South Korea (Hwang, et al. 205) 37.4 
US (Kennedy, et al. 198) 54.5 
Denmark (Nielsen, et al. 206) 86 
Netherlands (Godefrooij, et al. 207) 265 
France (Santiago, et al. 208) 1190 
New Zealand (Papali'i-Curtin, et al. 209) 520 and 2250  
Isreal (Millodot, et al. 210) 2340 
Iran (Hashemi, et al. 211) 3300 
Lebanon (Waked, et al. 212) 3300 
Saudi Arabia (Netto, et al. 213) 4790 
 
2.4.2 Histopathology 
Studies showed that the pathology of KC could be identified from three categories of 
(1) stroma layer thinning, (2) changes in Bowman's membrane and (3) deposition of iron 
in the epithelium (basal layer). 73 The thickness of epithelium is the centre of discussion 
as some reported thinning, others reported thickening and one study suggested a pattern 
can be identified in KC eyes’ epithelium. 214-216 It is reported that the Bowman’s 
membrane is distorted through penetration of collagens from stroma or the cellular 
elements from the epithelium. 217-219 In stroma collagenous lamellae and keratocytes are 
reduced, followed by widening and flattening of lamellae and degradation of the 
collagenous matrix by non-keratocyte cells. 219,220 This results in softening of the tissue 
as stroma occupies around 90% of corneal tissue. In advanced KC, damage to 
Descemet's membrane and stromal edema is reported. 221 In advanced stages, vision is 
severely influenced due to irregular astigmatism, high myopia and corneal scarring, 
among whom 12% to 20% have to undergo corneal transplants. 72,222-225 
 
2.4.3 Biomechanics  
The above-described microstructure changes in corneal tissues are expected to lead to 
changes in corneal biomechanics. Various studies using ORA showed that Corneal 
Hysteresis (CH) and Corneal Resistance Factor (CRF) reduced in KC.38,226 Also using 
Brillouin Microscopy, it was demonstrated that there was a reduction in longitudinal 
tissue modulus.150 Further studies conducted on the Corvis ST showed that the Dynamic 
Corneal Response (DCR) parameters related to corneal biomechanics had lower values 
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in comparison to healthy eyes.227-229 These studies suggest softening of the cornea with 
KC progression. However, it remains unclear that when the biomechanical alteration 
starts to occur. This requires longitudinal studies of tissue stiffness across the corneal 
surface of patients who have not yet developed KC signs. No study has been found to 
cover this area.  
 
2.4.4 Aetiology 
Genetic factors have been studied and identified to be the reason for keratoconus in 
some cases.230 A recent study estimated that those who had KC in their ancestor have a 
prevalence of 15% to 67% higher than the general population. 231 There are studies 
conducted to identify the mode of inheritance, but it is still not clear. 232-234 There are 
several environmental factors identified to be highly correlated with KC. Demography 
data of patients with KC indicated that the disease starts in adolescence and young 
adulthood (as early as 4) and develops during the second decade. The earlier the disease 
starts, the more rapid its progression is expected to be. 235-238 KC development is reported 
in older patients. The predominance of gender in KC varies significantly as in the UK 
the M/F ratio reported being 3.34 for Caucasians and 1.63 for Asians, 1.33 in the US, 
0.58 in Iran and 0.29 in India. 201,211,225,239,240 Eye robbing was also traditionally identified 
as a risk factor, and some studies reported that eye rubbing causes a faster progression 
of the disease.197,241 It remains unclear whether eye rubbing has any influence at all or it 
remains as a secondary or primary cause of KC. One study concluded that the contact 
lens movement in the cornea, especially alongside eye rubbing, can promote KC 
progression. 242 Other causes of the disease reported in the literature include 
inflammation and atopy, exposure to UV light, body weight, pregnancy and hormones. 
199,243-249 
 
2.4.5 Morphology  
Characterisation of keratoconus is based on the morphology of the anterior corneal 
surface. Most keratoconic corneas have a cone that is higher and steeper than the natural 
corneal surface. The characterisation of cone became a tool to categorise corneas.245,250 
For instance keratometry value higher than 46 diopters are considered as KC.251 
Literature concluded that 72% of cones are in the mid-periphery region and around 
25% in the central region. 252-254 The posterior surface movement starts at incipient 
phases of KC then leads to the thinning of the cone area. 255 One study looked at the 
correlation between the corneal radius, shape factor, thinnest point and power of 
anterior and posterior surfaces. This study concluded an excellent correlation between 
two surfaces in the 61 eyes that were studied.256 another study compared the spherical 
power and astigmatism on the anterior-posterior surface of 31 patients and concluded 
that the posterior surface must be observed for better diagnosis. 257 Clinicians find the 
interpretation of cone data to be difficult using available information reported by 
topography machines.258,259 There is only one parameter that was introduced with the 
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ability to detect the location and magnitude of the cone called CLMI (Cone Location 
and Magnitude Index). This algorithm works by searching a circular area with a defined 
radius on the surface of the cornea. At any location, the circle is comparing the curvature 
of the cornea with a mirrored location on the other side of the cornea. If the difference 
between curvature of these two locations are large, it is identified as abnormal area. This 
method is susceptible to other irregularities on the surface of the cornea such as 
astigmatism. 260,261 
 
2.4.5.1 Cone location and shape 
A study conducted on 827 KC patients using photokeratoscope reported steepening on 
mid-peripheral corneal at early stages of the diseases with a tendency to be located 
towards temporal and inferior sides, Figure 2-8. As the disease progressed in these 
patients, an egg-shaped ring was formed around the central part of the cornea and 
steepening progress to the periphery and inferonasal quadrant.262 With technology 
advancements and the use of digitalised videokeratoscope another researcher conducted 
a similar study on 14 KC eyes. Through comparison of power maps, the asymmetry 
between paired eyes and steepness of central cornea was confirmed. The curvature of 
inferior and superior sides found to be significantly different, with an average of 8 
diopters higher than healthy. A superimposed irregular bowtie shape was proposed as a 
diagnosis observation in KC eyes. 76 The topography of 62 KC eyes collected using 
photokeratoscope indicated that 72% of patients had peripheral cones that could reach 
limbus and were bound to two quadrants. The remaining had central cones, and paired 
eyes showed significant non-superimposable symmetry. Interestingly paired eyes showed 
variation in the power with a mean difference of 8.2 ± 6.0 D in apex power and 
4.3 ± 2.7 D in cyindical power. In this study majority of cones were located in 
inferonasal side in contradiction to the previous study. 252 Another study showed no 




Figure 2-8 The cone on the inferior side of the cornea of a patient with advance KC 264 
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Unilaterality incidence attracted attention and a study relied on 164 moderate to 
advanced KC cases and concluded low incidence rate and found even those who are 
initially unilateral, progress to bilateral with disease advancements. This limited 
performing refractive surgeries on the fellow healthy eyes. 265 These eyes that show no 
sign of KC are diagnosed as Forme-Frust KC (FFKC). 266,267 Later, age was found 
correlated with the shape of the cone in a study that recruited 251 patients with 482 KC 
eyes. This study concluded bowtie power maps for younger (<21 years), inferior cone for 
middle-aged (21-40 years) and inferotemporal cone for older (>40 years) groups. With a 
higher occurrence rate (7-20%) for cones on the temporal side, the study suggested 
attention to this area, especially in the younger group. 268 The power maps became 
increasingly important, and keratoconus suspect corneas were identified by a bowtie 
posterior or localised anterior steepening shapes using Placido. 269,270 With 
advancements in topographer a study using Orbscan IIz (Bausch & Lomb Surgical, 
Rochester, NY) and OPD-Scan (Corneal Navigator; Nidek Co., Ltd.) showed variation 
in thickness from the thinnest point to the periphery to be significant between FFKC 
or KC and healthy patients. 271 Future studies developed a number of parameters that 
could be used to help with the diagnosis of KC. Hence many recent studies looked at 
correlations of these parameters with the shape of the cornea or KC stage. 272-277 
 
2.4.6 Management of KC 
The review of the literature showed that various grading systems were developed to 
identify the KC stage. The most common one is Amsler-Kurmeich which classified 
based on the amount of astigmatism and myopia, corneal scarring or thickness and 
central power.278 The use of KSS (Keraotoconous Severity Score) which is based on root 
mean squared of the power of the cornea and Shabayek-Alio which is based on analysis 
of higher-order aberrations are also used often in the literature. 279,280 Treatment 
monograms are also developed to work with various grading systems to standardise the 
procedure and improve management. However, a standard approach is not yet being 
followed or found to be reliable for this purpose, and the goal of an ophthalmologist is 
to enhance vision and stop vision loss. In this section, various management techniques 
are discussed.  
 
2.4.6.1 Contact Lenses and spectacles  
It is advised that at the early stages of the disease, spectacles can be provided to improve 
the vision. However, once cornea develops irregular astigmatism, spectacles would not 
be suitable and contacts being offered to patients. 281 Researchers found that at the early 
stages, Toric soft lenses could provide enough correction for astigmatism and myopia. 
As the disease progresses, more special lenses such as Rose K, piggy-back, hybrid or 
scleral lenses are needed to correct the vision. However, due to the irregular shape of 
the cornea, patients may experience discomfort in wearing them. 282,283 It is reported that 
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contact lenses can improve the vision even after corneal grafting, crosslinking or ring 
implantation. 281,284 
 
2.4.6.2 Collagen Crosslinking (CXL) 
This invasive method of controlling KC progression relies on UVA interaction with 
topical riboflavin (vitamin B) for 30 minutes to form new bonds among collagen fibrils, 
Figure 2-9. One study reported an increase of nearly three times after CXL on strips of 
the porcine cornea. 117 A number of studies suggested improvement of corneal ectasia 
and safety in the long term, which led to the recommendation to use it for younger 
patients who are at higher risk of progression. 285-292 The standard CXL method is 
Dresden Protocol and is suitable for corneas with a minimum thickness of 400 microns. 
In advanced KC cases, the thickness may fall below this limit, and other methods such 
as hypo-osmolar riboflavin solution are used to avoid endothelial cell loss.288,290,293 The 
procedure can be done with both epithelium on and off; however, the former is not 
recommended, and inconsistent results were reported. 294-296 New protocols increase the 
irradiation intensity and reduce the time of CXL to reduce patient discomfort. These 




Figure 2-9 Collagen cross-linking application on the patient under UVA and the schematic view of 
structural changes between collagen fibrils 299 
The complications associated with CXL include infection, edema, haze and rarely 
melting despite the fact that the success rate is very high.300-305 To increase the efficiency 
of CXL, it is combined with other procedures including PRK, LASIK, Intacts, thermal 
keratoplasty and orthokeratology.290,291,306-308 The amount of stiffening in CXL is varying 
significantly from one study to another. Two studies on 23 and 17 enucleated porcine 
eyes tested under inflation reported a 58% increase in young’s modulus.309,310 Another 
study also done with inflation on 4 human corneas reported an 80% increase in anterior 
cornea and a 90% increase in the posterior cornea after standard CXL.311 Using atomic 
force microscopy on 12 pairs of cadaver human eyes showed a 90% increase in Yong’s 
modulus following Dresden protocol.312 Another study on 14 porcine eye globes using 
ultrasound showed an increase of 5% in stiffness after CXL.313 Finally, a study on 72 
porcine cornea strips showed a 30% increase when stress-strain curves were compared.314 
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2.4.6.3 Corneal rings 
Vision correction for both myopia and KC can also be achieved through the flattening 
of the cornea. For this reason, Intrastromal Corneal Ring Segments (ICRS) made of 
polymethyl methacrylate (PMMA) were developed to be implanted in the stroma, Figure 
2-10. In addition to flatting, in KC cases, ICRS can also prevent further deformation of 
the cornea. 315-317 Clinicians choose implants when contacts and spectacles do not work, 
and visual acuity is reduced severely, but patients have a clear cornea, CCT above 400 
microns and age 21 or older. It is possible that the implant penetrates through the 
cornea in some cases, and if this happens, keratoplasty is the only option to restore 
vision. 318 Stable results achieved in 3 to 12 months postoperatively. 319 A study on 12 
patients who developed ectasia after LASIK operation concluded the depth of 60% to 
80% is suitable for implants to achieve desired flattening. 320 The commonly used types 
of ICRS are Intacs (Addition technology Inc., IL, USA), Keraring (Mediphacos, MG, 
Brazil) and Ferrara Rings (Ferrara ophthalmics, MG, Brazil). The challenge in selecting 
suitable corneal rings remain untackled as it relies on clinicians experience and 
monograms do not always lead to a desirable outcome. ICRS can also be combined with 
other procedures such as PRK and CXL. 321-323 There are other types of implants that 
include MyoRing as intracorneal continuous rings and Phakic Intraocular lenses. 324,325 
 
 
Figure 2-10 The Intacs ICRS on the cornea and its position in the cross-sectional view. 326 
2.4.6.4 Corneal transplantation  
If necessary results cannot be achieved using other methods, the last option is to go with 
corneal transplants. It is reported that the surgery is being conducted on less than one-
fifth of KC patients, and among them include age over 70 years old. 327,328 Most patients 
achieve good vision with spectacles with penetrating keratoplasty after one year, 
although the rejection rate was reported at 5.8% to 41% in the first 24 months. 224,329-332 
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Deep anterior lamellar keratoplasty has shown a higher success rate and lower chance of 
rejection which is now the standard technique for keratoconus management. In this 
technique, a partial thickness of the cornea is being removed and transplanted, which 
enables endothelium and Descemet membrane to stay intact. 333,334 
  
2.5 Intraocular Pressure (IOP) and Tonometry Devices  
Intraocular pressure is the only modifiable factor for managing glaucoma, and its 
measurement is the principal test for diagnosing this disease. Glaucoma is the second 
cause of blindness and the most common eye disease. It is reported that 64.3 million 
people between the age of 40 to 80 had glaucoma in 2013, increasing to 76 million in 
2020 and by 2050 this will reach 112 million people.22 African has a higher prevalence 
in primary open-angle glaucoma, and Asian are higher in angle-closure glaucoma. 335 In 
2002, WHO estimated 4.4 million people out of 37 million were blind due to glaucoma, 
which was 12.3% of the blind population.336 Hence this gave significant weight to 
accurate IOP monitoring as part of daily clinical examinations. The commonly used 
tonometry devices are explored first in this section. In the second part, a critical 
literature review is provided to enable comparisons between their measurement 
techniques.  
 
2.5.1 Commonly Used Tonometry Devices 
This part reviews literature theories and the development of some of the commercially 
available tonometry devices. All tonometry devices in today’s market are functioning 
based on an old concept. These theories gradually improved with technological 
advancements over the past 200 years, and this fascinating area of literature is explored 
in this section.  
 
2.5.1.1 Applanation Tonometry 
A berlin professor, Von Graefe, invented the first indentation tonometer in 1862 that 
could apply a known pressure to the eyelid and measure its deformation, Figure 2-11-A. 
There were a few further developments of this device in the next few decades, but still, 
hand examination remained as the standard practice. Hand examination was less 
painful for the patient and a more comfortable method of examination. In 1897, 
Professor Hjalmar Schiøtz developed a new impression tonometer that could relate the 
deformation of the eye to the amount of pressure more easily and was widely used for 
the next 50 years or so, Figure 2-11-B. Since the tonometer was making contact, 
disinfection using alcohol or heat was needed before testing a new patient to avoid 
infectious diseases. 337-339 
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Figure 2-11 (a) The tonometer invented originally by Hjalmar Schiøtz that has various weights and could 
apply known pressure to the eye and measure deformations, (b) the Von Graefe tonometer able to measure 
IOP through eyelid in an era with no anaesthesia 340 
The gold standard applanation tonometer designed by Hans Goldmannin in 1954, 
referred to as the Goldmann tonometer, became globally accepted and still commonly 
used in clinical practice, Figure 2-12.29 This instrument overcomes some of the problems 
with other instruments such as avoiding the influence of ocular rigidity by applying it 
on the cornea and use of small plexiglass plate instead of metal that reduced pain and 
patient discomfort. This tonometer was working based on a concept that the pressure 
could gradually increase until flattened cornea could be achieved. Perkins Hand Held 
Applanation Tonometer introduced in the 80s is similar to the Goldmann tonometer 
(GAT) with the difference of being portable.341 In 1988 the digital handheld and 
portable version of indentation tonometry was invented, called Tonopen. This device 
had the advantage of having a smaller tip that could be more suitable for abnormal 
corneas. The downside is that this reduces reliability and multiple measurements (4-6) 
are required to ensure an accurate reading.342 All these tonometers function based on a 
simple concept. 343 They follow the Imbert-Fick principle which says the pressure inside 
a dry sphere with a thin wall is equal by force required to flatten a surface divided by the 






where P is the pressure in N/mm2, F is the force in N, and A is the area in mm2. 
Considering this theory assumes dry, perfectly spherical and infinitely thin wall; its 
application to measure intraocular pressure will lead to inaccurate measurements. In 
this theory, a surface area of 3.06 mm was calculated to cancel the rigidity of corneal 
thickness (assumed 520 microns in this case) and the attraction of tear meniscus.345 As 
a result, this is the area used in applanation tonometry to flatten the cornea. In clinical 
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practice, patients have a different corneal thickness, rigidity and curvature, and these 
factors influence accuracy. These inaccuracies in measuring IOP, contribute to high 
statistics of undiagnosed or misdiagnosed glaucoma patients to remain at 50% of all 
glaucoma patients. 346,347 One major issue with the use of Goldmann is the application 
of local anaesthetic and fluorescein before starting the examination. Also, the 
measurements are influenced by human errors as the process is entirely manual. 348 
 
Figure 2-12 Goldmann tonometer and the position of the flattened cornea after the force is applied 349 
 
2.5.1.2 Dynamic Contour Tonometry (DCT) 
DCT was developed to overcome problems associated with the deformation of the 
cornea. This tonometer was found to be less correlated with corneal biomechanics as 
the cornea does not need to deform. It provides a continuous measurement that lasts 
for 6 seconds. Different from applanation tonometry, this tonometer is based on the 
law of hydrostatic pressure by Blaise Pascal. It says in gasses and liquids, the pressure is 
constant and is applied to all boundaries perpendicularly.348 The tonometer is made of 
7mm ring that matches the topography of an average cornea. The device applies a small 
pressure to force the cornea into its curvature of 10.5 mm, and a small piezoelectric 
sensor in the centre of the hollow tube measures the pressure accurately, Figure 2-13.350 
This pressure is measured from the outside and assumed to be equal to internal pressure. 
This device is among the most accurate tonometry techniques available in the market. 
It requires the application of a local anaesthetic but is independent of human errors as 
the process is semi-automated. The significant drawback is the duration of each 
measurement, which takes over 2.5 minutes, and most patients require more than one 
readings. 351 
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Figure 2-13 The DCT tonometer and the methodology of measuring pressure using this device 352 
 
2.5.1.3 Non-Contact Tonometry 
By introducing the non-contact tonometry, routing glaucoma screening became more 
feasible. One of the earliest non-contact tonometry systems is AO NCT (American 
Optical) introduced in 1972. This device applied a burst of air to the cornea to deform 
the cornea and measured the pressure at which the cornea reached first applanation. 
The need for contact with the cornea was eliminated that led to a negligible retraction 
of the eyelid. The only discomfort is the noisy nature of the burst, which causes the 
patient to blink. Before measurement begins, the patient is asked to look at a fixation 
light to ensure proper alignment with the corneal surface. 30 Keeler Pulsair, introduced 
in 1986, was among the most commonly used tonometers that eliminated the need for 
specialist staff to use it. 353 As part of the modern non-contact tonometries, Ocular 
Response Analyser (ORA) and CorVis ST have attracted attentions and discussed next. 
 
2.5.1.3.1 Ocular Response Analyser (ORA)  
ORA is not only able to measure IOP, but also provides insights into corneal 
biomechanics. Traditionally, in non-contact tonometry, an electro-optical sensor 
identifies the flattened time. In ORA, made in 2005, both inward and outward corneal 
movements are being monitored, Figure 2-14. This new information could provide 
insights into the viscoelasticity of the cornea. The differences in time between the first 
and second applications is called corneal hysteresis, and the comparison velocity 
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provides corneal resistant factor (CRF).354 Although IOP measurements in ORA are 
correlated with corneal biomechanics, they are not identical to GAT.355-357 The 
measurement takes a few milliseconds, and as a result, it is shown to be influenced by 
ocular pulses and cardiac cycles. 358 
 
Figure 2-14 The methodology followed by ORA to estimate IOP and corneal biomechanics 359 
 
2.5.1.3.2 Corvis ST 
The more detailed investigation into the dynamic corneal response (DCR) to the air 
puff became possible with Corvis ST. This device was made in 2010 and using a high-
speed camera able to take 4330 frames per second, DCRs information could be 
accurately obtained. This camera is based on the Scheimpflug principle and can cover 
8.5 mm of the horizontal corneal cross-section.32 This principle is commonly used in 
corneal topography mapping. Corvis ST can provide information from the posterior 
surface of the cornea, which enables measurement of the thickness. Extensive research 
has been conducted to produce parameters able to analyse corneal biomechanics and 
provide more accurate IOP measurements. Among these parameters, biomechanically 
corrected IOP (bIOP) and Stress-strain index (SSI) provide crucial information.104,181,360 
Corneal Biomechanical Index (CBI) is able to separate between healthy and 
keratoconus.228 Stiffness Parameter (SP) is able to measure the overall stiffness of the 
cornea. 361 
 
2.5.1.4 Continuous Tonometry 
Research showed that IOP changes throughout the day. Hence continuous 
measurement of IOP is required to accurately diagnose patients who are likely to develop 
glaucoma. Sensimed Triggerfish claims to be able to monitor pressure for 24 hours and 
wirelessly communicates and transfers information, Figure 2-15. This device is placed 
on the cornea like a contact lens and monitors changes in the pressure. It records 144 
readings during 24-hour use.362,363 Since this device measures the changes in the 
curvature of the cornea, IOP measurements are not very accurate. 364 At the moment, 
this device is rarely used in clinical practice. A wireless intraocular pressure transducer 
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is another way of obtaining continuous measurement. However, this device requires a 
surgical procedure to be implanted and is only prescribed for patients with glaucoma 









Figure 2-15 Sensimed Triggerfish contact lens (a) setup 366 and (b) device 367 
 
2.5.2 Tonometry Methods Comparison 
A study conducted on 59 patients out of which 36 cases had glaucoma compared Corvis 
ST (CVS) IOP with GAT. They found CVSIOP 18.9 ± 5.8 mmHg and GAT 
20.3 ± 5.7 mmHg with no statistically significant differences between them. 32 At this 
time, CVS was recently launched, and the tonometer performed similarly to contact 
applanation tonometry. DCT was found to be more repeatable than ORA and GAT, 
while the IOP values from the three devices were not interchangeable. 355,368 NCT was 
found to be correlated with CCT more significantly than GAT. Since NCT is influenced 
by ocular pulse amplitude, multiple measures were needed. 369,370 GAT is most accurately 
represent the IOP of corneas with CCT 520 micros. 24,371 Knowing CCT varies 
significantly by diseases and ethnicity, many patients were misclassified as normal-
tension glaucoma with GAT.372,373 For instance, Caucasian corneas CCT estimated 
between 580 to 600 microns, whereas African American was around 520 to 540. 374 
Patients with Ocular Hypertension were found to have CCT greater than 600 microns 
which could lead to a higher estimation of IOP using GAT. 375 Every 10 microns increase 
in CCT was found to affect IOP measurements in healthy corneas using GAT between 
0.18-0.24 mmHg. 376 
 
CCT is important in diagnosing primary open-angle glaucoma patients as it was found 
that with disease progression, corneal thickness reduces. 377 On the other hand, patients 
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who undergo LASIK surgery found to have lower GAT IOP and the reduction in IOP 
was correlated to the amount of correction. 378 GAT requires calibration and a study on 
132 GAT tonometers found only 4% of them were calibrated to an acceptable tolerance 
of ±0.5 mmHg. 379 A study used GAT and DCT on 39 patients who undergo LASIK for 
myopia and concluded GAT reduced significantly postoperatively by 3.0 ± 1.9 mmHg 
while no significant changes were found in DCT (−0.2 mmHg ± 1.5 mmHg).380 
Comparison of GAT, ORA and DCT showed that both DCT and GAT were able to 
provide repeatable findings with coefficients of 2.3 and 2.2 mmHg respectively. ORA 
corneal compensated IOP (IOPcc) measurements had higher repeatability coefficients 
of 4.3 mmHg and it is believed to be due to high correlation with ocular pulse amplitude. 
GAT underestimated IOP in comparison to DCT and ORA by around 2 mmHg. In this 
study DCT had the most repeatable results. 381 Another study conducted on 694 subjects 
using GAT, DCT and ORA found the mean IOP for GAT to be 14.1±2.8 mmHg and 
for ORA IOPg and IOPcc to be 15.9±3.2 mmHg and 16.6±3.2 mmHg respectively and 
DCT to be 16.9±2.7 mmHg. In this study, DCT again showed the smallest standard 
deviation among all three, followed by GAT. The values of IOP found not to be 
interchangeable. 382 The high value of IOPcc in normal-tension glaucoma patients 
suggested that the value of IOP may be underestimated using GAT, DCT and IOPg. 383  
 
In a comparison of four devices on 76 healthy subjects, GAT, ORA, DCT and CSV 
values were respectively found to be 15.62 ± 2.33 mmHg, 15.99 ± 3.58 mmHg, 
17.44 ± 2.51 mmHg and 17.24 ± 3.44 mmHg. In this study, GAT and ORA plus CSV 
IOP and DCT were found to be not significantly different. 384 CVS IOP was also found 
to be less affected with LASIK in comparison to GAT (3.4 mmHg), IOPcc (1.0 mmHg) 
and IOPg (3.8 mmHg). 385 Another study on healthy patients found similar values 
between GAT (15.5 ± 2.8 mmHg) and CSV IOP (15.4 ± 2.8 mmHg). In 2015 a new 
biomechanically corrected equation (bIOP) was introduced for CSV. The bIOP reduced 
the correlation of measurements with CCT and Age (stiffness) when compared to non-
corrected IOP values. 386 With some further improvement, the equation was applied to 
14 LASIK and 22 SMILE corneas and compared with GAT. This study found the IOP 
decrease with GAT in both surgeries by −3.2± 3.4 mmHg and −3.2 ± 2.1 mmHg 
respectively, while the same comparison for bIOP was 0.1 ± 2.1 mmHg and 
0.8 ± 1.8 mmHg. 360. Later bIOP was validated experimentally and was found to estimate 
values close to the true IOP (0.3 ± 1.6 mmHg, P = 0.989) and better than the non-
corrected CSV IOP equation (7.5 ± 3.2 mmHg, P < 0.001). 104  
 
Although the bIOP equation performed reasonably well in most cases, it was still 
underestimating IOP in keratoconic corneas. Hence a new equation was developed to 
be used on these eyes and termed IOP for soft corneas or bIOPs. This equation had the 
mean IOP in KC eyes similar to the healthy with no statistically significant differences. 
387 Comparison of bIOP to GAT in patients with OHT and OAG in 122 eyes found 
overall bIOP (15.2±3.0 mmHg) was higher than GAT (14.1±3.2 mmHg) and concluded 
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that it is less affected by corneal biomechanics. 388 Another study in 94 healthy subjects 
compared bIOP with GAT and ORA. They found bIOP to be 16.11±1.66, which in 
comparison to both GAT (3.02±2.60 mmHg) and IOPcc (1.09±1.96 mmHg) had higher 
values. 389 The comparison of four tonometry devices of GAT, DCT, ORA and CSV in 
healthy subjects found respective IOP values of 12.9 ± 2.4 mmHg, 16.1 ± 2.6 mmHg, 
15.6 ± 3.3 mmHg and 13.5 ± 2.4 mmHg. This study concluded that bIOP is more close 
to GAT in comparison to ORA and DCT. 390 bIOP was found to have good repeatability 
in healthy and KC eyes, although the mean value in KC eyes was lower than in the 
healthy group. 391 
 
DCT was found to be less correlated with CCT than GAT, although the correlation was 
still significant. 392 Another study showed poor correlation with CCT in DCT (r2=0.01, 
P=0.017) compared to GAT (r2=0.28, P=<0.001). Both devices showed a weak 
correlation with age and statistically not significant. 393 ORA found to better compensate 
for changes in CCT than GAT as well. 394 Another study found no association between 
CCT and IOPcc in the healthy group. 395 ORA and GAT both showed significant 
correlations with corneal curvature. 396 CCT was found to be correlated in GAT, ORA, 
NCT and DCT in a recent study. Although DCT seems to be more correlated with the 
corneal radius. 397 The bIOP was showed to be less affected by CCT and Age. 360 
 
2.6 Concluding Remarks 
This chapter aimed to review the literature relevant to this study. Discussions were kept 
for the final chapter of this thesis, and only what was found in the literature was 
presented. It provided a review of ocular biomechanics with more focus on the cornea. 
After presenting the findings on material behaviour including age dependency, scientific 
methods for measuring corneal biomechanics both in vivo and ex vivo were reviewed. It 
then progressed to keratoconus and covered a review in all the aspects of the disease, 
including morphological and biomechanical changes and management techniques 
including corneal crosslinking. It then reviewed studies related to the IOP and the field 
of tonometry and errors associated with IOP measurements. A critical comparison 
between commonly used tonometers was also provided.  
 
As it was shown in this chapter, IOP measurements are influenced by corneal 
biomechanics and geometry. This is evident as patients with keratoconus and corneas 
after refractive surgeries consistently were measured with lower IOP. Non-contact 
tonometers with the ability to monitor the deformation of the cornea could also provide 
insights into corneal biomechanics. Hence this extra information was used to improve 
the accuracy of IOP measurements. Corvis ST introduced the new bIOP equation which 
at the moment is a measurement least associated with corneal biomechanics followed by 
DCT. This bIOP equation, however, still did not work well on patients with KC and a 
new equation was developed to measure IOP for these patients called bIOPs. However, 
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this method did not make it to the Corvis ST. This thesis develops a new bIOP equation 
and a universal method of measuring IOP that is not/weakly influenced by confounding 
factors.  
 
On the other hand, biomechanical parameters obtained from Brillouin microscopy, 
ORA and Corvis ST were discussed in this chapter. ORA parameters that are CH and 
CRF showed to provide insights into biomechanical changes in the cornea; however, 
they are both correlated with IOP, biomechanics and geometrical factors. Brillouin 
microscopy works by the light reflections from corneal molecules and measures the 
corneal longitudinal modulus. Since no deformation is applied, until today, this device 
has been unable to estimate corneal mechanical behaviour and is more suitable for 
comparative studies or disease diagnosis. Corvis ST introduced several biomechanical 
parameters including CBI, SP and SSI as discussed in this chapter. SSI is the only 
parameter that is able to estimate mechanical behaviour in-vivo, and this was only 
developed for healthy corneas. This thesis offers a parameter that can provide stress-
strain behaviour for all corneas with various diseases and geometries.  
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3. Methodology  
 
3.1 Introduction  
The methodology used in this study to achieve the goal of developing new methods for 
estimating intraocular pressure (IOP) and corneal material stiffness in-vivo is described 
in this chapter, Figure 3-1. The chapter starts with a method used to obtain properties 
of the cone in keratoconus patients. This method relied on elevation data collected from 
commercially available topographers. Cone properties obtained with this method 
included the cone centre location, area and height. This is followed by an introduction 
to the numerical models used for simulating the corneal response to air-puff tonometry, 
and their validation. Next, a description is provided of the information exported from 
analyses of the numerical models and how dynamic corneal response (DCR) parameters 
were calculated.  
 
A better understanding of corneal behaviour was needed to develop equations for 
estimating corneal mechanical response and IOP in vivo. For this reason, parameters 
such as corneal geometry, mechanical properties and abnormalities due to ecstatic 
diseases were modified and simulated in numerical models. These models were 
subjected to IOP followed by Corvis ST air puff pressure. The deformations of these 
models were analysed and DCR parameters were exported that construct the database. 
This large database could explain the corneal response to air puff and used to develop 
the required equations (to estimate both IOP and material stiffness). To develop these 
equations, a custom software package was produced. This software, which is explained 
in section 3.6,  read the data obtained from numerical models, generated new 
parameters by combining the DCRs and through multiple optimisation methods, 
equations were developed.  
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Figure 3-1 The overview of the methodology followed in this thesis. Each section is described in details in 
the following chapter. 
 
At this stage, the objective was for the IOP equation to estimate actual IOP values set in 
the numerical models. Similarly, the material stiffness equation needed to estimate the 
true corneal material properties that were set in the numerical models. The optimisation 
continued until the differences between equations outcome, and true values were 
minimised. Then these equations were applied to healthy clinical data, and some final 
adjustments were made. These adjustments were necessary as numerical models can 
simulate ideal scenarios, whereas clinical data include a significant amount of noise. 
Through these adjustments, equations performed well in healthy clinical cases and then 
applied to other clinical data for validation. At the end of this chapter, an explanation 
of clinical data is provided. For IOP, a second equation was developed to improve the 
accuracy of predictions in keratoconic eyes when the topography of the cornea is known. 
For material stiffness, two other equations were developed to compensate for changes 
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in corneal biomechanics in keratoconic or corneal crosslinked eyes and the flap/cap 
thickness in LASIK and SMILE.  
 
3.2 KC Topography  
This section describes the method adapted to analyse the topography of keratoconic eyes 
in order to determine the cone height and location of cone centre and cone edge. This 
information was needed to enable the accurate representation of keratoconic cones in 
the construction of numerical models of KC eyes. This method is intended to be generic, 
so it can be applied to data collected from various topography machines and 
independent of any device-specific information. The method and its main findings were 
published in the Journal of the Royal Society Interface. 398 
 
3.2.1 Analysis of Curvature  
 A custom-built MATLAB (2018b, The MathWorks, Inc., Natick, Massachusetts, 
United States) code was developed to process clinical data. Initially, the raw elevation 
data for anterior and posterior maps were imported for all patients. Only records that 
had a quality score “OK” were processed. A sphere was then fitted to the central 4 mm 
radius of each cornea using a Matlab function, and the coordinates of the centre point 
and the radius of the sphere were identified. The distance from each data point on the 
corneal surface to the centre of the sphere was calculated. The distances were then 
subtracted from the radius of the sphere and the position and magnitude of the largest 
distance were assumed to point at the location and height of the cone centre, 
respectively. It was demonstrated in the literature that the radius of the cone is much 
smaller than the radius of the cornea.398 Hence in corneas with KC, the fitted sphere 
will not be dominated by the cone curvature. However, if in rare cases the cone is so 
large that it dominates a large portion of the cornea, this method will be susceptible to 
errors.  
 
To locate the boundary of the cone, a second derivative of the elevation data was 
calculated along radially extending lines from the cone centre with a fixed angle and 
while the relevant elevation data was determined using Matlab built-in function through 
triangle-based cubic interpolation 399. As the first derivative of elevation would represent 
the gradient of the tangent to the surface, a second derivative represents the rate of 
change of this gradient. Since corneal curvature changes direction when the point of 
interest moves from the cone area to the surrounding healthy area, a sudden change in 
the sign of the rate of change in tangent gradient is indicative of an intersection with 
the boundary of the cone, Figure 3-2. Locating the cone boundary using this method 
then allowed calculating the cone area. 
 
Once the cone boundary was identified, the cone area was removed from the topography 
in an iterative process. During this stage, the above procedure including a sphere fitting 
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and calculation of the cone properties including cone height, cone apex and cone 
boundary were repeated until the difference between two subsequent analyses became 
smaller than 1.0 micron. At this point, cone properties were recorded and used for 
further analysis. This procedure was repeated for both anterior and posterior surfaces 
for every patient.  
 
The correlation of these cone parameters (location and height of cone apex and area of 
the cone) with disease severity and Pentacam keratoconus parameters were explored 
using the correlation coefficient ‘R’ and the corresponding significance value p using 
bespoke MATLAB code. The code was designed to analyse topography data and perform 
statistical analysis.  
 
 
Figure 3-2 (A) The best-fit sphere of the posterior corneal surface and the distances from the 
centre of the sphere to multiple points on the posterior surface are calculated. The edge is 
detected using second derivatives of elevation and variations in the curvature of the cornea. (B) 
Is a graph indicating the Euclidean distance from corneal surface points to the best-fit sphere 
and the largest values suggest the cone height and apex location 
3.2.2 Clinical Data  
In this retrospective study, the tomography maps of right and left eyes of 309 clinically-
diagnosed keratoconus patients enrolled in the Vincieye Clinic, and Humanitas Clinical 
and Research Hospital (Milan, Italy) were reviewed. The institutional review board of 
the University of Liverpool ruled that approval was not obligatory for this record review 
study. However, the ethical standards set out in the 1964 Declaration of Helsinki and 
their revision in 2013 were observed, and all patients provided informed written consent 
before using their de-identified data in the study.  
 
The inclusion criteria were the diagnosis of keratoconus made by an experienced cornea 
specialist (Paolo Vinciguerra) based on typical topographic patterns (e.g., inferior 
steepening, asymmetric bowtie, skewed axis) and/or characteristic slit-lamp findings 
(e.g., Vogt’s striae, Fleischer’s ring, apical thinning, or Rizutti’s sign). Exclusion criteria 
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included eye diseases other than keratoconus, extensive corneal scarring, former ocular 
procedures such as collagen crosslinking or implantation of intracorneal rings, 
connective tissue disease, as well as pregnancy or early puberty. All participants 
underwent a complete ophthalmic examination, including a Pentacam HR (Oculus 
Optikgeräte GmbH; Wetzlar, Germany) exam. Raw elevation data with a reference plane 
set at the corneal apex (from U12 file) were extracted using customised Pentacam 
software (version 1.21r41) and stored in comma-separated values (CSV) format 400. The 
data covered a square grid that was 14 mm wide and had a regular spacing of 0.01 mm. 
 
Patients were divided according to disease severity into three groups; mild, moderate 
and advanced, based on the Topographic Keratoconus Classification (TKC) provided 
by the Pentacam topographer 401. Mild keratoconus was defined with TKC classification 
of “Abnormal”, “Possible”, “-“ and “1”, moderate keratoconus included TKC grades “1-
2”, “2” and “2-3”, and advanced keratoconus included TKC grades “3”, “3-4” and “4”.  
 
Other tomographic parameters exported for this study included total deviation of the 
Belin-Ambrosio display (BAD-D), corneal thickness at the thinnest point, corneal 
astigmatism, maximum front surface curvature (KMax), anterior surface asphericity 
(AsphQFront), the custom Oculus topometric indices: index of surface variance (ISV), 
index of vertical asymmetry (IVA), keratoconus index (KI), centre keratoconus index 
(CKI), index of height asymmetry (IHA), index of height decentration (IHD) and the 
relative front surface elevation at the thinnest point in relation to the best fit sphere 
(BFS)  with 8mm diameter (EleFBFS8mmThinnest). These parameters and the 
important topography maps are explained next. 
 
3.2.3 Corneal Maps and Indices 
Keratoconus diagnosis and management rely on corneal maps and topography indices. 
Most studies in the literature were unable to process cone-specific properties such as 
height, area and location of the cone as this technology has not been available and 
information could not be obtained from any of the commercially available topographers. 
In clinical practice, clinicians look at the topography maps and identify the cone location 
and its existence, Figure 3-3. The three most commonly used maps are (1) curvature 
keratometric, (2) elevations and (3) thickness maps. It is needed to understand the 
usability of these maps to appreciate the underlying error in visual interpretations. 
Curvature keratometric maps provide information about the curvature of points on the 
surface of the cornea in a graphical manner set by the device manufacturer.402 Similarly, 
elevation maps show the difference between the measured points on the surface of the 
cornea and the reference maps. Elevation maps are accurate for data processing and 
numerical analysis. The reference map is playing a pivotal role, and usually, the best fit 
sphere is used to highlight subtle changes.403 They usually cover the central 8mm 
diameter on the cornea, and some of the data may be missing due to shadows cast form 
eyelashes and eyelids. 404,405 Finally, thickness maps are produced by processing elevation 
In vivo Measurement of Corneal Stiffness and Intraocular Pressure to Enable Personalised Disease Management and Treatment | 46 
 
 
46 | P a g e  
 
data, and they may not be as accurate as elevation maps. 406,407 To assist with the better 
diagnosis of keratoconus and disease stage, multiple indices were developed for different 
topographers among which some of them are being discussed in this section.  
 
 
Figure 3-3 A typical display of corneal topography that includes anterior surface curvature, the elevation 
of anterior and posterior surface and the thickness of the cornea. 408 
Maximum front surface curvature (KMax): Using curvature data it finds the maximum 
value across the cornea and reports in dioptre 409 
Anterior surface asphericity (AsphQFront): The value is “0” if the anterior surface is a 
perfect sphere, negative if it is prolate and positive if it is oblate 409 
Index of surface variance (ISV): Evaluates irregularity of corneal surface 409 
Index of vertical asymmetry (IVA): Evaluates the symmetry of the curvature in 
comparison to horizontal axis 409 
Keratoconus index (KI): Calculates the mean radius between upper and lower segments 
and reports the ratio between them 409 
Centre keratoconus index (CKI): Calculates the mean radius between the periphery 
and central segments and reports the ratio between them 409 
Index of height asymmetry (IHA): Evaluates the symmetry of the elevation points in 
comparison to the horizontal axis409 
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index of height decentration (IHD): Within a 3mm ring, Fourier analysis is performed 
to obtain the amount of vertical decentralisation. 409 
EleFBFS8mmThinnest: Relative front surface elevation at the thinnest point in relation 
to the best fit sphere (BFS) within 8mm diameter 409 
Total deviation of the Belin-Ambrosio display (BAD-D): This index is developed using 
regression analysis on multiple parameters. Values (higher than 2.1) can detect ectatic 
disease and showed to be able to diagnose KC with high accuracy 409,410 
Further information on other parameters can be found in published articles.411 It should 
be noted that these parameters are developed with the intention to provide more 
information about the corneal morphology and minimise the error associated with the 
qualitative judgment of maps by clinicians. None of these indexes can provide a 
universal solution for diagnosing the disease, and to a large extent, early diagnosis is 
subject to the experience of the clinician. In this thesis, a method is developed to address 
this shortfall. 
 
3.3 Numerical Model Development  
Numerical models were developed for a parametric study to understand the corneal 
response to Corvis ST tonometry. In all models, the rigid-body motion was prevented, 
section 3.3.2. The fluid cavity was introduced as an incompressible fluid with a density 
of 1,000 kg/m3 to behave similarly to vitreous and aqueous 412. 
 
This section starts by exploring the model structure, including the element type. This is 
followed by the development of a Matlab software code that simulated the application 
of Corvis ST air pressure on the cornea of these numerical models. A mesh density study 
was conducted to choose the optimum model formation to acquire reliable results as 
quickly as possible. The material parameters for the cornea were obtained through an 
inverse analysis process. 
 
3.3.1 Element Type  
Previous research in the Biomechanical Engineering Group (BioEG) at the University 
of Liverpool relied on the use of six-noded numerical models. It was found that these 
models are unstable for soft corneas. 413 A study was conducted to generate idealised 
numerical models for both 6-noded and 15-noded models using a custom-built mesh 
generator software which was developed by Wang 414, Figure 3-4. In this study, the same 
model geometries with the same material properties were generated. Both models were 
compared in terms of simulation time and rate of convergence. The outcome of this 
study was to recommend the use of 15-noded elements in future work, including this 
project. It should be noted that mass is not associated with the element and inertia is 
not at play in numerical models. In this study deformation of the cornea is only 
considered from the initial state to the highest concavity. Hence oscillation during this 
phase could be ignored as the data were extracted at two snapshots, when the cornea 
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becomes flat (applanation one) and when it reaches its maximum deformation (highest 
concavity).  
 
Figure 3-4 The difference between a 6-noded and a 15-noded element 
3.3.2 Boundary Conditions  
The rigid-body motion of the models was prevented by restricting the equatorial nodes 
in the anterior-posterior direction, allowing them to expand under IOP. Also, the 
posterior pole was fixed in both the superior-inferior and temporal-nasal directions, 
with the ability to move in the anterior-posterior direction. In addition, one point 
around the equatorial sclera was restricted on movement in superior-inferior direction 




Figure 3-5 Boundry condition of a typical model of the eye showing the equatorial and posterior points 
that were restricted on movement in different directions 
3.3.3 Corvis ST Pressure 
Experimental studies revealed that the pressure released from the device nozzle was 
reduced by 50% when it reached the surface of the cornea, Figure 3-6 181. In this thesis, 
pressure profiles of the left and right eyes of 140 healthy participants were evaluated 
over the 32-millisecond duration of air pressure. It was found that for all these 280 cases, 
the pressure profile followed a similar pattern with a standard deviation below 3.6% of 
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maximum applied pressure. Hence the mean profile obtained from this dataset was used 
as the pressure profile adopted in all numerical analyses. The spatial reduction of this 
pressure away from the corneal apex was obtained from an earlier study 386. The distance 
from the corneal apex to the nozzle was assumed to be fixed to 11mm, similar to the 
Corvis ST and the results of the experimental study.  
 
A PhD thesis developed numerical models in the context of a coupled models between 
computational fluid dynamics (CFD) and finite element analysis (FEA) using Arbitrary 
Lagrangian-Eulerian (ALE) deforming mesh.415 It demonstrated that the effect of 
changing corneal shape during the application of the air puff is not significant on the 
distribution of air-puff pressure on the corneal surface compared to a model without 
fluid-structure interactions. In addition, performing CFD simulations would be too 
time-consuming and would not enable the conduct of a large parametric study that was 
needed for this thesis. Hence the pressure distribution that was obtained experimentally 
using sensors on a curved surface was used in this thesis, Figure 3-6. 
 
 
Figure 3-6 (A) Reduction of pressure on the corneal surface away from apex and (B) variation 
of pressure on corneal apex and nozzle over time. 
The models produced by the mesh generator software included four files. These files 
included the input Abaqus commands, nodes, elements and material properties. A 
Matlab software code was developed to read the element files and locate the centre of 
each element on the anterior corneal surface. The distance from each centre point to 
the corneal apex was calculated and using linear interpolation, the value of pressure at 
this point was computed. The Matlab code then produced two files. The first defined 
how the pressure changed over time and during the simulation, while the second 
included the normalised value of pressure on each element. The number of elements 
that include a pressure value depends on the radial distance of the air pressure from the 
apex defined by the user in this code. 
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3.3.4 Mesh Convergence Study  
The mesh density study was split into three parts to obtaining the optimum model, 
Figure 3-7. It started with a study on corneal rings, where models with 5, 10, 15, 25, 35 
and 45 rings were generated. In this part, all models had 35 rings in the sclera and were 
subjected to inflation and air pressure. All parameters remained the same between these 
models apart from the number of corneal rings. Upon completion of the simulation, 
convergence time and deformation of cornea throughout the simulation were exported. 
The number for corneal rings was selected in a way to maintain model accuracy while 
using the smallest number of elements.  
 
 
Figure 3-7 Optimum ocular model mesh showing cornea and surrounding sclera. The third 
ring is highlighted in red to clarify ring positions. 
 
Once the optimum number of corneal element rings was determined, it was fixed in the 
second part of the study while varying the number of sclera rings. In this part, sclera 
rings were varied from 10 to 50 rings at steps of 10. In a similar manner to the previous 
step, deformations were compared, and the optimum number of rings was selected. 
After these two steps, a final stage of evaluating the number of segments on the cornea 
was needed. The numerical models of the eye could include four segments or six 
segments, as shown in Figure 3-8. The optimum mesh density values that were obtained 
for the cornea and sclera were used to generate both models. 6-segment models have 
more nodes and elements and result in longer computation times. Both models were 
subjected to inflation and air pressure. The deformations of the models were compared. 
Elements in Abaqus include integration points, which can adopt different 
biomechanical properties and have different stress values. As integration points are 
distributed through the thickness, a mesh density study through corneal thickness was 
not necessary. In addition, Keratoconus involves a slight change in geometry. Hence the 
mesh density should not be modified in KC eyes. Moreover, changing the mesh density 
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in cone area would create an artifact that could be responsible for differences between 
healthy and KC models that are not realistic.  
 
Figure 3-8 The model with different segmented rings where (a) has six segments and (b) 
has four segments 
 
3.3.5 Material Parameters  
An inverse analysis method was developed to obtain material properties of the models 
from previously published experimental data 123,124. The sclera was split into three 
different regions to match the tissue behaviour based on experimental findings 118. The 
15 noded models used in this study relied on Ogden constitutive material model. It was 
shown in the literature that the corneal material is viscoelastic and the Ogden material 
model can represent the soft tissue behaviour reasonably accurately 181,354,416-420. The 
hyperelastic Ogden strain energy equation is provided below and obtained from Abaqus 
Theory Guide documentation section 4.6.  














 ( 𝐽𝑒𝑙 − 1 )
2𝑖 
Equation 3-1 
where U is the strain energy, 𝜇 is the gradient of the line, 𝛼 is the nonlinearity of the 
curve, N is the Ogden order, 𝜆 is the principal stretch in 3D, 𝐽𝑒𝑙 is the volume of the 
particle and D is a constant. The stress-strain equation is derived from the equation 
above within the Abaqus. Ogden material model has proven to be able to present ocular 
material tissue and been used in a number of publications in this field. 181,354,416-420 Hence 
no further investigation in this material model was needed in this study. It should be 
noted that Ogden does not incorporate viscoelastic material behaviour such as strain-
rate dependency and hysteresis. In this study the rate of the applied pressure was 
constant and Ogden parameters were obtained to represent tissue behaviour at this rate. 
In addition, the behaviour of the cornea was considered only from the initial shape to 
the highest concavity. As a result of both of these, strain-rate dependency and hysteresis 
were not needed for numerical models.   
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A code was developed to use Matlab's built-in Particle Swarm Optimisation (PSO) 
function as an optimisation algorithm to obtain material parameters. There are two 
main reasons for using this metaheuristic approach. First, it has been used in this field 
and researchers are familiar with the algorithm and its performance which makes it more 
acceptable to be used in journal publications.421 Second, PSO relies on particles with 
variable velocity property that enables quick convergence. The algorithm does not get 
stuck in local minimums and is a highly efficient search algorithm.422 Since in this study 
optimisation is conducted alongside the FE models, the efficiency of the algorithm is 
crucial to reduce the overall time of the study.  
 
In this study, the code located the target curve from previous experimental data. This 
data served as target curves for the inverse analysis procedure using the 15-noded model. 
Two material parameters for Ogden order one (N=1) were modified as described in 
Equation 3-1. It then used Equation 3-2 to calculate the error. If the error was below 
10 microns, the analysis was terminated. Otherwise, it completed 200 iterations, and 
the lowest error was selected as the ideal material parameters that represent the same 
behaviour as experimental data. A python code was developed that could work with 
Abaqus ODB file for exporting deformations. Once the optimisation was completed for 
the defined target curves, and all parameters were obtained, the missing age groups could 
be identified using best-fit polynomials.  
𝐸𝑟𝑟𝑜𝑟 =  √





where 𝐷𝑒𝑓𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙  and 𝐷𝑒𝑓𝑁𝑢𝑚𝑒𝑟𝑖𝑐𝑎𝑙 are representing the deformation obtained 
from experiments and vertical (Z-axis) deformation of corneal obtained from 15 noded 
models, and “n” is the number of target points.  
 
3.4 Validation of Numerical Models 
Now that the numerical models were prepared, they needed to be validated using clinical 
data. In this section, patient-specific numerical models were generated. These models 
were built with knowledge gained from the previous section in regards to the mesh 
density study and air pressure applied to the cornea. The deformation of corneal models 
was compared with the clinical data to evaluate the performance of numerical models.  
 
3.4.1 Clinical Data  
Clinical data obtained from 9 healthy participants enrolled at the Vincieye Clinic in 
Milan, Italy. Institutional review boards at the institution ruled that approval was not 
needed for this record review study. However, ethical approval for using the data in 
53 | Methodology | Ashkan Eliasy 
 
53 | P a g e  
 
research had been secured when the data was collected, anonymised, and used in earlier 
studies. 228,423 Participants' informed and written consent was secured before collecting 
the data. Nevertheless, the ethical standards set out in the 1964 Declaration of Helsinki, 
and revised in 2000, were observed. All patients were evaluated with a complete 
ophthalmic examination, including the Corvis ST and Pentacam (OCULUS 
Optikgeräte GmbH; Wetzlar, Germany). All patients were free of any ophthalmic 
disease, with a Belin/Ambrósio Enhanced Ectasia total deviation index (BAD-D) 
derived from the Pentacam of smaller than 1.6 standard deviations (SD) from normative 
values in both eyes. Patients with previous ocular surgery or disease, myopia less than -
10D, concurrent, or previous glaucoma or hypotonic therapies were excluded. 
 
All Corvis ST exams were acquired by the same experienced technicians with good 
quality (QS) scores that enabled the calculation of all Corvis ST dynamic corneal 
response parameters (DCRs). Moreover, a frame-by-frame analysis of the exams was 
performed by an independent masked examiner to ensure the quality of each 
acquisition. Only one eye per patient was randomly included in the analysis to avoid the 
bias of the relationship between bilateral eyes that could influence the analysis result. 
Any Corvis ST readings with visible rotational misalignment in the corneal profile were 
excluded from the analysis. This data was previously published. 181 
 
This is important to note that there is a lot of noise in Crovis ST clinical data. Hence 
strict selection criteria had to be adapted to minimise these inconsistencies. Any 
measurement with quality standard not OK was rejected. Corvis  ST does not necessarily 
shoot perpendicular to the corneal apex, and due to rotations caused by the visual axis, 
there can be a tilt in how the pressure is applied on the cornea. Hence in this part of 
the study, cases with rotation had to be excluded. In this study, it was assumed that the 
distance from the corneal apex to the nozzle was fixed to 11mm in numerical models. 
In clinics, the 11mm distance cannot be guaranteed. Hence any clinical cases with 
variation in distance to the nozzle as indicated by the Corvis ST DCRs parameters were 
excluded. Among the remaining cases, with consideration to cover various CCT, IOP 
and Age, nine cases were selected. The demography for these cases is as shown in Table 
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Table 3-1 demography for patents used to validate numerical models 
Case 
Age 
(year) Exam Eye: QS 
IOP 
[mmHg] Pachy [µm] 
1 20 Right OK 17 537 
2 72 Left OK 17 539 
3 26 Right OK 14.5 600 
4 44 Left OK 16.5 565 
5 43 Left OK 13 595 
6 32 Left OK 16.5 601 
7 42 Left OK 17.5 592 
8 30 Left OK 11.5 539 
9 43 Left OK 13 608 
 
Using Corvis ST patient management software, the raw data were exported. These files 
included the deformation profile of the cornea throughout pressure application, Figure 
3-9. This profile covered the central zone of the cornea with a 4mm radius. It included 
both anterior and posterior surfaces and contained 140 measurements taken during the 
32 ms of air application. Only the loading part from the initial stage to the point of 
corneal highest concavity was considered.  
 
Figure 3-9 Corneal profile collected from Corvis ST in 140 measurements over a period of 32 
ms from Temporal-Nasal axis. The figure only shows corneal deformation up to the point of 
corneal highest concavity at 16.8 ms. 
 
3.4.2 Comparison with Numerical Models 
A process had to be taken to enable comparison of the results obtained from clinical 
data with numerical models. To do this first patient-specific numerical models had to 
























Corneal tempo-inferior Profile (mm)
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the whole eye movement. Finally, the deformation obtained from numerical models 
could be compared against those of clinical data for validation. These four steps are 
discussed below.  
3.4.2.1 Generating Models 
Patient-specific numerical models were generated using a bespoke mesh generator 414. 
Before generating each model, IOP and the age of the patients were set to the values 
obtained from clinical data. After the numerical models were generated, they were 
inflated, and the stress-free form (explained in section 3.5.6)  was obtained. Then Corvis 
ST pressure was added to these models using the code developed in section 3.3.3 426. 
Upon completion of the simulation and using a python software code developed to 
extract the deformations, the data needed for the comparative study were collected in a 
text file. A new Matlab code was developed to analyse and compare this data.  
3.4.2.2 Reading Clinical Data 
The software started by reading a patient’s corneal deformation under Corvis ST loading 
obtained from clinical data. The patients who had missing points were excluded, Figure 
3-10. A Matlab code was developed to process these files and identify the Corvis files 
that were suitable and had the required information to be used in this study. 
 
 
Figure 3-10 Corneal profile data with some information missing 
 
3.4.2.3 Whole Eye Movement 
In live patients, when the air-puff pushes against the cornea, the whole eye will move 
slightly backwards inside the orbit, this movement is called the Whole Eye Movement 
(WEM). Numerical models used in this study did not consider the muscles and orbital 
fat around the globe. Hence there was not any whole eye movement, and this 
deformation had to be excluded from the clinical data before it could be compared with 
the numerical predictions of displacement. To remove the WEM, a point within the 
8mm Corvis ST profile was selected at a given profile. If this point is near the edge, it 
could be influenced by the edge effect and the fitting errors. Hence points that were 
400 microns away from the edge of the 8mm region were found to be stable in all cases. 
At this location and to further reduce the noise, the elevation of all points within the 
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distance of 60 microns (from 400 to 460 microns) were averaged, and this value was 
recorded, Figure 3-11.  
This process was repeated for the left and right sides of each corneal profile up to the 
point of highest concavity. The difference between the elevation value obtained from 
the first profile and subsequent profiles was considered as the WEM and was removed 
from the deformation of that profile. Knowing the WEM on the left and right sides, a 
linear change was assumed between them to remove this deformation from all points, 
as shown in Figure 3-11.  
 
Figure 3-11 Whole eye movement at a specific time point. The WEM was calculated on both 
sides of the cornea and a linear distribution was assumed when removing the eye movement 
from corneal displacement. D1 and D2 are the displacements calculated at each side. 
 
3.4.2.4 Reading the Numerical Model 
As explained in section 3.4.2.1, the python file generated a text file with information on 
corneal deformation. This file included the position of the cornea at different time 
points during the 32ms air pressure simulation. Since a stress-free configuration 
(explained in section 3.5.6) was obtained, the inflated eye model had a matching profile 
with data obtained from the patient. Each profile was fitted to a polynomial order 12, 
similar to clinical data, to obtain an equation for that profile. A code was developed to 
prevent overfitting at this order, and order number 12 was obtained experimentally. 
Then using that equation, deformations at similar points as in clinical measurements 
were calculated. Also, a similar whole eye movement process was repeated to make sure 
all numerical model profiles were sitting on top of each other at the exact same point as 
in clinical data, Figure 3-12.  
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Figure 3-12 The Y-axis presents the elevations in mm, X-axis presents the distance in mm, and 
each colour is presenting a corneal profile at a different time point where (a) deformation 
obtained from clinical data that includes whole eye movement, (b) deformation obtained from 
clinical data after removal of eye movement, (c) deformation exported from numerical models 
and (d) adjusted deformation from numerical models to match clinical data 
3.4.2.5 Comparison between Clinical Data and Numerical Model 
The displacements of the cornea as measured clinically and predicted numerically were 
compared to validate the numerical models. In this method the known parameter is the 
deformation measured by the Corvis ST in clinics and the model behaviour was 
expected to match this behaviour. Deformation values were compared numerically and 
qualitatively (using plots) with the objective function as shown in, Equation 3-3. The 
output of this section is presented in the results section to serve as the validation of 
numerical models. This approach was taken by other researchers to validate numerical 
models 386,415,427,428.  
𝐸𝑟𝑟𝑜𝑟 =  √




where 𝐷𝑒𝑓𝐶𝑙𝑖𝑛𝑖𝑐𝑎𝑙  and 𝐷𝑒𝑓𝑁𝑢𝑚𝑒𝑟𝑖𝑐𝑎𝑙 are representing the deformation obtained from 
Corvis ST and 15 noded model, and “n” is the number of data measurement points on 
clinical data.  
 
3.5 Parametric Study  
A large parametric study was conducted to build the database for the development of 
new equations to estimate IOP and material stiffness in vivo. The variable used in this 
study were selected in a way to control geometry and stiffness aspects of the eye model. 
Parameters number 1 to 4 changed the geometry and material stiffness of healthy eyes 
In vivo Measurement of Corneal Stiffness and Intraocular Pressure to Enable Personalised Disease Management and Treatment | 58 
 
 
58 | P a g e  
 
while 5 to 7 introduced abnormalities to the cornea and number 8th varied the location 
of the abnormality in respect to Corvis ST profile. The parameters and the range defined 
for them are as below (in brackets the “x” refers to the total number of values considered 
for that variable):  
 
1. CCT (um):      395 to 645 at steps of 50     (x6) 
2. Material Stiffness Ratio:   0.25 to 2.0 at steps of 0.25  (x8) 
3. Radius (mm):      7.2, 7.8 and 8.4       (x3) 
4. IOP (mmHg):      10 to 35 at steps of 5       (x6) 
5. Cone Radius (mm):     0, 1 and 2        (x3) 
6. Anterior Cone Height (um):    0, 75 and 150        (x3) 
7. Radial cone distance to corneal apex (mm):  0, 1 and 2        (x3) 
8. The angular position of the cone (degree):  180 to 315 at steps of 22.5  (x7) 
 
The suitable range for material, thickness variations, IOP and corneal radius were 
obtained from the literature 118,181,429-433. The values for cone properties (parameters 5-7) 
obtained from the study performed in section 3.2. The angular position was selected in 
a way that covers the most likely locations of the cone while keeping the number as low 
as possible. The total number of simulations for this database was 163,296, which is the 
largest parametric study performed in this field. Considering this, all steps for the 
parametric study had to be automated to be able to obtain these results on a reasonable 
time scale. Hence a great amount of time was spent on the development of the software 
to perform this study. The process taken to develop this software at this stage is shown 
in Figure 3-13, and each step is explained in more details later in this section.  
 
Figure 3-13 Process adopted to build the database required for the development of IOP and 
material stiffness estimation equations  
 
3.5.1 Model Generation  
Idealised eye models were generated using the bespoke mesh generator, Figure 3-14 414. 
At this stage, the number of corneal rings was set to 10, and the number of sclera rings 
was set to 10. Four segments models using 15-noded C3D15H elements were generated 
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based on the earlier mesh density study. Each model had a single layer with a total of 
3606 nodes and 800 elements. The cornea was constructed from a single layer and the 
epithelium layer was not considered as a separate layer as its effect found to be negligible 
54. However, its thickness was considered in total corneal thickness. There was no need 
to consider optic nerves head (ONH) as its effect was found insignificant on corneal 
deformation 181.  
 
Corneal radius and CCT was set based on selected parameters for this study. Corneal 
shape factor was set to 0.82, Peripheral Corneal Thickness (PCT) was 150 microns more 
than CCT, the limbal radius was 5.85 mm, and the scleral radius was 11.5 mm. Sclera 
thickness varied with PCT where equatorial set to 80% of PCT and posterior sclera set 
to 120% of PCT. All these values were obtained from the literature 181. The sclera was 
divided into three segments to represent better the tissue behaviours based on the 
experimental studies conducted on various regions of sclera 118. Apart from the sclera 
with three segments, the model had one segment for the whole cornea. This was 
modified later when the cone location was identified as described in section 3.5.2. The 
eye model’s IOP was defined using a surface-based fluid cavity as described in 3.5.5. 
Stress-free was not performed at this stage. 
 
Figure 3-14 The numerical model generated for this study with variation in thickness. 
Different colours are referring to different material segments. 
3.5.2 KC Cone  
After desired idealised numerical models were generated, the corneal geometry had to 
be modified to introduce a cone. At this part, the knowledge of cone location on 
anterior and posterior surfaces, cone radius, cone height on anterior and posterior 
surfaces was required. The anterior cone height, cone radius and anterior cone location 
information defined by the parameters selected for this study and from section 3.2. Also 
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following the study in that section, more information was obtained about the remaining 
parameters, Equation 3-4, Equation 3-5 and Equation 3-6.  
 
𝑃𝐶𝐻𝑀 = 0.8138 × 𝐴𝐶𝐻 + 0.007 
Equation 3-4  
where PCHM is the posterior cone apex height location changes in millimetres 
compared to the anterior cone height and ACH is the anterior cone apex height in 
millimetres.  
 
𝑋(𝐴𝑛𝑡𝑒𝑟𝑖𝑜𝑟) = 0.591 × 𝑋(𝑃𝑜𝑠𝑡𝑒𝑟𝑖𝑜𝑟) − 0.296 
Equation 3-5 
𝑌(𝐴𝑛𝑡𝑒𝑟𝑖𝑜𝑟) = 0.7154 × 𝑌(𝑃𝑜𝑠𝑡𝑒𝑟𝑖𝑜𝑟) − 0.164 
Equation 3-6 
where  X(Anterior) and X(Posterior) are the location of the cone in temporal-inferior 
meridian for anterior and posterior surfaces, Y(Anterior) and Y(Posterior) are the location 
of the cone in superior-inferior meridian for anterior and posterior surfaces. All units 
are in millimetres.  
 
The software started by reading the node and element files. With the knowledge of the 
element type used in the model, nodes on the anterior surface, posterior surface and 
middle points were identified. Using the cone information provided by the user, the 
closest corneal point to the cone apex was identified. From the radius of the cone, all 
the corneal nodes within that range from cone apex were selected. At this stage, cartesian 
coordinates were converted to spherical coordinates to adjust the cone apex height to 
the desired value. Once the cone apex height is adjusted and with the information of 
the cone boundary, “griddata” function in Matlab was used that utilised triangle-based 
cubic interpolation to smoothly adjust all the corneal points within the cone area to be 
located between the cone apex and boundary.  
 
This process was repeated for the posterior surface to adjust the coordinates of the points 
within the cone. Then using the coordinates of anterior and posterior surface, middle 
element points were recalculated, and the coordinates were updated. Then the node file 
was updated to reflect the cone coordinates in its geometry, Figure 3-15. Finally, the 
minimum corneal thickness was calculated to be used in future calculations. Then the 
input file was read in the Matlab code. Two node sets for anterior and posterior points 
of the cone and one element set that identified the cone area was introduced into the 
input file. A new reference for cone material was also defined to enable variation of cone 
material properties manually. The change in material stiffness is introduced as described 
in section 3.5.4. The mesh density did not need to be modified as described in section 
3.3.4. 
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Figure 3-15 Cross-section of a model showing a keratoconus cone appearing as a bulge on 
both the anterior and posterior surfaces 
3.5.3 Axial Power 
It was necessary to calculate corneal axial power in the central 3mm diameter for 
identifying the material properties of the cone as described in the next section. Nodes 
from the anterior and posterior surface of the cornea were identified to calculate the 
axial power. The cornea was divided into 360 meridians where each meridian was 
analysed separately. Every point on every meridian was fitted to a circle in a way that the 
central point of the circle passed through the central line. This was done while 
maintaining a perpendicular tangential line to the radius of the circle, as shown in Figure 
3-16. Once this point was identified, the radius from the centre of the circle to the point 
could be calculated.  
 
Figure 3-16 Axial power determined at a general point on a corneal surface. The power is 
calculated by identifying the radius of a circle that passes through the central axis while being 
perpendicular to the tangential line at this point. The derivate is calculated from the 3D 
coordinates of the surface collected from Pentacam or FE models.  
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Every point on the corneal surface had a different radius. This process was repeated for 
every point and across all meridians for both anterior and posterior surfaces. Once all 
radiuses were calculated, axial power at every point was estimated using Equation 3-7 434. 
Then the average power of corneal central 3mm diameter was calculated as a single 
number to be used for the next step. This process was similar to what commercial 
topographer use to calculate power 435,436.  
 

















where P is the axial power in dioptre applied over the corneal surface, 𝑛𝑠 is the refractive 
index of stroma (1.376), 𝑛𝑎 is the refractive index of air (1.0), 𝑛ℎ is the refractive index 
of aqueous humour (1.336), 𝑅𝐴 and 𝑅𝑃 are the radius of anterior and posterior corneal 
surfaces respectively in microns and CCT is the central corneal thickness in microns 
437,438.  
 
The equation above is the correct method for calculating the refractive power of a thick 
lens, as described in the literature 434. However, most topography devices use a thin lens 
equation, where the third part of the equation was excluded. Since in this study, it was 
required to compare these findings with a commercial topographer, a simplified version 
was used as in Equation 3-8.  
 








3.5.4 Material Parameters 
In this section, material properties were defined for cornea, sclera and cone. A recent 
study developed an equation that estimates the softening of the cone using some 
parameters, as described in Equation 3-9 439.  
 
𝐶𝑟 = −0.0406 × 𝐶𝐴 − 0.0073 × 𝑃 + 0.000165 ×  𝑡𝑚𝑖𝑛 + 1.312 
Equation 3-9 
where 𝐶𝑟 is the cone stiffness reduction factor, 𝐶𝐴 is the cone area in mm, P is the power 
in central 3mm of the cornea in dioptre and 𝑡𝑚𝑖𝑛 is the minimum corneal thickness. 
The material properties of the cornea were identified using age. Ogden material model 
and parameters used in the simulations were described in section 3.3.5. An equation 
was obtained from data that related the stiffness of the corneal tissue to age, Equation 
3-10 123.  
 
𝐵𝑒𝑡𝑎 =  0.5852 × 𝑒𝑥𝑝0.0111 ∗ 𝐴𝑔𝑒 
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Equation 3-10 
Beta in the equation above provides the stress-strain behaviour of the cornea 
corresponding to a particular age. Using the equation above the stiffness variation 
between Age and material stiffness could be found and used as target curves. An 
optimisation technique was employed to obtain constitutive Ogden material 
parameters that provide the same behaviour as experimental data. A similar technique 
was used to obtain constitutive material parameters of the sclera in relation to age and 
using experimental data. 120 Hence the material properties of the whole eye could be 
now controlled using a single universal parameter, age,  
 
Table 3-2. The software used this value to obtain all parameters and update the material 























0 0.104 1.678 0.922 0.443 119.80 31.543 41.521 53.016 
25 0.115 1.913 1.081 0.554 119.80 35.303 43.876 53.016 
50 0.132 2.224 1.291 0.743 119.80 40.265 46.983 53.016 
75 0.157 2.633 1.568 1.096 119.80 46.815 51.084 53.016 
100 0.197 3.174 1.934 1.830 119.80 55.458 56.497 53.016 
 
 
3.5.5 Application of IOP 
The IOP values of the parametric study were defined in the input file to apply this 
pressure in the form of a fluid cavity to the internal surface of the eye, Figure 3-17. At 
this stage, the input file was read, and the value of internal pressure in the first step of 
loading was modified to the desired value. This value was inserted in Mega Pascal (MPa) 
and was converted from millimetre mercury (mmHg) by being multiplied to 
“0.000133322” value.  
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Figure 3-17 The fluid cavity surface inside the ocular numerical model 
 
During the application of IOP, the pressure inside the eye is changing and this change 
in pressure results in expansion of the ocular shell. The fluid cavity allows for the 
pressure to change, however, there was no need to measure this change in pressure in 
this study. There are two effects involved here, one is the direct effect of the external 
pressure and the other is the effect of pressure waves inside the eye. The effect of these 
two is not separated in this study and the FE model considered both effects while 
calculating the behaviour.   
 
Ocular rigidity is considered as the change in pressure that would be required to cause 
a unit change in volume, and this is commonly used as an overall measure of the stiffness 
of the ocular globe.440 The interest in this project is the stiffness of the ocular tissue and 
not the ocular globe. Hence the change in volume is considered in FE models however 
these data are not collected. In addition, the choroid is known to have a much lower 
tissue stiffness than the cornea and sclera and for this reason, it had been ignored in the 
numerical models. It is treated as part of the internal fluid of the eye due to this low 
stiffness.  
 
3.5.6 Stress-Free Configuration  
Until this step, the model included the desired geometry, IOP and material properties. 
However, the current geometry was before inflation, and the addition of IOP after 
running this model would change the geometry. For the parametric study, it was 
required for the model to have specific dimensions after being inflated. Hence it was 
required to find the geometry of the model at stress-free configuration 426. In this 
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process, the model ran through multiple iterations, and the nodes’ coordinates were 
modified at every iteration until the inflation model forms the desired geometry. In this 
study, this process was repeated five times to ensure the RMS between the desired 
geometry and inflated model was below 1 micron.  
 
Figure 3-18 Schematic figure describing the stress-free procedure. Source: Elsheikh et al. 426 
 
3.5.7 Corvis ST Air-puff 
Once the stress-free configuration of the model was obtained, it was time to add a 
second loading step to the input file. At this stage, the input file reread by the software 
and Corvis ST pressure was added after the inflation step, Figure 3-19. This step 
simulated 32 ms of real air-puff application and required defining how the pressure 
changed over time and how much was the maximum pressure on every element during 
this process. This was done through the code developed for section 3.3.3 where a 
detailed explanation is provided on how the pressure was applied. It should be noted 
that the pressure was applied normal to the surface of each element. Outputs required 
for simulation was the coordinates and deformation of the model during the application 
of air pressure.  
 
 
Figure 3-19 Corvis ST air pressure applied normal to the surface of each element (purple 
arrows) 
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3.5.8 Model Analysis 
The models were ready at this stage for simulation. The previous seven steps were 
repeated in a loop, and a custom-built Matlab software code modified/generated and 
ran the models one by one. Upon completion of the simulation, it ran a python code to 
export corneal deformation for both anterior and posterior surfaces into a single text 
file. Then all the extra files generated during this process was removed to reduce the file 
size. The remaining files were those required to run the model again if necessary, plus 
the output text file. This process for every model took 4 minutes to complete. 
Considering there were 163,296 models, it would take 454 days and would not make 
the study feasible. Considering the nature of the models, seven different profiles of the 
cornea could be obtained from a single run, Figure 3-20. This meant instead of generating 
new models for every rotation of the cone and always exporting the horizontal line of 
the cornea; the cone remained the same, and different profiles were exported from a 
single model. This reduced the number of models to 23,328, reduced the total 
simulation time to 65 days until completion. This study was performed using a custom-
built code and was performed on a Linux cluster at the University of Liverpool.  
 
Figure 3-20 The blue region is the cornea, the red region is highlighting the cone area, and 
seven black lines are assuming different cone locations. In doing this, the cone was kept on the 
inferior side. 
 
3.5.9 Calculation of Dynamic Corneal Response (DCRs) parameters  
The text file generated from the python code explained in the previous step was read at 
this stage. It provided the cartesian coordinates of nodes on anterior and posterior 
surfaces of the corneal over time. Some information, including corneal radius, IOP, 
corneal material stiffness, cone height, cone radius and cone location, were provided 
from previous steps. At this stage, corneal CCT had to be recalculated. This is because 
CCT was influenced by the creation of the cone. Hence at this stage, the apex thickness 
was calculated. The Corvis ST profile was exported from the model similar to clinical 
data to perform DCR calculations. This profile was exported at different angles to 
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simulate the effect of cone movement around the eye and only on the inferior side, 
Figure 3-20. The Corvis ST parameters described below were calculated in this section 
are as below. Please note that the deformation parameters could not be calculated as 
there is no whole eye movement in these numerical models. Hence deflection in 
parameters below is referring to the corneal movement only.   
• Deflection Amplitude Maximum (DeflAmpMax): This is the travelled 
distance from apex to the highest concavity. It was calculated by identifying the profile 
that has the highest deformation, Figure 3-21. 
 
Figure 3-21 Schematic graphical description of Deflection Amplitude Maximum 
• Highest Concavity Time (HCT): This is the time that cornea reached the highest 
concavity. It was obtained by estimating the time of the profile that deformed the most, 
Figure 3-22.  
 
 
Figure 3-22 Schematic graphical description of HC Time 
• Peak Distance (PD): This is the distance between two peaks at the highest concavity. 
This distance was calculated using the profile that deformed the most under Corvis ST 
pressure, Figure 3-23.  
 
Figure 3-23 Schematic graphical description of Peak Distance 
• Applanation 1 Time (A1T): This is the time at which the cornea becomes flat. 
This was calculated using the first derivate. This time was identified by selecting the 
profile before which cornea has three points with first derivate equal by zero, Figure 
3-24.  
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Figure 3-24 Schematic graphical description of A1 Time 
 
• A1 Length (A1L): This is the length of all the points that have the first derivate 
between ±10 microns. This value was obtained from the company, Figure 3-25.  
 
Figure 3-25 Schematic graphical description of A1 Length 
 
• A1 Deflection Amp. (DeflAmpA1): This is the distance travelled by the cornea 
from natural position to A1 time, Figure 3-26.  
 
Figure 3-26 Schematic graphical description of A1 Deflection Amp. 
 
• A1 Velocity (A1V): The velocity is calculated using the first derivate of corneal 
deformation over time. A1 Velocity is the sum of first derivate values until A1 time, 
Figure 3-27.  
 
Figure 3-27 Schematic graphical description of A1 Velocity 
• Applanation Pressure 1 (AP1): This is the pressure at the nozzle which was 
provided for the simulation using amplitude file, described in section 3.3.3 and shown 
in Figure 3-6. The precise value was obtained through interpolation, Figure 3-28.  
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Figure 3-28 Schematic graphical description of AP1 
 
• Radius at HC (HCR): This is the radius of the best fit circle at the highest concavity. 
It was calculated using a Matlab built-in function, Figure 3-29.  
 
Figure 3-29 Schematic graphical description of HC Radius 
• Stiffness Parameter at A1 (SPA1): This parameter which was initially introduced 
by Cynthia Roberts et al. 441, is known to be correlated with overall corneal stiffness, 
Equation 3-11.  
 






• Stiffness Parameter at HC (SPHC): This parameter is similar to SPA1, and the 









• Corneal Asphericity (P and R Values): Using corneal asphericity Equation 3-
13, coordinates of each profile at the relaxed position and after inflation was inserted 
into an optimisation algorithm to obtain shape factor (P) and apical radius (R) values. 
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The “fminsearch” Matlab function was used to minimise the error in differences 
between Y values predicted from Equation 3-13 and actual elevation data of corneal 
profile by optimising P and R.  
 
𝑌2 = 2 × 𝑅 × 𝑋 − 𝑃 × 𝑋2 
Equation 3-13 
where:  R = apical radius 
  P = shape factor 
 
when  P < 1 prolate ellipse – flattens from centre to periphery 
  P = 1 circle 
  P > 1 oblate ellipse – steepens from centre to periphery 
 
The analysis above was repeated for seven different corneal profiles at angles defined in 
section 3.5. This calculation took 1.5 minutes for each model, and as a result of 
analysing 23,328 models, this section took 25 days to complete. The analysis was 
performed on the University of Liverpool’s Linux cluster system.  
 
3.6 Development of IOP and Material Stiffness Equations   
For this study, two main equations needed to be developed to estimate biomechanically 
corrected Intraocular Pressure (bIOP2) and material stiffness or Stress-Stain Index 
(SSI2). Two healthy equations were developed that are applicable to the majority of eyes. 
In regards to bIOP2, to further improve the accuracy of estimation, a new equation was 
developed for a particular disease that distorts both geometry and corneal material 
stiffness, keratoconus. The parameters utilised in this equation incorporate 
topographical features that can be obtained from section 3.2.1. This new equation is 
denoted as bIOP2kc to distinguish the difference from the healthy equation in this study. 
In terms of SSI2, two specialised equations were developed to improve the performance 
of estimating corneal mechanical behaviour in (1) patients who undergo LASIK and 
SMILE surgical procedures and (2) those who have keratoconus or done crosslinking. 
The method used to develop these equations are similar, and this is explained in the 
next section and also in Figure 3-30. 
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Figure 3-30 Optimisation method developed to generate equations 
 
3.6.1 Biomechanically Corrected IOP  
This section describes the method utilised to develop bIOP2 healthy and keratoconic 
equations. The data collected from the numerical simulation, as explained in section 
3.5 was deployed into a Matlab script explicitly developed for finding optimum 
equations. Statistical analysis was performed to evaluate the correlation between various 
parameters and IOP. All parameters that showed any correlation with IOP were 
considered in the equation.  
 
3.6.1.1 bIOP2 for Healthy (bIOP2) 
The equation developed in this section was obtained through multiple optimisations 
procedures. The base parameters (bPar) selected for this equation as inputs are CCT, age, 
AP1, HCR, DeflAmpA1, A1V, DefAmpMax, HCT, PD, P and R while the output defined 
as IOP. In the optimisation algorithm developed for obtaining optimum equation, the 
base parameters were used in many different combinations to obtain a term (Te) that 
can predict the IOP with the highest accuracy. The formula for these terms is shown in 
Equation 3-14. The objective of this optimisation was to minimise the difference 
between predicted IOP and the actual IOP values set for numerical models. This code 








4. 𝑏𝑃𝑎𝑟𝑖 × 𝑏𝑃𝑎𝑟𝑗 
5. 𝑏𝑃𝑎𝑟𝑖 × 𝑏𝑃𝑎𝑟𝑗 × 𝑏𝑃𝑎𝑟𝑘 
The code was able to change these parameters, add to the number of terms and in each 
case optimise the coefficients and calculate the error of the predicted IOP in comparison 
to the actual value, Equation 3-14. Once the optimisation was completed, and the 
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optimum terms were found, the equation was tested on clinical data obtained from 
healthy cases described in section 3.7.2.  
 
𝑂𝑢𝑡𝑝𝑢𝑡 = 𝐶1  × 𝑇𝑒𝑖 + 𝐶2  × 𝑇𝑒𝑗 + 𝐶3  × 𝑇𝑒𝑘 + ⋯ + 𝐶4 
Equation 3-14 
Once the estimated IOP values were obtained from clinical data, output IOP correlation 
with CCT and Age was assessed, and final adjustments were made to improve the 
accuracy. The final equation was then applied to several different databases, including 
patients who underwent corneal crosslinking (CXL) or refractive surgeries and those 
who had glaucoma or keratoconus. It should be noted that corneal asphericity 
parameters were calculated for clinical data in the same manner as it was described in 
section 3.5.9. Since corneal profiles on clinical data were tilted, this equation was slightly 
modified to consider the rotation of the data as an extra parameter in optimisation.  
 
3.6.1.2 bIOP2 for KC (bIOP2-KC) 
The equation developed in section 3.6.1.1, provided good results when applied to 
keratoconic eyes. bIOP2 equation only used the information that could be obtained 
from Corvis ST. To further improve the accuracy of this equation, using the method 
developed in section 3.2.1, cone parameters that include cone height, cone area, cone 
distance to the apex and cone location were incorporated into the equation. A similar 
optimisation technique (section 3.6.1.1) was developed to optimise coefficients of these 
parameters and develop a new equation able to predict IOP in KC data with more 
accuracy. The accuracy in prediction was defined by the differences between the mean 
KC and healthy IOP values.  
 
3.6.2 Stress-Strain Index   
As described in chapter two, section 2.2, the corneal tissue behaviour is non-linear, 
which means it has a different stiffness at different stress or strain level. A previous study 
conducted by Biomechanical Engineering Group at the University of Liverpool found 
that there was a clear trend between stress-strain curves of different age groups 123,442. In 
simple form, as people aged, the corneal tissue became stiffer while the stress-strain 
curves did not intersect, Figure 3-31. The equation that described this relationship was 
discussed in section, 3.5.4. With this knowledge stiffness of the cornea at different age 
groups could be calculated in relation to stiffness at age 50. Hence with this one single 
parameter (SSI), the complete stress-strain curve could be obtained. Based on this, 
theoretically, if SSI could be obtained in clinics, then the mechanical behaviour of the 
patient could be measured in-vivo.  
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Figure 3-31 biomechanical behaviour of the cornea changes with age without any intersection 
as shown in figure “a” but instead consistently as shown in figure “b” that could translate to 
tangent modulus changes with stress as shown in figure “c”. SSI equal by one represent the 
material stiffness of a healthy cornea at age 50 and as the age increases the stiffness increases 
and vice versa. 
This section describes the method utilised to develop SSI2 equations. An equation was 
developed that could predict the material properties of healthy corneas with no known 
abnormality or surgical procedures that could influence mechanical response. A second 
equation was developed that was able to incorporate changes in corneal biomechanics 
due to keratoconus. Finally, the third equation was able to compensate for changes in 
mechanical response after LASIK or SMILE refractive correction surgical procedures. If 
it is not known that the eye has undergone refractive correction or has keratoconus, the 
healthy equation could still be applied, but the accuracy would be lower. The methods 
utilised to develop these equations are described below.  
 
3.6.2.1 SSI2 for Healthy (SSI2-H) 
Following a similar optimisation procedure, as described in section 3.6.1, the healthy 
SSI2-H equation was developed. The base parameters (bPar) selected for this equation 
as inputs were CCT, IOP, Age, AP1, HCR, DeflAmpA1, A1V, DefAmpMax, HCT, PD, P 
and R Values, SPA1 and SPHC while the output defined as corneal material stiffness. 
The objective here was to minimise the differences between the predicted corneal 
material stiffness and the actual value that was set for the numerical models. The 






4. 𝑏𝑃𝑎𝑟𝑖 × 𝑏𝑃𝑎𝑟𝑗 
5. 𝑏𝑃𝑎𝑟𝑖 × 𝑏𝑃𝑎𝑟𝑗 × 𝑏𝑃𝑎𝑟𝑘 





Once the optimum equation was obtained (similar to Equation 3-14), it was applied to 
healthy clinical cases as described in section 3.6.1.1 and final adjustments in regards to 
the correlations with CCT, IOP and Age were made. The equation was able to predict 
the material stiffness with good accuracy for all patients, including those with KC and 
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post LASIK or SMILE surgeries. However, there was room for further improvement for 
these exceptional cases by introducing other parameters which demanded the 
development of two more equations.  
 
3.6.2.2 SSI2 for KC (SSI2-KC) 
When the healthy SSI2 equation was applied to clinical data described in section 3.7, 
the mean value of SSI2-H was reducing with disease progression as expected. However, 
there were considerable overlaps between KC and healthy groups. A new equation was 
developed to improve the accuracy for the moment that clinical diagnosis is available. 
To develop this equation, the expected corneal stiffness in these patients were used as a 
benchmark and the coefficient of the equation in section 3.6.2.1 were optimised to 
provide the desired results. This equation was then applied to clinical data and evaluated 
by comparing them to healthy cases. No further correction was applied from clinical 
data to this equation.  
 
3.6.2.3 SSI2 for Post LASIK and SMILE (SSI2-PLS) 
The healthy SSI2 equation was applied to three different types of refractive surgeries 
that are PRK, LASIK and SMILE. In the PRK group, the mean pre and post values were 
similar for SSI2, which is expected. However, in LASIK and SMILE, due to the nature 
of the procedure and the flap/cap that does not contribute much to overall mechanical 
behaviour, the post-op values were estimated lower than the pre. In this group, similar 
to SSI2 in KC patients, coefficients of the generic SSI2 equation were optimised to 
correct the error induced by surgery. When the equation was developed, it then applied 
to various clinical databases and evaluated. The reason for this difference is discussed in 
details in chapter five, section 5.1.3.  
 
3.7 Validation of Equations   
To validate equations developed in this study, they were applied to various clinical data. 
Some of the healthy and KC cases are previously described in sections 3.2.2 and 3.4.1. 
Other clinical data that used were as below. Please note that these data were provided 
by Oculus for this research and due to confidentiality agreements, the name of clinics 
are not revealed.  
 
3.7.1 Experimental Validation 
Five ex-vivo human ocular globes (age 69±3 years) were obtained from the Fondazione 
Banca degli Occhi del Veneto Onlus, Venice, Italy, and tested within 3-5 days post 
mortem. Ethical approval to use the specimens in research was obtained by the eye bank 
in accordance with the Declaration of Helsinki. The central corneal thickness (CCT) 
was measured using a DGH 55 Pachmate pachymeter (DGH Technology, Exton, USA). 
After removing the extraocular tissues, a G14 needle was inserted through the posterior 
pole, glued around the insertion point to prevent leakage, and used to remove the 
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vitreous. The inside of the globe was washed with Phosphate Buffered Saline (PBS, 
P4417, Sigma-Aldrich, Darmstadt, Germany) a few times until a smooth movement of 
fluid was achieved through the needle and a syringe connected to it. The eye was then 
injected with a 10% Dextran solution (Sigma-Aldrich, Darmstadt, Germany) to prevent 
swelling during the experiment, before fitting it inside the test rig. Throughout these 
steps, the eye was kept moist using Everclear; a viscous tear film supplement (Melleson 
Pharma, Breda, Netherlands) to prevent drying. Information presented in this section 
was previously published. 104 
 
3.7.1.1 Test Setup 
A custom-built inflation rig was used in the study to control the IOP in ex-vivo eye 
globes, and measure it with the Corvis ST, Figure 3-32. The rig included a support 
mechanism for the eye to allow it to sit in its natural position with the cornea 
horizontally facing the Corvis ST while preventing both vertical and horizontal rigid-
body motion. Inside the horizontal support, a skin-safe, soft silicone rubber padding 
(Ecoflex® Series, Smooth-On, Pennsylvania, USA.) was placed to simulate the effect of 
fatty tissue around the eye. 
 
Figure 3-32 the diagram shows the structure of the test rig. 
 
The needle that had been inserted through the posterior pole was connected to a 4mm 
diameter tube attached to a syringe pump, which was controlled using bespoke 
LabVIEW software. The pressure applied through the syringe pump on the inside of the 
globe was monitored using an FDW pressure transducer (RDP Electronics, 
Wolverhampton, UK) fixed at the same horizontal level as the centre of the eye to avoid 
pressure head differences. The readings of the pressure transducer were assumed to 
represent the true IOP (IOPt) acting on the eye globe. IOPt was controlled to vary 
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between values that covered the natural variation in IOP seen in ophthalmic practice; 
10, 15, 20, 25 and 30 mmHg. These variations were introduced through the movement 
of a stepper motor connected to the syringe pump. After reaching each IOPt level, the 
eye was allowed to stabilise for 60 seconds before measuring IOP using the Corvis ST, 
which provided an uncorrected measurement (CVS-IOP) and a biomechanically-
corrected measurement (bIOP and bIOP2). Corvis ST measurements, which included 
CCT, were taken at each IOPt level until at least three readings of acceptable quality 
were achieved. Acceptable quality was in reference to the Corvis ST built-in standards 
in assessing a reading, and as part of this assessment, the device could trace and record 
fully the deformation profiles of the cornea during the application cycle of the air puff. 
At least 120 seconds were allowed between successive Corvis measurements at the same 
IOPt that should enable the cornea to recover fully from the distortion caused by 
previous air puffs. 
 
3.7.2 Healthy Cases 
This section provides clinical information from data obtained from healthy participants. 
Institutional review boards at all institutions ruled that approval was not needed for 
record review studies. However, ethical approval for using the data in research had been 
secured at both institutions when the data was collected, anonymised, and used in 
earlier studies228,423, before which participants' informed and written consent was 
secured before collecting the data. Nevertheless, the ethical standards set out in the 1964 
Declaration of Helsinki, and revised in 2000, were observed. All patients were evaluated 
with a complete ophthalmic examination, including the Corvis ST and Pentacam 
(OCULUS Optikgeräte GmbH; Wetzlar, Germany). All patients were free of any 
ophthalmic disease, with a Belin/Ambrósio Enhanced Ectasia total deviation index 
(BAD-D) derived from the Pentacam of < 1.6 standard deviations (SD) from normative 
values in both eyes. Patients with previous ocular surgery or disease, myopia <-10D, 
concurrent, or previous glaucoma or hypotonic therapies were excluded. 
 
All Corvis ST exams were acquired by the same experienced technicians with good 
quality scores (QS) that enabled the calculation of all Corvis dynamic corneal response 
parameters (DCRs). Moreover, a frame-by-frame analysis of the exams was performed 
by an independent masked examiner to ensure the quality of each acquisition. Only one 
eye per patient was randomly included in the analysis to avoid the bias of the 
relationship between bilateral eyes that could influence the analysis result. Any Corvis 
ST readings with visible rotational misalignment in the corneal profile were excluded 
from the analysis. 
 
3.7.3 Keratoconic Cases 
This multicenter retrospective study comprised persons enrolled at different hospitals 
to include variability from more than one continent. An institutional review board ruled 
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that approval was not obligatory for this study comprising a records review. However, 
the ethical standards set in the 1964 tenets of the Declaration of Helsinki and revised 
in 2000 were observed. All patients provided informed consent before their data were 
used in the study. All patients had a complete ophthalmic examination, including 
Corvis ST dynamic Scheimpflug analyzer and Pentacam rotating Scheimpflug camera 
(Oculus Optikgeräte GmbH) evaluations. Some of these data are previously published 
and used in this study. 387 
 
The inclusion criterion in the keratoconic groups was bilateral keratoconus without any 
former ocular surgeries, such as corneal crosslinking or intracorneal ring implantation. 
Moreover, to confirm the diagnosis, all examinations from each clinic were blindly 
reevaluated by a corneal expert at the other clinic. Only dynamic Scheimpflug analyzer 
examinations with good quality scores that enabled the calculation of all DCRs were 
included in the analysis. All measurements with the dynamic Scheimpflug analyzer were 
acquired by the same experienced technicians, and an additional manual frame-by-
frame evaluation of the examinations, made by an independent masked examiner, was 
implemented to ensure the quality of acquisitions. Also, anterior and posterior 
topography maps were acquired using the rotating Scheimpflug camera and analyzed to 
determine the topography and thickness profiles of keratoconic eyes, which were then 
considered in the numerical parametric study. Only one eye per patient was randomly 
included in the analysis to avoid the possible effect of the relationship between bilateral 
eyes on the analysis results. 
 
Further evaluation was performed by considering keratoconic eyes with different disease 
stages. For this purpose and based on the Topographic Keratoconus Classification 
(TKC) provided by the rotating Scheimpflug camera,401 the keratoconus datasets were 
divided into three groups each as follows: mild, moderate, and advanced. According to 
this classification, mild keratoconus was defined as a TKC classification of abnormal, 
possible, −, and 1. Moderate keratoconus included TKC grade 1 to 2, 2, and 2 to 3, and 
advanced keratoconus included TKC grade 3, 3-pellucid marginal degeneration, 3 to 4, 
and 4.” 
 
3.7.4 Refractive Surgeries Cases  
Some of these clinical data are previously published by Joda et al. and reused in this 
study. 425 
Patients were treated for the correction of myopia or myopic astigmatism at different 
clinics. Inclusion criteria were myopia of fewer than 10 diopters (D) and/or astigmatism 
of less than 5D and a spherical equivalent (SE) higher than 1D but less than 10D. 
Patients with a central corneal thickness (CCT) less than 480µm, abnormal corneal 
topography, patients with glaucoma, glaucoma suspects, and patients receiving IOP-
lowering medications were excluded from the study. The study was thoroughly discussed 
with each patient, and informed consent was obtained from all participants. The study 
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was approved by the local institutional review board and adhered to the tenets of the 
Declaration of Helsinki.  
 
3.7.5 Glaucoma Cases  
These data are previously published by Vinciguerra et al. and reused in this study. 443 
“Patients diagnosed using the criteria described below with Hypertension Glaucoma (HTG), 
Normal Tension Glaucoma (NTG), Ocular Hypertension (OHT) and healthy subjects were 
recruited over a period of 8 months in St Paul’s Eye Unit, Royal Liverpool University Hospital, 
UK. All patients provided informed consent for using their anonymised data in the study prior to 
the study commencement. 
Inclusion criteria  
POAG was defined as open-angle gonioscopy, glaucomatous optic disc and an abnormal visual 
field (VF) consistent with glaucoma confirmed by at least two reliable VF examinations. The 
definition of glaucomatous visual field defect was defined by two glaucoma hemifield tests graded 
“outside normal limits” and a cluster of three contiguous points at the 5% level on the pattern 
deviation plot, using the threshold test strategy with the 24-2 test pattern of the Zeiss-Humphrey 
field analyzer. Patients were divided into HTG and NTG based on an untreated GAT-IOP 
greater or lower than 21 mm Hg. OHT patients were defined as normal VF with an untreated 
GAT-IOP greater than 21 mm Hg, respectively. Healthy controls had an untreated GAT-IOP 
lower than 21 mm Hg, healthy discs and no ocular pathologies. 
Exclusion criteria: 
• Hypermetropia or myopia >5 diopters (D), and/or astigmatism >3 D, best-corrected visual acuity 
<20/40 
• Ocular conditions that could mimic glaucomatous visual field loss, particularly congenital or 
acquired optic nerve diseases, or systemic conditions that could affect ocular blood flow, 
particularly diabetes mellitus and cerebrovascular diseases 
• Previous ocular or intraocular surgery or previous trauma or corneal scarring 
Ophthalmological examination 
All participants underwent an initial complete ophthalmic examination. The OHT group also 
underwent automated perimetry using Humphrey Field Analyzer II (Carl Zeiss Meditec, Jena, 
Germany), with a full threshold 24–2 SITA standard programme. Global visual field parameters, 
including mean deviation (MD) and pattern SD (PSD), were recorded. IOP (mean of 3 
measurements) and central corneal thickness (CCT) (mean of 25 measurements, one touch) were 
recorded using (GAT-IOP, Haag-Streit, Switzerland) and ultrasound pachymetry (DGH 55B 
Pachmate 2, DGH Technologies, Exton, Pennsylvania, USA), respectively, as well as corneal 
biomechanics and IOP measurement using the Corvis-ST. GAT-IOP was adjusted for pachymetry 
(GATAdj) using the manufacturer’s correction algorithm provided with the Pachmate 2, which is 
based on a reference corneal thickness of 545 µm from the work of Kohlhaas et al.444 Corvis 
measurements All measurements with the Corvis-ST (software V.6.08r22) were captured by the 
automatic release on alignment with the corneal apex and were all with ‘OK’ quality score. The 
DCRs used in the study were previously described. 445,446 “ 
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3.7.6 CXL Cases 
Clinical data of patients were collected by different clinics. IRB approval in the form of 
written and informed consent was obtained to use the data in scientific research. The 
study followed the tenets of the Helsinki Deceleration revised in 2013.  
 
Patients with progressive keratoconus were identified from an increase in corneal 
curvature on instantaneous maps of at least 1.00D within the cone area whether 
accompanied by thinning of 20µm in the minimal corneal. These patients were referred 
to CXL and were included in this study. Exclusion criteria included other concomitant 
ocular diseases or the use of eye drops other than artificial tears, presence of central or 
paracentral corneal scars, corneal infection, systemic autoimmune diseases, pregnancy 
or breastfeeding. If both eyes of the same patients were submitted to the procedure, an 
eye was randomly chosen to conduct the analyses. 
 
The data were obtained pre-CXL and at least four weeks after CXL using Corvis ST 
(OCULUS Optikgeräte GmbH; Wetzlar, Germany). The dynamic response parameters 
(DCR), including CCT and IOP values, were recorded and used to perform the 
statistical analysis required for this study. Data were collected using two different Corvis 
ST devices placed at two different centres. To increase the statistical power of the study, 
these data were combined to increase the reliability of the analysis. Also combining these 
data with reducing the biases associated with the data collection and variations between 
devices or technicians. 
3.8 Summary  
This section provided a detailed explanation of the methodology used to conduct this 
research and achieve the research goals. It started by introducing the newly developed 
method that was able to analyse tomography data obtained from commercially available 
devices to provide insights into cone properties in KC patients. It then dived into the 
development of numerical models and validation of models using clinical data. This was 
followed by running a complex parametric study to build the database needed for 
developing equations. After the simulation data were collected, they were analysed, 
DCR parameters were calculated and exported. Then through a new software program 
able to perform multiple optimisation processes, two main equations for bIOP2 and 
SSI2-H were developed. For specific conditions like keratoconus, CXL and those after 
LASIK and SMILE surgeries, further equations were developed to improve the accuracy 
of estimations. Finally, these equations were applied to a large clinical database with 
various eye conditions and experimental tests for validations.   
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4. Results  
 
4.1 Introduction  
This chapter presents the main results produced by the methods and equations 
developed in this project. It starts by characterising cones of clinical cases, finding the 
cone centre locations, evaluating cone characteristics’ (area, height and distance from 
the corneal apex) correlations with disease progression, analysing posterior cone’s and 
establishing a relation between them and the anterior cones. Further analysis is provided 
for exploring cone height and area and the relation between cone characteristics and 
key topographical indices. The information obtained in this part fed into the 
development of numerical models and establishing a range of values used for parametric 
study. Section 4.3 is provided for numerical simulations that include results of the mesh 
density study that led to the optimum model structure. Once the model was developed, 
it was then validated by comparing patient-specific corneal FE models‘ deformations 
under air puff with nine healthy clinical cases, and the results are presented in section 
4.4. 
 
After the model validation and collection of parametric study data, new equations were 
developed to estimate IOP and material stiffness. The newly developed biomechanically 
corrected IOP is called bIOP2. Two bIOP2 equation were developed one for healthy, 
which relies purely on Corvis ST indices and another for keratoconic patients which in 
addition to Corvis ST, requires topographical analysis. This analysis of topography 
should be done using the method introduced in this thesis for the characterisation of 
the cone. Then bIOP2 equations are validated using experimental and clinical data. 
Experimental studies were conducted in a previous study. 104 The data of this study 
enabled a comparison between the new bIOP2 and true IOP values. Then bIOP2 
applied to a large clinical data, including healthy and diseased and those after refractive 
surgery and corneal crosslinking. The bIOP2 values were compared with bIOP and 
Corvis ST uncorrected IOP (CVSIOP) and if available to Goldmann tonometry. This 
section is concluded by applying bIOP2-KC to eight datasets that included keratoconic 
patients, and the values were compared to bIOP2 to demonstrate improvements.  
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In this thesis, a new methodology was followed to develop equations for estimating the 
corneal material stiffness in vivo. This parameter is called Stress-Strain Index 2 (SSI2). 
There are three new equations developed for SSI2 that apply to different conditions. 
The discussion on this is provided in section 5.1.3. Initially, the results of SSI2-H is 
presented when applied to healthy eyes and those who undergo PRK surgery. Then the 
results for SSI2-KC are presented, and this equation was applied to keratoconic patients 
both before and after corneal crosslinking. Finally, the SSI-PLS developed specifically 
for post LASIK and SMILE corneas and evaluated in three different datasets. In all cases, 
the new SSI2 values were compared to previously developed SSI.107 Finally, a brief 
conclusion is provided at the end of this chapter.  
 
4.2 KC Topography  
For the 309 keratoconic patients included in the study, the mean, standard deviation 
and range of age were 33±11 years (9 – 72). The gender and ethnicity of patients were 
not recorded and therefore, not included in this analysis. Among the right eyes, those 
with mild, moderate and severe KC were 102, 130 and 77 respectively, while the 
corresponding numbers for left eyes were 90, 148 and 130. For each eye, the location 
and normal height of the cone centre and the transition zone between the cone-shape 
area and the remaining corneal tissue were estimated using the proposed method. Figure 
4-1 presents a typical example where the cone centre and transition zone (presented by 
a black dot and a dashed line, respectively) are plotted on corneal tangential curvature 
maps and standard elevation maps for both the anterior and posterior surfaces. 
 
Figure 4-1 Location of cone centre and transition zone estimated using the proposed method for the left 
eye of a 29-year-old patient with moderate keratoconus. The results are plotted on tangential curvature 
maps (A, B) and maps of elevation relative to the optimal sphere (C, D). 
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4.2.1 Cone Characteristics   
The results showed a mirror symmetry between right and left eye groups. Whereas in 
the right eyes, 76% and 82% of anterior and posterior cone centres were located in the 
temporal-inferior quadrant, respectively, the corresponding figures in the left eyes were 
82% and 84%. The posterior cone centre was superiorly located relative to the anterior 
cone centre by 0.119±0.216 mm in right eyes and 0.096±0.227 mm in left eyes 
(p=0.070). The areas of the cone in the right and left eyes were also similar; with values 
of 7.36±2.27mm2 (0.01 – 12.54) and 7.21±2.22 mm2 (1.13 – 12.54), respectively 
(p=0.051). The cone centre heights were also similar in right and left eyes at 
36±22 um (2 – 107) and 37±23 um (3 – 129), p= 0.559, in anterior surfaces and 
74±44 um (8 – 244) and 75±45 um (5 – 243), p= 0.619, in posterior surfaces. The results 
further demonstrate consistently that posterior cone height was larger than anterior 
cone height in 90% of cases and by 37±24 um (0 – 158) on average. On the other hand, 
the cone area presented was larger on the anterior surface (7.77±3.07 mm2) than on the 
posterior surface (7.26±3.92 mm2, p< 0.001) 
 
4.2.2 Cone Centre Location  
Considering only the majority of the cones, which are located in the temporal-inferior 
quadrant, the anterior cone centre was located at 1.019±0.403 mm (0.1 – 1.8) on the 
inferior side and 0.663±0.434 (0.1 - 1.8) mm on the temporal side of the left eyes and 
located at 0.939±0.388 (0.1 – 1.7) mm on the inferior side and 0.683±0.424 (0.1 – 1.8) 
mm on the temporal side of right eyes. In posterior surfaces, the cone centre was located 
at 0.938±0.344 (0.2 – 1.6) mm towards the inferior side and 0.610±0.359 (0.1 – 1.4) 
mm towards the temporal side in left eyes and at 0.813±0.345 (0.2 – 1.5) mm towards 
the inferior side and 0.734±0.371 (0.1 – 1.5) mm towards the temporal side in right 
eyes, Figure 4-2.  
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Figure 4-2 Frequency of cone centre location in (A) anterior surfaces of right eyes, (B) anterior surfaces of 
left eyes, (C) posterior surfaces of right eyes, and (D) posterior surfaces of left eyes 
 
The results further show a strong correlation between the locations of cone centres on 
the anterior and posterior surfaces (p< 0.001). This correlation could be used to estimate 
the shifts between the two cone centres using the relationship used in chapter three, 
Equation 3-5 and Equation 3-6.  
 
4.2.3 Correlation between Cone Characteristics and Disease Severity  
The results showed evidence that with increased disease severity, the distance from 
corneal apex to cone centre reduced (p< 0.001, R= -0.312), while cone height increased 
(p< 0.001, R=0.716). On the other hand, the cone area did not show statistically 
significant differences among the disease stages (p= 0.002, R= -0.092), Figure 4-3. 
 
In vivo Measurement of Corneal Stiffness and Intraocular Pressure to Enable Personalised Disease Management and Treatment | 84 
 
 
84 | P a g e  
 
 
Figure 4-3 Mean, standard deviation, minimum and maximum values of distance from cone centre to corneal apex (left column), cone height (middle column) and area of 
cone (right column) for eyes with mild KC (left = 90, right = 102), moderate KC (left = 148, right = 130) and advanced KC (left = 71, right = 77). Results are presented 
for anterior and posterior surfaces of right and left eyes. 
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4.2.4 Posterior Cone Height in Relation to Anterior Cone 
The results also show strong correlation between anterior cone height and posterior 
cone height (p< 0.001, R = 0.784 for right eyes and p< 0.001, R= 0.774 for left eyes). 
This strong correlation was evident when combining all the data or considering data 
separately for eyes with different KC severity extents, Figure 4-4. The relationship 
between the two cone heights follows the relationship used in chapter three, Equation 
3-4 
 
Figure 4-4 Correlation between anterior cone height and posterior cone height when considering all data 
(Note: the y axis is the extra change in the posterior cone height in comparison to the anterior cone height) 
4.2.5 Correlation of Cone Height and Pathology Area with Radius of 
Optimum Sphere 
The results show a significant correlation between the cone height and radius of the 
optimum sphere for anterior surfaces (R= - 0.584, p< 0.001) and posterior surfaces 
(R = - 0.568, p< 0.001) in all eyes. Meanwhile, there was no significant correlation 
between the area of pathology and the radius of the optimum sphere (obtained from 
sphere fitting to the cornea without the cone) for both anterior surfaces (R =0.012, 
p =0.769) and posterior surfaces (R =0.003, p= 0.945), Figure 4-5.  
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Figure 4-5 Correlation of cone height and pathology area with the radius of the sphere of optimal fit for 
both anterior and posterior surfaces 
4.2.6 Evaluation of Cone Properties with Pentacam Indices 
The correlations of cone height, cone area and distance from corneal apex to cone centre 
with age and key Pentacam parameters were explored in   
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Table 4-1, and showed similar results in the right and left eyes. As expected, cone height 
and location were not correlated with age in both right and left eyes and both corneal 
surfaces (p> 0.11). On the other hand, cone height was strongly correlated with almost 
all tomographic parameters, especially the BAD-D, KMax and EleFBFS8mm (R>0.9). 
The distance to the corneal apex, as expected, showed a negative correlation with central 
metrics like central asphericity and CKI (R<-0.6).   
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Table 4-1 Correlation between distance from corneal apex to cone centre, cone area and cone height with 
Pentacam parameters (p values that indicate significant correlation are highlighted in green). 
Pentacam 
Parameters 
Right eyes Left eyes 















































) BADD -0.355 0 -0.462 0 -0.347 0 -0.459 0 
Pachy 0.166 0.003 0.306 0 0.201 0 0.324 0 
Age 0.102 0.074 -0.049 0.387 0.041 0.475 0.031 0.593 
AstigD -0.024 0.672 -0.098 0.084 0.091 0.109 -0.041 0.476 
EleBFS8mm -0.237 0 -0.254 0 -0.161 0.005 -0.194 0.001 
Kmax -0.405 0 -0.469 0 -0.466 0 -0.542 0 
AsphQ 0.645 0 0.634 0 0.727 0 0.732 0 
ISV -0.255 0 -0.336 0 -0.255 0 -0.327 0 
IVA -0.091 0.11 -0.158 0.005 -0.084 0.142 -0.138 0.015 
KI -0.227 0 -0.279 0 -0.244 0 -0.297 0 
CKI -0.637 0 -0.636 0 -0.718 0 -0.724 0 
IHA 0.001 0.987 -0.023 0.685 -0.164 0.004 -0.202 0 












BADD 0.898 0 0.961 0 0.903 0 0.965 0 
Pachy -0.549 0 -0.587 0 -0.528 0 -0.564 0 
age 0.071 0.214 0.094 0.118 0.033 0.56 0.088 0.141 
AstigD 0.594 0 0.553 0 0.555 0 0.486 0 
EleBFS8mm 0.926 0 0.886 0 0.922 0 0.887 0 
Kmax 0.895 0 0.882 0 0.862 0 0.833 0 
AsphQ -0.636 0 -0.644 0 -0.471 0 -0.507 0 
ISV 0.96 0 0.911 0 0.97 0 0.913 0 
IVA 0.863 0 0.794 0 0.902 0 0.832 0 
KI 0.892 0 0.835 0 0.904 0 0.853 0 
CKI 0.721 0 0.72 0 0.629 0 0.644 0 
IHA 0.366 0 0.339 0 0.302 0 0.279 0 










) BADD -0.174 0.002 -0.158 0.008 -0.123 0.031 -0.025 0.671 
Pachy 0.104 0.069 0.077 0.196 0.054 0.347 0.015 0.802 
age 0.163 0.004 0.032 0.593 0.158 0.005 0.133 0.025 
AstigD -0.141 0.013 -0.132 0.027 -0.115 0.044 -0.031 0.602 
EleBFS8mm -0.121 0.034 -0.118 0.047 -0.083 0.145 0.033 0.577 
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Kmax -0.192 0.001 -0.103 0.085 -0.19 0.001 0.007 0.908 
AsphQ 0.103 0.071 -0.024 0.692 0.182 0.001 -0.052 0.383 
ISV -0.168 0.003 -0.088 0.142 -0.108 0.059 0.043 0.469 
IVA -0.173 0.002 -0.117 0.05 -0.107 0.061 0.025 0.68 
KI -0.121 0.034 -0.054 0.366 -0.089 0.118 0.039 0.513 
CKI -0.12 0.036 -0.005 0.935 -0.136 0.017 0.069 0.249 
IHA -0.103 0.072 -0.139 0.02 -0.127 0.026 -0.085 0.152 
IHD -0.248 0 -0.183 0.002 -0.176 0.002 -0.053 0.37 
 
 
4.3 Numerical Simulation  
4.3.1 Element Type  
In this study, two identical models with the only difference of element types were 
compared. Under air puff pressure, the 6-noded models with 5 and 15 corneal rings 
converged successfully. Models with 25, 35 and 45 corneal rings crashed during the 
simulation at different time points. Models with 15-noded elements converged in all 
cases. The details of these results are provided in section 4.3.3. 
 
4.3.2 Corvis ST Pressure 
The mean and standard deviation of Corvis ST pressure in 280 clinical cases were 
calculated. The pressure applied to the cornea was the mean pressure values at the nozzle 
that was reduced by 50%, as shown in Figure 4-6.  
 
Figure 4-6 the mean and standard deviation of 280 cases and the pressure applied on the cornea 
4.3.3 Mesh Density Study  
Corneal rings were varied from 5 to 45 rings. Apex deformation under air puff with 10 
to 45 rings produced similar results in 15-noded elements, Figure 4-7. The average 
corneal deformation under air puff for these cases were 798.2 ± 3 microns. The model 
In vivo Measurement of Corneal Stiffness and Intraocular Pressure to Enable Personalised Disease Management and Treatment | 90 
 
 
90 | P a g e  
 
with ten rings was found to be closest to this value with a difference of only 2.3 microns, 
and this was the number of corneal rings selected for this study. This model could run 
in 16 minutes.   
 
  
Figure 4-7 Mesh convergence study for cornea showing the deformation of apex under air puff pressure 
(left) and the computational time for corresponding rings (right) 
The mesh convergence study for sclera followed a similar path to the cornea; the sclera 
rings were varied from 10 to 50, Figure 4-8. As can be seen from the deformations of 
the corneal apex, changes in sclera rings did not have a significant effect on the 
deformation of the cornea under air puff. The average value for this deformation was 
795.7 ± 0.2 microns, and the closest model to this number had ten rings with a 
0.2 microns difference. Hence the 10 rings model was selected for sclera in this study, 
and it reduced the simulation time to 3 minutes.  
  
Figure 4-8 Mesh convergence study for sclera showing the deformation of the apex under air puff (left) and 
the time of simulation for corresponding rings (right) 
When four and six segmented models were compared, no differences were found in 
corneal apex deformation throughout the simulation for both inflation and air pressure. 
The model with six segments took 2.7 minute, whereas four-segment models due to 
having fewer elements could run in 1.8 minutes. Hence the optimum mesh for the 
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4.4 Validation of Numerical Models 
To validate the performance of numerical models and ensure they are representative of 
clinical data, nine healthy cases were tested. The demographics for these patients were 
provided in the methodology chapter section 3.4.1. The material stiffness of the cornea 
and sclera was adjusted based on the age of the patient and IOP was accordingly set as 
measured in the clinic. All models showed good agreement with clinical data, as shown 
in Figure 4-9. The RMS for these nine cases were found to be 31 ± 8 (20 - 45) microns 
across the 8 mm profile. Due to the stress-free process and the use of Pentacam 
topographies for each patient, the initial profile after inflation and before the start of air 
puff perfectly matched the clinical data.  
 
Figure 4-9 Comparison of numerical and clinical data for nine healthy corneas showing the deformation 
under air puff at the initial profile and highest concavity. The error presented above each plot is referring 
to the root mean squared of the deformation (mm) error across the full profile. 
4.5 Equations   
This section provides the results of applying methods developed in chapter three to 
clinical data. It starts with the bIOP2 equation in comparison to bIOP, CVSIOP and 
GAT. Then the comparison between bIOP2 and bIOP2-kc are provided. In terms of 
SSI2, all three equations were compared with SSI in healthy, KC, CXL and refractive 
surgery data. The aim of this section is to demonstrate that the bIOP2 has a weak 
correlation with CCT and age while SSI2 has a weak correlation with CCT and IOP with 
an increased correlation with age. This is the standard method of evaluation for IOP 
and material stiffness measurement methods in the literature.  
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4.5.1 Biomechanically Corrected IOP (bIOP2) 
Two IOP equations were developed in this study, bIOP2 for healthy eyes which uses 
information collected from Corvis ST and bIOP2KC. The latter requires elevation data 
to be analysed, as described in section 4.2 and incorporates cone properties into the 
equations. The first section applies bIOP2 for healthy eyes on various clinical data. The 
second section explores bIOP2KC equation in comparison to bIOP2 in the KC 
database.  
 
4.5.1.1 bIOP2 Healthy Equation 
The bIOP2 equation for healthy eyes relies purely on parameters obtained from Corvis 
ST. This section applies this equation to various datasets, including KC eyes to evaluate 
its performance. The parameters presented in Equation 4-1 showed to be able to 
compensate for biomechanical and geometrical changes while estimating the IOP and 
hence they were selected for this equation.  
 
𝑏𝐼𝑂𝑃2 =  𝑓(𝐶𝐶𝑇, 𝐴𝑔𝑒, 𝐴𝑃1, 𝑃𝐷, 𝐻𝐶𝑅, 𝐷𝑒𝑓𝐴𝑚𝑝𝑀𝑎𝑥, 𝐴1𝑉, 𝐷𝑒𝑓𝑙𝐴𝑚𝑝𝐴1, 𝐻𝐶𝑇) 
Equation 4-1 
where CCT is the central corneal thickness (microns), AP1 is the pressure at applanation 
one (mmHg), PD is the Peak Distance (mm), HCR is the radius at highest concavity 
(mm), DeflAmpMax is the deflection amplitude maximum (mm), A1V is the velocity at 
applanation one (m/s), DeflAmpA1 is the deflection amplitude at applanation one (mm) 
and HCT is the time at highest concavity (ms). 
 
4.5.1.1.1 Experimental Validation 
The experimental study was done in a previous study, and the data was available to 
evaluate the performance of bIOP2, 447. The purpose of this is to demonstrate how the 
IOP values measured from ex-vivo human eyes using Corvis ST compare to the true IOP 
that was set in strict laboratory conditions. In cases where CCT was above 600, the error 
in CVSIOP significantly increased, whereas in bIOP and bIOP2 there were no sudden 
changes in estimations. The average error in prediction of true IOP in percentage for 
CVSIOP found to be the highest 36 ± 37 (-3 - 155)% and consistently overestimating 
the true IOP. This was followed by bIOP where the error was - 1 ± 1 ( - 3 - 19) % and 
bIOP2 with the error of 0 ± 4 (-6 - 15)%. Both bIOP and bIOP2 had underestimation 
and overestimation of IOP values with minimal standard deviations. Although bIOP2 
overall performed better in predictions, the standard deviation of errors was smaller in 
bIOP results. No significant differences were found between both bIOP (p=0.989) and 
bIOP2 (p=0.976) with true IOP. CVSIOP was significantly different (p < 0.001) from 
the true IOP.  The detailed comparisons of the findings are provided in Table 4-2.  
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4.5.1.1.2 Healthy Patients 
For brevity, only one of the datasets is presented in this section. A similar analysis was 
conducted on other datasets and results are available in Appendices, Section A.   
 
Dataset 1 
Dataset 1 includes 528 healthy patients with mean age of 39.9 ±16.8 (7.0 -91.0) years 
and CCT of 537 ±33 (444 -635) microns. The mean IOP values obtained from CVSIOP, 
bIOP and bIOP2 were 15.0 ±2.7 (6.0 -29.0) mmHg, 14.4 ±2.3 (9.1 -23.9) mmHg and 
15.4 ±1.3 (12.4 -22.6) mmHg, respectively. bIOP2 was least correlated with CCT 
(p:0.285, R:-0.047) and age (p:0.050, R:0.085). bIOP performed better in correlation 
with CCT ( p:0.139, R:-0.064) than CVSIOP (p:0.000, R:0.345). CVSIOP showed 
weaker correlation (p:0.011, R:0.111) with age in comparison to bIOP (p:0.004, 
R: - 0.124), Figure 4-10.  
 
 
Figure 4-10 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Dataset 1 
Summary of Results 
bIOP2 was applied to 7 datasets with a total of 2117 healthy patients. Each dataset was 
obtained from a different clinic, located in various parts of the world. Specific details 
remain confidential based on the agreement in place with the device manufacturer and 
BioEG. The bIOP showed a weak correlation with CCT in the majority of these datasets. 
Although small improvements were achieved by bIOP2 in regards to CCT, it is not 
significant. Interestingly in six datasets, bIOP showed negative correlations with age 
whereas bIOP2 remained insignificant in all seven datasets. The overall comparison 
showed the correlation with CCT (p:0.986, R:-0.000) and age (p:0.981, R:-0.001) was 
weakest in bIOP2. bIOP showed weaker correlation with CCT (p:0.972, R:-0.001) 
CVSIOP       bIOP         bIOP2 
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compared to CVSIOP (p:0.000, R:0.367). In terms of correlation with age, CVSIOP 
(p:0.122, R:-0.034) performed better than bIOP (p:0.000, R:-0.196). 
 
4.5.1.1.3 Comparison between GAT, DCT, ORA and Corvis ST 
This dataset consists of 422 healthy patients with a mean age of 27.114±5.513 (17-42) 
years, CCT of 543±28 (474-630) microns, DCT IOP of 17.2±2.7 (10.3-28.1) mmHg, 
GAT IOP of 13±2.2 (6.5-18.5) mmHg, ORA IOPg of 14.7±2.7 (7.3-23.3) mmHg, ORA 
IOPcc of 15.4±3.5 (8.5-66.5) mmHg, CVSIOP of 14±1.9 (8.8-20.8) mmHg, bIOP of 
13.7±1.7 (9.4-19.1) mmHg and bIOP2 of 14.9±1 (12.7-18.9) mmHg. The results of the 
correlation analysis are provided in Table 4-3. It is clear that all measurements are 
influenced by age apart from bIOP2 and all measurements are influenced with CCT 




Figure 4-11 Correlation between DCT, GAT, ORA and three Corvis ST IOP measurements with age 
and CCT 
 
Table 4-3 The correlation between various IOP measurements and tonometry devices with CCT and age 
 Age (year) CCT (microns) 
DCT IOP (mmHg) R: -0.124, p: 0.012 R: 0.274, p < 0.01 
GAT IOP (mmHg) R: -0.120, p: 0.015 R: 0.264, p < 0.01 
ORA IOPg (mmHg) R: -0.151, p < 0.01 R: 0.452, p < 0.01 
ORA IOPcc (mmHg) R: -0.152, p < 0.01 R: 0.189, p < 0.01 
CVSIOP (mmHg) R: -0.143, p < 0.01 R: 0.401, p < 0.01 
bIOP2 (mmHg) R: -0.034, p: 0.497 R: -0.071, p: 0.150 
bIOP (mmHg) R: -0.138, p < 0.01 R: 0.017, p: 0.726 
CVSIOP       bIOP         bIOP2 
DCT       IOPg         IOPcc 
GAT 
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Summary of Results 
A comparison was conducted between different tonometers in 422 healthy eyes. In this 
study GAT, DCT, ORA and Corvis ST were used on patients. From ORA, two IOP 
values of IOPg and IOPcc were exported, and from Corvis ST three IOP values for 
CVSIOP, bIOP and bIOP2 were exported. In this study, all devices apart from Corvis 
ST showed significant correlations with age and CCT. Among Corvis ST values, 
CVSIOP was significantly correlated with both age and CCT. The correlation with CCT 
was not significant for both bIOP (R: 0.017, p: 0.726) and bIOP2 (R: -0.071, p: 0.150). 
In regards to age, bIOP2 (R: -0.034, p: 0.497) was the only parameter that showed no 
correlation. This study showed that with the use of bIOP2, Corvis ST becomes the only 
device able to estimate IOP values that are least influenced by corneal biomechanics and 
geometrical variations between patients. 
 
 
4.5.1.1.4 Refractive Surgeries 
For brevity, only one of the datasets is presented in this section. A similar analysis was 
conducted on other datasets and results are available in Appendices, Section A.   
 
Dataset 1 - LASIK 
Dataset 1 includes 52 patients who undergo LASIK surgery with mean age of 
36.8 ± 6.7 (26.0 - 47.0) years, CCT of 543 ± 36 ( 473 - 611) microns, CVSIOP of 
15.2 ± 3.2 (10.5 - 28.5) mmHg, bIOP of 14.8 ±  2.4 (  11.6 -  25.2) mmHg and bIOP2 
of 15.7 ± 1.5 (13.5 - 22.0) mmHg.  The correlation with age was weak for CVSIOP 
(R:0.196, p:0.159), bIOP (R:0.088, p:0.532) and bIOP2 (R:0.235, p:0.090). CCT 
correlation was the weakest for bIOP2 (R:0.063, p:0.656) followed by bIOP (R:0.253, 




Figure 4-12 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in pre-surgery LASIK Dataset 1 
Demographics for post-operative data showed mean age of 37.1 ±  6.9 (27 - 48) years, 
CCT of 481 ±  33 ( 409 - 537) microns, CVSIOP of 11.6 ± 1.7 (7.5 - 14.5) mmHg, bIOP 
of 12.9 ± 1.5 (9.6 - 16.0) mmHg and bIOP2 of 15.3 ±   1.0 (  13.0 -  17.2) mmHg. The 
CVSIOP       bIOP         bIOP2 
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Wilcoxon signed-rank test showed no significant differences between pre and 
post- surgery measurements of bIOP2 (p:0.088), whereas both bIOP (p=0.000) and 
CVSIOP (p=0.000) were significantly different. The correlation remained weak with age 
for CVSIOP (R:0.223, p:0.109), bIOP (R:0.043, p:0.760) and bIOP2 (R:-0.005, 
p:0.973). The correlation with CCT was weakest for bIOP (R:-0.090, p:0.520) followed 
by bIOP2 (R:-0.127, p:0.364) and CVSIOP (R:0.164, p:0.240), Figure 4-13.  
 
 
Figure 4-13 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in post-surgery LASIK Dataset 1 
To better evaluate the differences between pre and post-refractive surgery data, Bland 
Altman plots were produced for each measurement method, Figure 4-14. Among all 
data, bIOP2 had the least differences in mean IOP values between pre and post with 
only 0.42 mmHg and the smallest standard deviation. This was followed by bIOP with 
differences of 1.9 mmHg and CVSIOP with differences of 3.6 mmHg.  
 
(A) 
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Figure 4-14 The Bland Altman plots for (A) bIOP, (B) bIOP2 and (C) CVSIOP comparing the pre and 
post IOP values in LASIK Dataset 1 
Dataset 1 - SMILE 
Dataset 1 includes 82 patients who undergo SMILE surgery with mean age of 
34.8 ± 7.7 (22.0 - 51.0)  years, CCT of 541 ±33 (480-642) microns, CVSIOP of 
14.5 ± 2.4 (9.0 - 25.5) mmHg, bIOP of 14.3 ± 2.0 (9.6 -  21.1) mmHg and bIOP2 of 
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15.6  ± 1.3 (13.2 - 19.6) mmHg. The correlation with age was weak for CVSIOP 
(R:0.062, P:0.577), bIOP (R:0.062, P:0.581) and bIOP2 (R: 0.144, P:0.197). CCT 
correlation was the weakest for bIOP (R:-0.017, P:0.880) followed by bIOP2 (R:-0.132, 




Figure 4-15 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in pre-surgery SMILE Dataset 1 
Demographics for post-operative data showed mean age of 35.2 ±7.5 (22.0 -51.0) years, 
CCT of 444 ±  39 (351-545)  microns, CVSIOP of 10.3 ± 2.2 (5.5 - 15.0) mmHg, bIOP 
of 12.3 ±2.0 (8.1 -16.1) mmHg and bIOP2 15.7 ± 0.8 (12.5 -18.6) mmHg. The Wilcoxon 
signed-rank test showed no significant differences between pre and post-surgery 
measurements of bIOP2 (p:0.278), whereas both bIOP (p=0.000) and CVSIOP 
(p=0.000) were significantly different post-surgery. The correlation remained weak with 
age for CVSIOP (R:0.122, P:0.274), bIOP (R:0.021, P:0.854) and bIOP2 (R:0.090, 
P:0.421). The correlation with CCT was weakest for bIOP (R:0.111, P:0.320) followed 
by bIOP2 (R:-0.154, P:0.167) and CVSIOP (R:0.217, P:0.051), Figure 4-16.  
 
 
Figure 4-16 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in post surgery SMILE Dataset 1 
To better evaluate the differences between pre and post-refractive surgery, Bland Altman 
plots were produced for each IOP measurement method, Figure 4-17. Among all data, 
bIOP2 had the least differences in mean IOP values between pre and post with only 
0.14 mmHg and the smallest standard deviation. This was followed by bIOP with 
differences of 2.0 mmHg and CVSIOP with differences of 4.2 mmHg.  
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Figure 4-17 The Bland Altman plots for (A) bIOP, (B) bIOP2 and (C) CVSIOP comparing the pre and 
post IOP values in SMILE Dataset 1 
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Summary of Results 
IOP values were calculated in 4 different refractive surgery datasets. Each dataset was 
from a different clinic, different device and different country. The details of clinics must 
remain confidential, and they were only provided by Oculus for the development of new 
equations. In these datasets that included LASIK, SMILE and PRK surgeries, the IOP 
values pre and postoperatively were compared. Further, the correlations with CCT and 
age were evaluated for pre-op separate from the postoperative data. In these datasets, 
CCT significantly reduced after surgery which would enable assessment of the influence 
of change in geometrical components on the same patient while isolating biomechanical 
changes.  
 
In Dataset one, there was no correlation between CCT and age in bIOP and bIOP2 
measurements for pre and post LASIK and SMILE groups. Only bIOP2 values remained 
insignificant when compared to postoperative measurements for SMILE (p:0.278) and 
LASIK (p:0.088). Comparison in Bland Altman plots showed the mean differences (post 
minus pre) of 0.14±2.3 mmHg for bIOP2, -2.0±4.3 mmHg for bIOP and 
- 4.2±5.0 mmHg for CVSIOP. That indicates significant improvements in bIOP2. In 
Dataset two, weak or no correlations were observed with CCT and age for both bIOP 
and bIOP2. In PRK group bIOP (p:0.632) showed no significant changes between pre 
and post-surgery measurements. Looking closely at Bland Altman plots, the mean 
difference for bIOP of -0.12±4.2 mmHg and for bIOP2 of 0.47±2.1 mmHg and for 
CVSIOP of -2.9±5.2 mmHg could be observed. This clearly highlights that although 
changes in bIOP2 were significant, the differences are less than 0.5 mmHg and in fact, 
bIOP2 improved on standard deviations and provided estimations with more stability. 
In LASIK (p:0.153) and SMILE (p:0.795) groups, bIOP2 was the only measurement 
method with no statistically significant differences with smallest means and standard 
deviations when pre and post data were compared.  
 
Dataset 3 included all three surgeries in addition to longitudinal data at 1, 3 and 
6 months postoperatively. This provided a unique opportunity to evaluate the 
performance of different IOP measurement methods over a more extended period of 
time. The CCT was reduced to around 100 microns on average for each patient. 
CVSIOP showed significant correlations with CCT in PRK and LASIK groups and no 
significant correlations in SMILE groups. bIOP showed no significant correlations with 
CCT in all three datasets and bIOP2 no significant correlation in preop data and some 
correlations with postoperative data in all groups. In PRK and LASIK, in all cases, 
bIOP2 was significantly correlated with CCT postoperatively while in SMILE group 
showed no significant correlations at six months data. Age was weakly correlated with 
all three measurement methods and in all cases. Looking closely at changes between the 
three methods CVSIOP reduced by 3.7+2.0(-5.7 - 9.0) mmHg after surgery while this 
value for bIOP was 1.4+1.8(-8.3 - 6.3) mmHg and for bIOP2 it increased by 
0.5+0.9 (- 5.4 - 3) mmHg. This clearly showed that the bIOP2 values are less influenced 
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by geometrical changes and improved on both mean differences and significantly on 
standard deviations which are nearly half of the bIOP values. The statistical comparisons 
showed significant differences between pre and post IOP values for all measurements in 
all groups.   
 
4.5.1.1.5 CXL Data 
For brevity, only one of the datasets is presented in this section. A similar analysis was 
conducted on other datasets and results are available in Appendices, Section A.   
 
Dataset 1 
Dataset 1 includes 16 KC patients before and after CXL. Post CXL data divided into 
two groups, early (around One month after surgery) and late (3-6 months after surgery). 
The mean age was 31.1 ± 12.3 (18 - 62) years with CCT of 483 ± 47 (360 - 557) microns. 
Before surgery CVSIOP, bIOP and bIOP2 measurements were  
12.3 ± 2.8 (5.5 - 16)  mmHg, 13.7 ± 2.6 (7.4 - 18) mmHg and 16.0 ± 1.3 (14.3 - 19.0) 
mmHg respectively. There was no significant correlation with CCT for CVSIOP 
(R: 0.3536 ,p: 0.1791), bIOP (R: 0.0904,p: 0.7393), bIOP2 (R:-0.3031, p: 0.2537). 
Similarly no significant correlation was found with age for CVSIOP (R: -0.0215, 
p: 0.9370 ), bIOP (R: -0.0050 ,p: 0.9854) and bIOP2 (R: 0.3727 ,p: 0.1551), Figure 4-18.  
 
Figure 4-18 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Pre CXL Dataset 1 
In early group, CCT was 461 ± 50 (328 - 518) microns, CVSIOP 14.2±3.1 (8.0 - 20.5) 
mmHg, bIOP 15.8 ± 2.8 (10.6 - 21.7) mmHg and bIOP2 17.1 ± 1.4 (15.2 - 20.7) mmHg. 
The correlation with CCT was significant for CVSIOP (R: 0.6357, p: 0.0081 ) and on 
border line for bIOP(R: 0.4470 , p: 0.0826 ) and not significant for bIOP2 (R: 0.1331, 
p: 0.6232). The correlation with age was not significant for CVSIOP (R: -0.0046, 
p: 0.9864), bIOP (R: -0.1691, p: 0.5313) and bIOP2 (R 0.0105, p: 0.9691), Figure 4-19. 
CVSIOP       bIOP         bIOP2 
In vivo Measurement of Corneal Stiffness and Intraocular Pressure to Enable Personalised Disease Management and Treatment | 104 
 
 




Figure 4-19 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in early post CXL Dataset 1 
 
In the late group, CCT was 468.7±52.1 (351 -559) microns, CVSIOP 
13.19±2.95 (9.00 - 20.50) mmHg, bIOP 14.71±2.67 (10.20 -21.10) mmHg and EIOP 
16.01±1.43(12.65 -19.44) mmHg. The correlation with CCT was not significant for 
CVSIOP (R: 0.4202, p: 0.0579), bIOP(R: 0.1618, p: 0.4834) and bIOP2 (R: -0.1868, 
p: 0.4176). The correlation with age was not significant for CVSIOP (R: -0.0646, 
p: 0.7807), bIOP (R: - 0.0374, p: 0.8723) and bIOP2 (R: 0.1991, p: 0.3868), Figure 4-20. 
Comparison of pre and post values are showen in Table 4-4 
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Figure 4-20 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in late post CXL Dataset 1 
 
 
Table 4-4 The differences between IOP values for CVSIOP, bIOP and bIOP2 for early and late post CXL 


































Summary of Results 
Evaluation of IOP values was also done on four different crosslinking datasets from 
different clinics and different countries. In all these data, both bIOP and bIOP2 showed 
no significant correlations with CCT and age. In dataset one for early data which was 
collected around one month post-op, all three methods showed significant differences 
with the pre IOP measurements while this was inversed for late (3 months or more) 
results. Similarly, dataset two showed no significant differences between pre and post 
IOP values for all methods. In dataset three, only bIOP2 was not significant, and in 
dataset four, all methods were significantly different. In all datasets, bIOP2 significantly 
improved on mean and standard deviations compared to bIOP when pre and post IOP 
values were compared. For instance, in dataset four, mean differences for bIOP2 was 
1.2 ± 1.6 (-5 - 2.6) mmHg while bIOP was 2.5±3 (-12.6 - 2.9) mmHg. In dataset three 
the mean bIOP2 was 0.59± 1.18 (-2.69 - 1.9) mmHg while bIOP was 1.56 ± 2.07 (-6.3 - 
1.2) mmHg. 
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4.5.1.1.6 Glaucoma Patients 
Dataset 1 
Dataset 1 includes 111 patients with Hypertension Glaucoma (HTG) with mean age of 
72.3 ±9.7 (38.0 -91.0) years, CCT of 523 ±31 (451 -597) microns, CVSIOP of 15.7 ±4.0 
(10.0 - 31.5) mmHg, bIOP of 14.6 ±3.3 (9.8 -26.4) mmHg and bIOP2 of 15.5 ±2.1 
(11.4 - 22.6) mmHg. The correlation with CCT was significant with CVSIOP (p:0.000, 
R:0.331) and insignificant with bIOP (p:0.243, R:0.112) and bIOP2 (p:0.199, R:0.123). 
Age was not significantly correlated with CVSIOP (p:0.702, R:-0.037), bIOP (p:0.543, 
R:-0.058) and bIOP2 (p:0.236, R:-0.114), Figure 4-21. 
 
 
Figure 4-21 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in HTG group of Dataset 1 
Furthure, this dataset included 122 patients with Ocular Hypertension (OHT) with 
mean age of 65.1 ±11.2 (34.0 -86.0) years, CCT of 552 ±37 (476 -640) microns, CVSIOP 
of 19.0 ±4.0 (11.5 -30.5) mmHg, bIOP of 16.9 ±3.7 (9.0 -29.0) mmHg and bIOP2 of 
17.4 ±2.3 (12.5 -23.8) mmHg. The evaluation of bIOP (p:0.007, R:-0.243) showed 
significant correlation with CCT. CCT was not significantly correlated with EIOP 
(p:0.080, R:-0.159) and CVSIOP (p:0.447, R:0.069). Correlation with age was not 
significant with CVSIOP (p:0.912, R:-0.010), bIOP (p:0.413, R:-0.075) and bIOP2 
(p:0.157, R:-0.129), Figure 4-22. 
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Figure 4-22 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in OHT group of Dataset 1 
Summary of Results 
Two different datasets were used with patients who had Hypertension Glaucoma 
(HTG), Ocular Hypertension (OHT) and Normal-Tension Glaucoma (NTG). In dataset 
one, bIOP2 was not correlated with age and CCT while bIOP showed correlations with 
CCT in the HTG group. The mean values for CVSIOP of 15.7 ±4.0 (10.0 - 31.5) mmHg, 
bIOP of 14.6 ±3.3 (9.8  - 26.4) mmHg and bIOP2 of 15.5 ±2.1 (11.4 - 22.6) mmHg 
showed that in HTG group bIOP had the lowest and CVSIOP had the highest values. 
Similarly in OHT mean CVSIOP of 19.0 ±4.0 (11.5 -  30.5) mmHg, bIOP of 16.9 ± 3.7 
(9.0 - 29.0) mmHg and bIOP2 of 17.4 ±2.3 (12.5 -23.8) mmHg showed similar trends. 
In the second dataset where GAT was also available, bIOP2 consistently did not have a 
significant correlation with both CCT and age in NTG, HTG and OHT groups. 
Whereas bIOP showed some correlation with CCT in the NTG group. In NTG group, 
the mean bIOP of 12.9 ±2.3 (8.9 - 18.3) was the lowest IOP values and followed by 
CVSIOP of 13.4 ±2.4 (8.5 - 17.5), GAT of 13.7 ±1.0 (12.3 -16.6), bIOP2 of 14.4 ±1.0 
(12.3 - 16.6) and AdjGAT of 16.3 ±1.0 (12.3  - 16.6). In HTG, GAT and AdjGAT had 
the highest values and bIOP the lowest values while bIOP2 15.8 ±1.9 (13.0  - 22.6) 
stayed in between. A similar trend was observed in the OHT group, where bIOP2 was 
17.6 ±2.4 (13.6 - 23.8). These results showed that bIOP2 values were higher than bIOP 
and lower than CVSIOP while GAT is sometimes higher and sometimes lower than 
bIOP2.  
 
4.5.1.1.7 Keratoconus Patients  
For brevity, only one of the datasets is presented in this section. A similar analysis was 
conducted on other datasets and results are available in Appendices, Section A.   
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Dataset 1 
Consist of 255 KC patients with mean age of 34.8 ±12.7 (13.0 -83.0) years, CCT of 
481 ± 38 (353 -579) microns, bIOP of 13.9 ±2.4 (6.1 -20.2) mmHg, CVSIOP of 
12.6 ± 2.5 (4.5 -20.5) mmHg and bIOP2 of 15.5 ±1.1 (13.0 -19.0) mmHg. Correlations 
with bIOP (p:0.030, R:-0.145), CVSIOP (p:0.010, R:0.172) and bIOP2 (p:0.001, 
R:- 0.228) were significant with CCT. There was no significant correalitons with age for 
bIOP (p:0.501, R:-0.045), CVSIOP (p:0.155, R:0.095), bIOP2 (p:0.092, R:0.113), 
Figure 4-23.  
 
Figure 4-23 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in KC Dataset 1 
Comparison of healthy bIOP2 with different groups (based on disease severity) showed 
no significant differences with FFKC (p: 0.8839), Mild (p: 0.9854), Moderate (p: 0.7467) 
and Severe (p: 0.6839) KC IOP values.  Whereas bIOP was significantly different 
(p< 0.001) in all cases. The mean differences are shown in Figure 4-24. 
 
Figure 4-24 The changes in bIOP2 and bIOP in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 1 
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Summary of Results 
The bIOP2 equation was applied to keratoconic eyes. In these seven datasets, overall, 
bIOP showed significant correlations with age and CCT while bIOP2 showed no 
correlation with Age and reduced correlation with CCT compared to bIOP. However, 
bIOP2 correlations with CCT remained significant in some cases. Next, a comparison 
between the IOP values of the healthy group and different stages of the disease, 
including FFKC, Mild, Moderate and Severe cases were conducted. These data showed 
that as the disease progressed, bIOP values were reduced in mean significantly. This is 
most likely due to the correlation with CCT as patients with more severe cases had 
thinner corneas. In contrast, bIOP2, consistently showed no change as the disease 
severity progressed. The change, in most cases, remained statistically not significant for 
bIOP2 while significant in all cases for bIOP. 
 
4.5.1.2 bIOP2-KC Equation 
This section shows the differences between bIOP2 healthy and bIOP2-KC. bIOP 
healthy only uses Corvis ST parameters, whereas bIOP-KC uses parameters obtained 
from Pentacam elevation data. The parameters used for developing bIOP2-KC are 
shown in Equation 4-2.   
𝑏𝐼𝑂𝑃2 − 𝑘𝑐 =  
𝑓(𝐶𝐶𝑇, 𝐴𝑔𝑒, 𝐴𝑃1, 𝑃𝐷, 𝐻𝐶𝑅, 𝐷𝑒𝑓𝐴𝑚𝑝𝑀𝑎𝑥, 𝐴1𝑉, 𝐷𝑒𝑓𝑙𝐴𝑚𝑝𝐴1, 𝐻𝐶𝑇, 𝐶𝐻, 𝐶𝐴, 𝐶𝐷𝐴, 𝐶𝐿) 
Equation 4-2 
where CCT is the central corneal thickness (um), AP1 is the pressure at applanation one 
(mmHg), PD is the Peak Distance (mm), HCR is the radius at highest concavity (mm), 
DeflAmpMax is the deflection amplitude maximum (mm), A1V is the velocity at 
applanation one (m/s), DeflAmpA1 is the deflection amplitude at applanation one (mm), 
HCT is the time at highest concavity (ms), CH is the cone height (um), CA is the cone 
area (mm2), CDA is the cone distance to the corneal apex (mm), and CL is the cone 
location (degree).  
 
The problems with bIOP in KC eyes were reviewed from the literature in section 2.5. 
The comparison between bIOP and bIOP2 is also presented in section 4.5.1.1.7. Since 
the performance of bIOP in KC eyes was not suitable and bIOP2 performed consistently 
better, the comparison in this section is only provided between bIOP2 and bIOP2-KC 
to demonstrate the improvements offered by considering new geometrical parameters. 
For brevity, only one of the datasets is presented in this section. A similar analysis was 
conducted on other datasets and results are available in Appendices, Section A.   
 
Dataset 1 
This dataset includes 222 KC eyes with a mean age of 34.9±12.7(13 -83) years, CCT of 
480.7±38.1(353 -579) microns, bIOP2 of 15.5±1.1(13 -19) mmHg and bIOP2KC of 
15.5±1.1(13.3 -18.9) mmHg. The correlation with CCT for bIOP2 (p:0.0007, 
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R: - 0.2267) was significant while bIOP2KC (p:0.0889, R:-0.1144) remained 
insignificant. the correlations with age was no significant for bIOP2 (p:0.0926, R:0.1132 
and significant for bIOP2-kc (p:0.0482, R:0.1328). There were no significant differences 
between the two IOP values (p:0.9732), Figure 4-25.  
 
Figure 4-25 Correlation of IOP values from bIOP2 and bIOP2-KC with CCT (left) and age (right) in 
KC Dataset 1 
The differences between IOP values in each group separated based on disease severity 
were compared to healthy and remained close to the previously calculated values in 
section 4.5.1.1.7. Hence the numbers are not presented again for this section as the 




Figure 4-26 The changes in bIOP2 and bIOP2-KC in healthy, FFKC, Mild, Moderate and Severe 
keratoconic cases in Dataset 1 
bIOP2-KC       bIOP2 
bIOP2-KC       bIOP2 
111 | Results | Ashkan Eliasy 
 
111 | P a g e  
 
Summary of Results 
The bIOP2 and bIOP2-KC were applied to seven KC datasets where elevation data were 
available. After processing the topographies and obtaining cone characteristics, a 
comparison was provided. Interestingly, when IOP values were compared between 
disease stages and healthy group, not a significant improvement was gained from 
bIOP2- KC. The difference between bIOP2 and bIOP2-KC was not statistically 
significant, and they were both not significantly different from the healthy group. Also, 
the correlation between bIOP2-KC and bIOP2 with age remained unchanged and not 
significant. However, bIOP2-KC performed better in terms of its correlation with CCT. 
All seven datasets showed reduced correlation with CCT and six of them not 
significantly correlated. Looking at all data combined, bIOP2 (p:0.000, R:-0.1204) 
showed significant correlations with CCT and bIOP2-KC (p:0.4228, R:-0.0207) 
remained uncorrelated in 1522 KC eyes. 
 
4.5.2 Stress-Strain Index (SSI2) 
In this study, three SSI2 equations were developed. All three SSI2 equations use Corvis 
ST parameters. The SSI2-H  can be applied to the healthy cornea and post PRK surgery. 
The SSI2-KC equation is suitable for patients with distorted corneal geometry such as 
keratoconus and post CXL. Finally, SSI2-PLS is suitable for corneas post LASIK and 
SMILE surgeries.  The reason why three different equation was required is discussed in 
the next chapter. All three equations were applied to clinical data accordingly and 
presented in this section.  
 
4.5.2.1 SSI Healthy Equation  
This section shows the differences between SSI2-H  and the previously developed SSI. 
The SSI2 intends to improve on correlations with Age, CCT and IOP. The IOP formula 
use in this section is bIOP2 as it is believed to be less influenced by corneal biomechanics 
and provides a more accurate IOP value. The parameters used to develop SSI2-H  are 
shown in Equation 4-3.   
 
𝑆𝑆𝐼2 − 𝐻 =  
∫(𝐶𝐶𝑇, 𝑏𝐼𝑂𝑃2, 𝐴𝑔𝑒, 𝐴𝑃1, 𝑃𝐷, 𝐻𝐶𝑅, 𝐷𝑒𝑓𝐴𝑚𝑝𝑀𝑎𝑥, 𝐴1𝑉, 𝐷𝑒𝑓𝑙𝐴𝑚𝑝𝐴1, 𝐻𝐶𝑇) 
Equation 4-3 
 
where CCT is the central corneal thickness (um), bIOP2 is the newly developed 
biomechanically corrected IOP equation (mmHg), AP1 is the pressure at applanation 
one (mmHg), PD is the Peak Distance (mm), HCR is the radius at the highest concavity 
(mm), DeflAmpMax is the deflection amplitude maximum (mm), A1V is the velocity at 
applanation one (m/s), DeflAmpA1 is the deflection amplitude at applanation one (mm) 
and HCT is the time at highest concavity (ms).  
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4.5.2.1.1 Experimental Validation  
An experimental test was conducted on ex-vivo human corneas using an inflation rig 
that concluded there is a relationship between age and corneal stiffness in healthy 
human corneas 123. This was explained in more details in Chapter three, section 3.5.4. 
In this section to validate the performance of the new equation, a comparison is 
provided between SSI and SSI2-H  in healthy cornea against ex vivo expectations for 
that age in seven different datasets, Figure 4-27. The correlations between SSI, SSI2-H, 
and ex vivo SSI are compared and presented in Table 4-5. Both SSI and SSI2-H  showed 
significant correlations with ex vivo results using Spearman's rho correlation as the data 
were not normally distributed. However, the new SSI showed a better correlation as it 
followed the trend almost parallel to the ex-vivo result. The details of these datasets are 
provided in section 4.5.1.1.2. 
 
 
Figure 4-27 The comparison between SSI, SSI2-H  and ex vivo SSI values obtained from human donor 










113 | Results | Ashkan Eliasy 
 
113 | P a g e  
 
Table 4-5 The correlation of Ex-vivo SSI, SSI2-H  and SSI with age plus the mean and standard deviation 
of the differences between “ex-vivo and SSI” and “ex-vivo and SSI2-H ” in addition to Spearman's rho 
correlation p-value 
Dataset Ex-vivo SSI SSI2-H SSI 
Ex vivo vs. SSI2-H 
Mean±SD 

































































0.15±0.093 (p<0.01) 0.124±0.207 (p<0.01) 
 
 
4.5.2.1.2 Healthy Patients 
For brevity, only one of the datasets is presented in this section. A similar analysis was 
conducted on other datasets and results are available in Appendices, Section B.   
 
Dataset 1 
It included 414 patients with a mean age of 40.2±16.7(7-91) years, CCT of 
541±32 (454 - 634) microns, bIOP of 15.5±1.3(12.4-22.8) mmHg, bIOP2 of 
14.8±2.3(7.7-24.5) mmHg, SSI of 1.06±0.26(0.54-1.87) and SSI2-H  of 
1.08±0.21 (0.67- 1.74). Correlation with CCT for SSI was R:0.11 (p:0.026), and for 
SSI2-H, it became weaker with R:0.029 (p:0.552). Correlation with age for SSI was 
R:0.540 (p:0.000) and for SSI2-H was R:0.905 (p:0.000). Correlation with bIOP2 for 
SSI and SSI2-H  was R:0.547 (p:0.000) and R:0.123 (p:0.012). Although the correlation 
of bIOP2 with SSI2-H  is weaker, it is still significant and positively correlated, Figure 
4-28.  
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Figure 4-28 The correlation of SSI and SSI2-H  with CCT (left), age (middle) and IOP (right) in 
Dataset 1 
Summary of Results 
Next, a correlation comparison was conducted in seven healthy datasets where SSI and 
SSI2 were evaluated against CCT, age and IOP. As described before, there should be no 
correlation between them and CCT or IOP, while the correlation with age should 
remain strong. In four datasets CCT was significantly correlated with SSI while only one 
dataset showed significant correlations with SSI2. Correlation with age was stronger in 
SSI2 consistently and in all datasets. Correlation with IOP was insignificant in five 
datasets for SSI2 while it remained significant with SSI in all cases. SSI2 consistently 
showed reduced correlation with IOP compared to SSI. Overall, analysis of 1410 
patients showed correlation with CCT for SSI was significant with R:0.111 (p:0.000), 
while SSI2 was not correlated with R:-0.003 (p:0.899). Correlation with age for SSI was 
R:0.419 (p:0.000) and for SSI2 was R:0.841 (p:0.000). Correlation with bIOP2 for SSI 
and SSI2 was R:0.471 (p:0.000) and R:0.000 (p:0.999). This clearly showed that SSI2 is 
more representative of true material stiffness by being less correlated to IOP and CCT.  
 
4.5.2.1.3 PRK Surgery 
For brevity, only one of the datasets is presented in this section. A similar analysis was 
conducted on other datasets and results are available in Appendices, Section B.   
 
Dataset 1 
Dataset 1 consist of 38 patients who undergo PRK surgery with a mean CCT of 
541 ± 33 (458 - 623) microns, age of 38.1 ± 10.7 (21 - 79) years, bIOP of 
15.3±2.2 (10.4 - 21.7) mmHg, bIOP2 of 15.9 ± 1.4 (13.2 - 19.9) mmHg, SSI of 
0.94 ± 0.15 (0.59 - 1.27) and SSI2-H of 1.03 ± 0.16 (0.78 - 1.6). After LASIK these 
values changed to CCT of 414 ± 37 (343 - 502) microns, age of 
39.8 ± 10.7 (23 - 80) years, bIOP of 15.2 ± 2.0 (11.2 - 19.6) mmHg, bIOP2 of 
16.3 ± 0.9 (14.8 - 18.2) mmHg, SSI of 0.91±0.23(0.64-1.57), SSI2-H of 
1.03 ± 0.16 (0.84 - 1.75). To evaluate the performance of SSI values, (Pre SSI – Post 
SSI)/ Pre SSI was calculated. This value for SSI was 0.006±0.277 and for SSI2-H was 
0.003±0.071. Bland Altman plots are provided to visualise these changes, Figure 4-29.  
SSI SSI2-H 
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Figure 4-29 The Bland Altman plot for SSI2-H  (top) and SSI (bottom) comparing the pre and post PRK 
surgery results in Dataset 1 
Further, the correlations between changes in CCT and SSI/SSI2-H were evaluated. The 
correlation for SSI was R:-0.203 (p:0.221) and for SSI2-H was R:0.319 (p:0.051). both 
remained insignificant where SSI2-H had a positive correlation, and SSI was negatively 
correlated, Figure 4-30.  
SSI2-H  SSI 
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Figure 4-30 The evaluation of correlation in changes in CCT with changes in SSI and SSI2-H  in PRK 
group of Dataset 1 
 
Correlations with CCT before surgery for SSI was R:-0.270 (p:0.101) and for SSI2-H 
was weaker with R:0.078 (p:0.643). Age correlation with SSI was R:0.575 (p:0.000) and 
with SSI2-H was R:0.840 (p:0.000). Correlation of bIOP2 with SSI was high and 
significant with R:0.559 (p:0.000) while SSI2-H remained weak and insignificant with 
R:0.021 (p:0.900), Figure 4-31. 
 
Figure 4-31 The correlation of SSI and SSI2-H  with CCT (left), age (middle) and IOP (right) in pre-
surgery PRK group of Dataset 1 
Correlations with CCT after surgery for SSI was R:0.133 (p:0.426) and for SSI2-H was 
significant and stronger with R:0.432 (p:0.007). Age correlation with SSI was R:0.143 
(p:0.393) and with SSI2-H was R:0.898 (p:0.000). Correlation of bIOP2 with SSI was 
strong and significant with R:0.525 (p:0.000) while SSI2-H remained insignificant and 
weak with R:-0.081 (p:0.627), Figure 4-32. 
SSI SSI2-H 
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Figure 4-32 The correlation of SSI and SSI2-H  with CCT (left), age (middle) and IOP (right) in post-
surgery PRK group of Dataset 1 
Summary of Results 
The SSI2 was applied to patients who undergo PRK in two different datasets. In both 
cases for pre and post data, correlation with CCT and IOP was weaker in SSI2, and it 
had a stronger correlation with age. In SSI (0.02±0.48 and 0.02±0.37) and SSI2 
(0.00±0.14 and 0.02±0.21), the mean differences between pre and post remained close 
to zero in both datasets. The differences in correlation with CCT between SSI (p:0.221) 
or SSI2 (p:0.051) remained insignificant in dataset one while it was only insignificant 
for SSI2 (p:0.961) in dataset two. This observation can now help explain the stability of 
SSI/SSI2 values following PRK. While the PRK ablation of stromal tissue and reduction 
in corneal thickness undoubtedly lead to a reduction in the cornea’s geometric stiffness 
and hence overall stiffness, it should not lead to significant changes in the material 
stiffness measured by the SSI and SSI2. Perhaps the only material-related change that 
could be expected in this case is wound healing following surgery 448. However, while 
there is still no agreement on the nature and magnitude of this effect (and whether it 
leads to increases or decreases in tissue stiffness), most evidence points at a small stiffness 
change affecting a thin zone immediately next to the incision surface 449-453. 
 
4.5.2.2 SSI2-KC Equation  
This section shows the differences between SSI2-KC and the previously developed SSI. 
The SSI2 intends to improve on correlations with Age, CCT and IOP. The IOP formula 
used in this section was bIOP2 as it is believed to be less influenced by corneal 
biomechanics and provides a more accurate IOP value. The parameters used to develop 
SSI2-KC equation are similar to healthy SSI2 and shown in Equation 4-3. Only the 
terms and coefficients were optimised to suit these data better.  
 
4.5.2.2.1 Keratoconus Patients  
For brevity, only one of the datasets is presented in this section. A similar analysis was 
conducted on other datasets and results are available in Appendices, Section B.   
Dataset 1 
It included 222 patients with a mean age of 34.9 ± 12.7 (13 - 83) years, CCT of 
481 ± 38 (353 - 579) microns, bIOP of 13.9 ± 2.4 (6.1 - 20.2) mmHg, bIOP2 of 
SSI SSI2-H 
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15.5 ± 1.1 (13 - 19) mmHg, SSI of 0.88 ± 0.26 (0.46 - 2) and SSI2-KC of 
0.76 ± 0.18 (0.32 - 1.53). Correlation with CCT for SSI was R:0.212 (p:0.002), which is 
stronger than SSI2-KC with R:0.177 (p:0.008). Correlation with age for SSI was R:0.306 
(p:0.000) and for SSI2-KC was R:0.778 (p:0.000). Correlation with bIOP2 for SSI with 
R:0.557 (p:0.000) was stronger than SSI2-KC with R:0.184 (p:0.006), Figure 4-33. 
 
Figure 4-33 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in 
Dataset 1 
When comparing the changes in SSI and SSI2-KC with disease progression, it is clear 
that both equations followed a clear trend. In severe cases, corneal biomechanics 
changed and became softer than less severe or healthy patients. SSI2-KC showed a 
more significant softening in Mild, Moderate and Severe cases, Figure 4-34. The 
detailed analysis for means, standard deviations and statistical comparison of SSI 
values to the healthy group is provided in  
Table 4-6.   
 
Figure 4-34 The changes in SSI2-KC and SSI in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 1 
SSI SSI2-KC 
SSI SSI2-KC 
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Table 4-6 Showing the mean, standard deviation (SD) and statistical comparison with the healthy group 
for SSI / SSI2-KC in the same format as shown here in Dataset 1 
Mean 1.06/1.08 1.04/1.02 0.94/0.84 0.87/0.74 0.78/0.66 
SD 0.26/0.21 0.23/0.18 0.23/0.18 0.29/0.16 0.21/0.16 
p value 1/1 0.727/0.180 0.000/0.000 0.000/0.000 0.000/0.000 
 
Summary of Results 
SSI2-KC was compared with SSI in seven KC datasets. There was a clear strength in 
correlation with age in SS2-KC in all cases compared to SSI. SSI2-KC showed weak 
correlations with CCT and IOP while SSI had positive and strong correlations with 
both. SSI2-KC showed a significant correlation with CCT in three datasets while SSI 
was correlated significantly in six datasets. The correlation with IOP was significant in 
only one dataset for SSI2-KC while it was significant with SSI in all cases. Overall, 
analysis of 1522 KC eyes showed correlation with CCT for SSI was strong with 
R:0.257 (p:0.000), and for SSI2 weaker with R:0.131 (p:0.000). Correlation with age for 
SSI was R:0.164 (p:0.000) and for SSI2 was R:0.716 (p:0.000). Correlation with bIOP2 
for SSI was strong with R:0.516 (p:0.000) while SSI2 was weaker with R:0.068 (p:0.008) 
but still significant.  
 
It is expected that as the keratoconus progresses, the material stiffness reduces.454,455 KC 
patients were split into four groups of FFKC, Mild, Moderate and Severe keratoconus. 
In all cases, SSI2-KC reduced with disease progression. On the other hand, SSI also 
reduced in most cases, but the reduction in values was smaller than SSI2-KC. The 
overall comparison showed SSI2-KC mean reduced from 1.03 in healthy eyes to 0.95, 
0.74, 0.69 and 0.62 in FFKC, Mild, Moderate and Severe cases, respectively. On the 
other hand, in SSI this change was from 1.00 to 0.97, 0.87, 0.81 and 0.69. This showed 
there is a more consistent reduction in SSI2-KC with a larger gap between FFKC and 
Mild KC. Whereas, in SSI, there is a larger gap between Moderate and Severe KC cases. 
All changes were statistically significant when compared to healthy groups for both 
parameters.  
 
4.5.2.2.2 Crosslinked Corneas 
For brevity, only one of the datasets is presented in this section. A similar analysis was 
conducted on other datasets and results are available in Appendices, Section B.   
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Dataset 1 – Early Term Results  
Dataset 1 consist of 16 patients who undergo CXL with a mean CCT of 
482.8 ± 46.6 (360 - 557) microns, age of 31.1 ± 12.3(18 - 62) years, bIOP of 
13.7 ± 2.6 (7.4 - 18) mmHg, bIOP2 of 16 ± 1.3 (14.3 - 19) mmHg, SSI of 
1 ± 0.3 (0.7 - 1.8) and SSI2-KC of 0.7±0.1(0.5 - 1). After crosslinking these value 
changed to a mean CCT of 461.1 ± 50.7 (328 - 518) microns, bIOP of 
15.8 ± 2.8 (10.6 - 21.7) mmHg, bIOP2 of 17.1 ± 1.4 (15.2 - 20.7) mmHg, SSI of 
1.2 ± 0.3 (0.6 - 1.7) and SSI2-KC of 0.7 ± 0.2 (0.4 - 1.1). In SSI, 25% of patients showed 




Figure 4-35 The mean and standard deviation of pre-CXL and post-CXL data for SSI and SSI2-KC in 
the early group of CXL Dataset 1 
Correlations with CCT before crosslinking for SSI was strong and negative with 
R: - 0.526 (p:0.036) while SSI2-KC was weakly correlated and not significant R:0.046 
(p:0.890). Age correlation with SSI was R:0.429 (p:0.097) and with SSI2-KC was 
R:0.731 (p:0.001). Correlation of bIOP2 with SSI and was strong and significant with 
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Figure 4-36 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in the 
early pre-surgery group of CXL Dataset 1 
Correlations with CCT after crosslinking for SSI was strong with R:0.444 (p:0.098) and 
for SSI2-KC became weaker with R:0.246 (p:0.359). Age correlation with SSI was 
R:0.359 (p:0.189) and with SSI2-KC was R:0.842 (p:0.000). Correlation of bIOP2 with 
SSI was strong and significant with R:0.516 (p:0.049) while bIOP showed no significant 
correlations with R:-0.095 (p:0.727), Figure 4-37.  
 
Figure 4-37 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in the 
early post-surgery group of CXL Dataset 1 
Dataset 1 – Late-Term Results  
Dataset 1 also consists of 21 patients who undergo CXL with a mean CCT of 
486 ± 47 (360 - 563) microns, age of 30.2 ± 11.5 (17 - 62) years, bIOP of 
13.8 ± 2.4 (7.4 - 18) mmHg, bIOP2 of 15.7±1.3(14-19) mmHg, SSI of 
0.98 ± 0.32 (0.57 - 1.84) and SSI2-KC of 0.66±0.14(0.47-1). After crosslinking these 
value changed to a mean CCT of 469 ± 52 (351 - 559), bIOP of 
14.7 ± 2.7 (10.2 - 21.1) mmHg, bIOP2 of 16 ± 1.4 (12.7 - 19.4) mmHg, SSI of 
0.94 ± 0.28 (0.5 - 1.49) and SSI2-KC of 0.68 ± 0.19 (0.27 - 0.98). In SSI, 42.9% of 
patients showed softening after crosslinking, whereas with SSI2-KC 28.6% showed 
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Figure 4-38 The mean and standard deviation of pre-CXL and post-CXL data for SSI and SSI2-KC in 
the late group of CXL Dataset 1 
Correlations with CCT before crosslinking for SSI was negative and strong with 
R: - 0.405 (p:0.069) while for SSI2-KC it remained insignificant and not correlated with 
R:0.038 (p:0.870). Age correlation with SSI was R:0.440 (p:0.046) and with SSI2-KC 
was R:0.698 (p:0.004). The correlation of bIOP2 with SSI was strong with R:0.706 
(p:0.000) while SSI remained uncorrelated with R:0.364 (p:0.105), Figure 4-39.  
 
Figure 4-39 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in the 
late pre-surgery group of CXL Dataset 1 
Correlations with CCT after crosslinking for SSI was R:-0.145 (p:0.555) and for 
SSI2- KC was R:-0.119 (p:0.609) where both remained insignificant and negatively 
correlated. Age correlation with SSI was R:0.298 (p:0.215) and with SSI2-KC was 
R:0.444 (p:0.044). Correlation of bIOP2 with SSI was strong and significant with 
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Figure 4-40 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in the 
late post-surgery group of CXL Dataset 1 
Summary of Results 
Application of SSI2-KC in five CXL datasets showed consistently weak correlations with 
CCT and IOP and strong positive correlations with age. In SSI the correlation with IOP 
was positive and strong in all cases, while the correlation with CCT and age were 
inconsistent (positive and negative). SSI values were then compared to pre and post 
surgeries. In three datasets, SSI showed a larger percentage of softening after CXL 
compared to SSI2-KC. Overall, the changes in SSI were larger than changes in SSI2-KC 
when pre and post data were compared. However, SSI2-KC values were consistently 
lower and in the severe KC region (SSI2≈0.65) while SSI varied significantly and had 
the same values as for healthy corneas in 2 datasets. A possible explanation for the large 
variations in SSI could be its strong correlation with IOP. IOP after CXL is normally 
overestimated compared with the pre IOP measurements due to the influence of the 
changes in corneal biomechanics. However, since SSI2-KC is using bIOP2, which was 
shown to be less correlated with biomechanical changes, this error is reduced with SSI2. 
On average SSI2-KC showed a 6.5 ± 4.3% increase while SSI showed a 7.8 ± 4.2% 
increase after CXL. The mean SSI2-KC always increased after CXL, but in SSI it was 
reduced in one case. In the literature, changes in corneal stiffness varied from 5% 313 to 
90% 312. Hence the actual changes in corneal stiffness are not known, but it is believed 
that there will be an increase in stiffness or prevention of further softening and 
deformation in most patients.  
 
4.5.2.3 SSI-PLS for post LASIK and SMILE  
Similar to SSI2-KC, the equation developed for the SSI2-PLS incorporated the same 
parameters as the healthy equation. The main difference is that since the LASIK and 
SMILE surgeries leave a loose flap on the cornea, the thickness of the flap would result 
in different behaviour of the cornea as described in section 3.6.2.3. Hence in SSI2-PLS, 
this flap separation was considered while optimising coefficients and terms of the 
equation.  Please note that in refractive surgery, patients have healthy eyes prior to the 
surgery. Hence SSI2-H was applied to pre-op data. And for post-op, the SSI2-PLS was 
applied to compensate for changes induced by the surgery. For brevity, only one of the 
datasets is presented in this section. A similar analysis was conducted on other datasets 
and results are available in Appendices, Section B.   
SSI SSI2-KC 
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Dataset 1 consist of 82 patients who undergo SMILE Surgery with a mean CCT of 
541 ± 33 (480 - 642) microns, age of  34.8 ± 7.7 (22 - 51) years, bIOP of 
14.3 ± 2 (9.6 - 21.1) mmHg, bIOP2 of 15.6±1.3(13.2-19.6) mmHg, SSI of 
1.18 ± 0.19 (0.62 - 1.57) and SSI2-H of 1.02±0.2(0.68-2.43). After SMILE these values 
changed to a mean CCT of 444 ± 39 (351 - 545) microns, age of 35.3 ± 7.5 (22 - 51) 
years, bIOP of 12.3 ± 2 (8.1 - 16.1) mmHg, bIOP2 of 15.7 ± 0.8 (12.5 - 18.6) mmHg, 
SSI of 1.06 ± 0.22 (0.69 - 1.81) and SSI2- PLSof 0.96 ± 0.11 (0.78 - 1.4). To evaluate 
the performance of SSI values, (Pre SSI – Post SSI) / Pre SSI was calculated. This value 
for SSI was 0.092 ± 0.163 and for SSI2 was 0.048 ± 0.114. Bland Altman plots are 
provided to visualise these changes, Figure 4-41. 
 
 
Figure 4-41 Bland Altman plot for SSI2 (top) and SSI (bottom) comparing the pre and post SMILE 
surgery results in Dataset 1 
SSI2  SSI 
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Further, the correlations between changes in CCT and SSI/SSI2 were evaluated. The 
correlation for SSI was R:-0.187 (p:0.093) and for SSI2 R:-0.010 (p:0.372). This showed 
changes in SSI2 had a weaker correlation with changes in CCT compared to SSI 
equation, Figure 4-42.  
 
Figure 4-42 The evaluation of correlation in changes in CCT with changes in SSI and SSI2 in SMILE 
group of Dataset 1 
 
Correlations with CCT before surgery for SSI was strong and significant with R:-0.225 
(p:0.042) while SSI2-H was not correlated with R:0.008 (p:0.946). Age correlation with 
SSI was R:0.403 (p:0.000) and with SSI2-H was R:0.528 (p:0.000). Correlation of bIOP2 
with SSI was significant and large with R:0.564 (p:0.000) while SSI2-H remained 




Figure 4-43 The correlation of SSI and SSI2-H with CCT (left), age (middle) and IOP (right) in the pre-
surgery SMILE group of Dataset 1 
Correlations with CCT after surgery for SSI remained strong with R:0.269 (p:0.015) 
and for SSI2-PLS became significant with R:0.248 (p:0.025). Age correlation with SSI 
was R:0.388 (p:0.000) and with SSI2-PLS was R:0.799 (p:0.000). Correlation of bIOP2 
with SSI remained strong and significant with R:0.515 (p:0.000) while SSI2- PLS 
remained insignificant and not correlated with R:0.017 (p:0.880), Figure 4-44. 
SSI SSI2 
SSI SSI2-H 
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Figure 4-44 The correlation of SSI and SSI2-PLS with CCT (left), age (middle) and IOP (right) in the 
post-surgery SMILE group of Dataset 1 
 
Dataset 1 includes 53 patients who undergo LASIK with a mean CCT of 
543±36 (473 - 611) microns, age of 36.8±6.7 (26-47) years, bIOP of 
14.8±2.4 (11.6 - 25.2) mmHg, bIOP2 of 15.7±1.5(13.5-22) mmHg, SSI of 
1.16±0.21(0.78-1.7) and SSI2-H of 1.05±0.13 (0.59-1.35). After LASIK these values 
changed to a mean CCT of 481±33(409-537) microns, age of 37.1±6.9(27-48) years, 
bIOP of 12.9±1.5(9.6-16) mmHg, bIOP2 of 15.3±1 (13-17.2) mmHg, SSI of 
1.09±0.26 (0.55-2.22) and SSI2-PLS of 0.99±0.14 (0.39-1.51). To evaluate the 
performance of SSI values, (Pre SSI – Post SSI)/ Pre SSI was calculated. This value for 
SSI was 0.051±0.242 and for SSI2 was 0.044±0.163. Bland Altman plots are provided 
to visualise these changes, Figure 4-45. 
 
SSI SSI2-PLS 
SSI2  SSI 
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Figure 4-45 Bland Altman plot for SSI2 (top) and SSI (bottom) comparing the pre and post LASIK 
surgery results in Dataset 1 
Further, the correlations between changes in CCT and SSI/SSI2 were evaluated. The 
correlation for SSI was R:0.297 (p:0.031) and for SSI2 R:0.243 (p:0.080). In this case, 
both had the same trend and closely related while SSI2 was insignificant, and SSI was 
significant, Figure 4-46.  
 
Figure 4-46 The evaluation of correlation in changes in CCT with changes in SSI and SSI2 in the 
LASIK group of Dataset 1 
Correlations with CCT before surgery for SSI was negative with R:-0.115 (p:0.414) and 
for SSI2-H was stronger but insignificant with R:0.249 (p:0.073). Age correlation with 
SSI was R:0.386 (p:0.004) and with SSI2-H was R:0.446 (p:0.001). Correlation of bIOP2 
with SSI was strong and significant with R:0.366 (p:0.007) while SSI2-H remained 
weakly correlated and insignificant with R:0.098 (p:0.487), Figure 4-47. 
 
SSI SSI2 
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Figure 4-47 The correlation of SSI and SSI2-H with CCT (left), age (middle) and IOP (right) in the pre-
surgery LASIK group of Dataset 1 
Correlations with CCT surgery for SSI was R:0.244 (p:0.078) and for SSI2-PLS was 
R:0.264 (p:0.056) where both remained positive and insignificant. Age correlation with 
SSI was R:0.168 (p:0.228) and with SSI2-PLS was R:0.541 (p:0.000). Correlation of 
bIOP2 with SSI was significant and strong with R:0.458 (p:0.000) while SSI2-PLS was 
negatively and insignificantly correlated with R:-0.192 (p:0.169), Figure 4-48. 
 
 
Figure 4-48 The correlation of SSI and SSI2-PLS with CCT (left), age (middle) and IOP (right) in the 
post-surgery LASIK group of Dataset 1 
Summary of Results 
In all four datasets, SSI2-PLS mean differences ranged from 0.01 to 0.06 reduction in 
values with standard deviations ranging from 0.13 to 0.35. On the other hand, SSI 
experienced a reduction of 0.08 to 0.15, with standard deviations ranging from 0.22 to 
0.55. It is clear that SSI showed significant reductions in both means and standard 
deviations compared to SSI2-PLS. The correlation analysis showed that SSI was 
positively correlated with IOP and inconsistent correlations (positive and negative) with 
age and CCT. In general, the correlations with CCT and IOP was weakest in SSI2 for 
preoperatively and SSI2-PLS for postoperative data. Comparing the changes in CCT 
with changes in stiffness values, SSI2-PLS had a weaker correlation compared to SSI. 
With SSI2-PLS, it was possible to show that the material stiffness did not undergo 
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4.6 Concluding Remarks 
At the beginning of this chapter, a trend was found that could define the expected 
location of the cone and its geometry. The analysis for developing numerical models, 
including a mesh convergence study, was presented next. The numerical models were 
then validated using clinical cases. This chapter then presented the results of both 
bIOP2 and SSI2 equations on various clinical data in healthy, keratoconus, post 
crosslinking, refractive surgeries and glaucoma. In doing this, previously developed 
parameters were compared to demonstrate the improvements introduced by the new 
equations. These improvements were assessed in regards to correlations with CCT, age 
and IOP and through statistical analysis to compare pre and post-operative data. These 
results suggest noticeable improvements in estimating IOP and SSI compared to 
previously developed methods. These results are discussed in the next chapter.  
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5. Discussion  
 
5.1 Overall Discussion  
This project started with the aim of enabling in vivo measurement of corneal 
biomechanics and further improve the diagnosis of glaucoma through a more accurate 
estimation of intraocular pressure (IOP). To achieve this, the study relied on 
representative numerical simulations to better understand corneal behaviour under 
tonometry air pressure. For numerical models to be representative, it was required to 
adopt realistic corneal geometry. This was particularly important in diseased eyes, such 
as those with keratoconus, where corneal geometry is distorted. The information that 
was available in the literature on this matter was not enough to construct these models. 
Hence a study was conducted to obtain this information. For this purpose, a method 
was developed that led to a software package that could receive elevation data from eye 
topographers and analyse them. This analysis was of particular importance in KC eyes 
so the cone properties could be characterised. These properties include the boundaries 
of the cone, the area of the cone, and its location and height.  
 
Once the required information was obtained, the second piece of software was 
developed to utilise this information to build realistic numerical models, conduct a large 
parametric study and estimate corneal behaviour. This automated process alongside 
parallel and high-performance computing ability enabled conducting a large parametric 
study. Upon completion of these simulations, there was a need to analyse a large amount 
of data which would not be feasible by using manual techniques. Hence the third piece 
of software was designed to not only analyse the data collected from numerical models 
but also to calculate the dynamic corneal response parameters. Then the fourth and final 
piece of software was developed to read this information, and through having a detailed 
and multiplex objective function find the best parameters, build equations and estimate 
the required output with the smallest possible error.  
 
This novel approach led to the development of new equations for biomechanically 
corrected IOP 2 (bIOP2) and Stress-Strain Index 2 (SSI2) which was a measure of 
corneal biomechanical stiffness in vivo. Upon development of these equations, their 
output was compared with previously developed parameters within Corvis ST and other 
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devices such as the DCT, ORA and GAT where their readings were available. This 
comparison was made with both previously conducted experimental data and a large 
clinical database. The clinical database included healthy, keratoconus and glaucoma 
patients in addition to post-surgery patients such as those who underwent refractive 
corrections and corneal crosslinking. These analyses served to validate the new 
methodologies and equations in addition to providing a holistic view of the performance 
of each. This section provides an overall discussion of all three main outcomes of (1) 
KC topography analysis, (2) biomechanically correlated IOP2 (bIOP2) and (3) Stress-
Strain Index 2 (SSI2). 
 
5.1.1 KC Topography Analysis 
Keratoconus (KC) is a condition that causes an alteration in the curvature of the cornea 
and localised thinning 69-72. It commonly begins in early adolescence, progresses over the 
next two decades 73 and can significantly reduce visual acuity and vision-related quality 
of life 74,75. While the characteristic topographic patterns of keratoconus can be 
identified on corneal topographic and tomographic maps, it is still difficult to precisely 
locate the centre of the cone and the transition zone between the pathology area and 
the rest of the corneal tissue 76-80. As classifying and managing keratoconus can be more 
efficient when the affected corneal region is located, especially in the case of customized 
corneal crosslinking 81-84, techniques were developed to address this challenge 85-87. 
However, some of the available techniques to detect the keratoconus cone were based 
on methods that analysed corneal tangential or axial curvature maps, which were 
influenced by the variations in their algorithms 85-87. 
 
Tangential curvature maps typically have high noise-to-signal ratios and are based on 
the second derivative nature of the curvature calculation. This creates the need in 
elevation-based systems, such as Scheimpflug tomographers, for smoothing or low-pass 
filtering to derive tangential curvature from height data 456,457. Conversely, axial maps 
assume centre points of surface curvature to be always located on the central reference 
axis and this assumption reduces the sensitivity of the curvature maps in identifying 
surface changes due to cone development 458. Mahmoud et al. 85 initially proposed a 
method using axial and tangential maps to locate the cone position and to quantify its 
magnitude. Later, axial and tangential curvature, and the relative elevation of both the 
anterior and the posterior surfaces, as well as the pachymetric maps were included in 
the method which exhibited improved accuracy in detecting the presence of keratoconus 
459. The Brillouin frequency shift at the point of maximum posterior elevation in relation 
to the best-fit sphere was also related to several curvature indices 460. Its magnitude 
showed a high correlation with corneal stiffness reduction assessed by means of the 
Brillouin frequency shift 460. Even though these methods have been demonstrated to be 
effective in detecting the presence of keratoconus cone and quantifying the relative 
stiffness reduction associated with the local pathology, they do not evaluate the size of 
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the pathologic area. Furthermore, as the cone centre is different in curvature, elevation, 
and pachymetry maps, there is a need for a method for detecting the location of the 
cone axis normal to the surface, in its natural three-dimensional position. 
 
While estimating the area of pathology from the elevation data offers a direct method, 
a particular challenge is caused by the smooth transition between the natural curved 
shape of the corneal surface and the steeper curvature within the cone. Further, as the 
cone may be only a few microns above the curved shape of the cornea, it may be difficult 
to detect. This project attempted to overcome this difficulty by expressing corneal 
surface data normal to the surface and relative to the centre of the best-fit sphere to 
generate a ‘spherical height map’. This map eliminates the effect of corneal surface 
curvature and hence increases the precision in locating cone centre and estimating the 
size of the affected area of the cornea. 
 
A novel method to detect the cone centre and height normal to the surface, as well as 
the transition zone between the area of pathology and the surrounding healthy corneal 
tissue in keratoconic patients, was developed. The method relies on spherical 
coordinates relative to the centre of the cornea’s optimal sphere fit and measured 
normal to the surface, in order to reduce the effect of the cornea’s natural curvature in 
determining the cone’s geometric features. When applying the method to 618 eyes of 
309 KC patients, more than 80% of cases had infra-temporal cones, which is 
intermediate between the 95% figure reported by Auffarth, et al. 461  and 65% reported 
by Demirbas and Pflugfelder 462, but different from findings by Wilson, et al. 463 where 
the majority of 48 eyes under study had the cone centre located in the inferior-nasal 
quadrant. The reason for this mismatch could be that Wilson, et al. 463 used a relatively 
small sample that may have particular characteristics which cannot be generalised. These 
results also showed significant mirror-image symmetry (enantiomorphism) between 
right and left eyes in cone location, similar to what was reported by Rabinowitz and 
McDonnell 76 and Holland, et al. 265. As no direct comparison was made between the 
fellow eyes of individual subjects in this study, the disease could be more advanced in 
one eye than the other. 
 
The results further showed a trend of increased cone height (R= 0.716, p< 0.001) and 
reduced distance from corneal apex to cone centre (R= -0.312, p< 0.001) with disease 
severity – this trend was significant in both anterior and posterior surfaces of the right 
and left eyes. Cone height was also negatively correlated with the radius of the optimum 
fit sphere in both the anterior surfaces (R= -0.584, p< 0.001) and posterior surfaces (R 
=-0.568, p< 0.001). 
 
In contrast, while having the radius of the optimal sphere as a co-variate, the cone area 
was not correlated with the disease stages in the anterior surface (R= 0.002, p=0.753) 
and was weakly correlated in the posterior surface (R= 0.093, p= 0.003). This lack of 
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difference may be due to the simultaneous inclusion of different cone morphologies. 
Perry et al., 81 described two types of cone morphologies in advanced cases; the centrally 
restricted cone with nipple-shaped pattern and the peripheral cone with more oval 
shapes. As nipple cones typically have smaller areas and locate closer to corneal apex 
compared with oval cones in severe keratoconus, the use of both cone height and 
distance of cone centre to the apex as biomarkers for keratoconus severity may be less 
effective, leaving only cone height as a robust biomarker 72,260,464-467. 
 
There is also strong evidence that the posterior cone increased in height faster in 90% 
of cases than the anterior cone, which was likely affected by epithelial remodelling. This 
finding supports the notion that the evaluation of both surfaces would be important for 
a reliable diagnosis 245. The study also revealed a strong correlation between the shift of 
the posterior cone (relative to the anterior cone) and the height of the anterior cone. 
This is an important finding which can be used to provide a realistic representation of 
cone geometry in numerical simulations of the biomechanics of keratoconic eyes. It 
could also help the design and optimisation of corneal implants used to correct 
refractive errors in KC patients. 
 
Another important earlier study by Mahmoud et al. identified the 2mm-diameter 
circular zone of the cornea with the steepest curvature and used it to locate the cone 
centre 260. The method known as CLMI was initially developed for anterior surface axial 
and tangential curvature maps but later expanded to consider the posterior surface, 
surface elevation and corneal thickness maps. While this method was sensitive in 
separating keratoconic and normal corneas, and in locating and quantifying the 
alterations that occur in the central area of the disease, it was not designed to evaluate 
the cone shape or locate its transition zone. 
 
The proposed method in this research is also different from the Belin/Ambrósio 
enhanced best-fit sphere method 468,469. In the Belin/Ambrosio method, the height of 
the cone is obtained by the difference in Z coordinate between the cornea and the BFS 
obtained after excluding a fixed area around the thinnest point. In the method 
presented in this study, the height is obtained by the radial differences between the 
cornea and the optimal sphere, calculated normal to the surface, obtained in an iterative 
process to exclude the pathologic area specific for each case.  
 
This thesis provided a comparison between cone characteristics and key topographical 
indices obtained from the Pentacam. Cone area showed weak correlations with the 
majority of Pentacam indices related to KC diagnosis. Cone Height showed the strongest 
correlations with all parameters and specifically BADD,  EleBFS8mm, Kmax, IVA and 
KI. The evaluation of distance from the cone centre to corneal apex showed moderate 
correlations with the majority of parameters where the correlation was highest in AsphQ 
and CKI. Comparison between anterior and posterior surfaces showed similar 
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correlations between them and Pentacam indices. In regards to cone height and distance 
from cone centre to corneal apex, all parameters apart from IHA showed similar 
correlations between left and right eyes. In regards to the area of the cone, no clear 
pattern could be detected between disease progression stages, Penatacm indices, anterior 
and posterior surfaces as well as left or right eyes.  
 
With numerical simulations being used in ophthalmology, the findings of this study are 
valuable for future research. Numerical models require geometric information to be able 
to perform simulations and provide reliable results. To model eyes with keratoconus, 
the availability of the information provided in this research would enable modelling of 
corneal geometry, including the representation of the pathologic area which could then 
be simulated as softer than the surrounding area. The proposed method can also be 
used on data provided by different corneal topographers to identify the cone location, 
height and transition zone. This should enable researchers to develop computer 
programs based on this logic and analyse mass information in a customised manner 
using only the elevation data of the anterior and posterior cornea. In addition, in the 
era of artificial intelligence, access to large datasets is crucial for machine learning 
purposes. A problem with data collection is that information provided by different 
devices often cannot be used due to variations in data format 466,470. This method bridges 
this gap and enables consistent use of raw elevation data allowing multi-device data 
collection. 
 
5.1.2 Biomechanically Corrected IOP 2 (bIOP2) 
Measurement of intraocular pressure is an essential part of the treatment and screening 
of eye pathologies such as ocular hypertension, and glaucoma. IOP was identified as the 
only modifiable risk factor in glaucoma, which is one of the most common eye diseases 
and the second leading cause of blindness globally. 471 Every 1 mmHg increase in the 
IOP value was found to increase the risk of glaucoma by 11%. 472 Hence accurate 
measurement of IOP is extremely important to clinicians. Goldmann Applanation 
Tonometer (GAT) is the reference standard for measuring IOP. 473 The details on how 
this device estimates IOP is discussed in Section 2.5.1.1. In brief, this device makes 
contact and applanates the cornea and assumes that the pressure applied to deform the 
cornea is equal to the internal pressure at first applanation. Although this assumption 
is true in an infinitely thin-walled sphere, in terms of the cornea it is susceptible to 
corneal thickness, curvature and biomechanics. As a result, measurements from GAT 
showed significant correlations with these cofounding factors. 474,475  
 
A number of attempts have been made to overcome these challenges and estimate more 
accurate IOP values. Among these attempts, newly developed devices such as Dynamic 
Contour Tonometer (DCT), 350 Ocular Response Analyzer (ORA) 476 and Corvis ST 477 
have been particularly successful to varying degrees. DCT is based on a completely 
different principle that is less influenced by corneal biomechanics, however, is 
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influenced by corneal geometrical parameters such as corneal radius. 478,479 A detailed 
discussion is provided in section 2.5.1.2 on this topic. Both ORA and Corvis ST are 
non-contact tonometers that function based on the same concept as GAT. However, 
since they can capture more information about corneal deformation under external 
pressure, further adjustments could be introduced. 25,480 Corvis ST has a high-speed 
Scheimpflug camera that enables monitoring the deformation of the anterior and 
posterior surfaces of the cornea at every location throughout the applanation process, 
section 2.5.1.3.2. ORA is using a laser-based system and can only identify the first and 
second applanation, section 2.5.1.3.1. in earlier studies, bIOP in Corvis ST was found 
to be the most accurate and least influenced by changes in corneal biomechanics and 
geometry. 424,446 This was followed by DCT and then corneal-corrected IOP (IOPcc) in 
ORA. 166  
 
The effectiveness of IOP measurements from different tonometers are obtained through 
clinical studies. In these studies, the correlation between the estimated IOP and various 
parameters and most importantly, central corneal thickness (CCT) and age (strongly 
correlated with stiffness) was examined. 481,482. Some other researchers have compared 
the estimated IOP values with in-vivo manometry measurements with a limited number 
of patients due to practical reasons. 483,484 Ex-vivo studies have been conducted that 
relied on measuring the pressure inside the eye using a transducer and comparing this 
true IOP value with what is estimated by a tonometry device. Although this is the most 
accurate method for measuring true IOP, difficulties in obtaining donor eye globes and 
the cost of experimental procedures have limited the ability to conduct large scale 
studies. 447  
 
The bIOP was developed using numerical modelling of healthy corneas through 
parametric studies and the equation included four parameters of CCT, age, AP1 and 
Radius at Highest Concavity (RHC). The bIOP equation performed well, and studies 
had reported its better performance when compared to other IOP measurement 
methods. In particular, bIOP performed well in healthy eyes 485 and when compared 
between pre and post-refractive surgeries 360. In some publications, it was reported that 
bIOP was correlated with age 390. Also, bIOP was not designed for keratoconic eyes, and 
a second equation was developed for soft corneas (bIOPs). 387 In the development of 
bIOPs, a study on KC eyes was conducted and all corneas for healthy and KC patients 
were divided into five groups based on corneal curvature. Using this information, a 
rotationally symmetric FE parametric study was conducted which considered variations 
in CCT, corneal material stiffness, and corneal curvature.  
 
In a study where bIOPs was compared to bIOP it showed improvement in estimating 
IOP values in the sense that the mean IOP of KC group was closer to the healthy eyes.387 
However, there were three main flaws with this algorithm. First, it relied on an initially 
estimating corneal material stiffness which on its own is inter-related to IOP. 
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Inaccuracies in the estimation of material stiffness would lead to inaccurate IOP 
measurements. Second, it used rotationally symmetric numerical models to develop the 
parameter which is not representative of KC corneas. Third, numerical models did not 
consider the localised softening in the KC cornea. This simplification was found 
necessary to conduct that study using available resources, information and time span. 
The total number of models included in that study was 4500. 428 
 
A more recent study developed a new IOP algorithm (fIOP) for healthy eyes using more 
complex simulations.486 A novel multi-physics fluid-structure interaction model of the 
air-puff test was employed in a parametric numerical study simulating human eyes with 
a wide range of central corneal thickness (CCT), curvature (R), material stiffness and 
IOP. The models were internally loaded with IOP using a fluid cavity and externally 
with air-puff loading simulated using a turbulent computational fluid dynamics model. 
fIOP used the same parameters as bIOP, and the equation development strategy was the 
same. 415 It was concluded that fIOP performed as well as bIOP and no action was taken 
to implement the new algorithm into Corvis ST. Among the new fIOP, bIOP and 
bIOPs, only bIOP was implemented in Corvis ST and is in current use.  
 
In this study, a new biomechanically-corrected IOP (bIOP2) was developed with the 
same goal as bIOP, which was to reduce the influence of biomechanics and geometrical 
components on IOP measurements. The FE models were also internally loaded using 
fluid cavity to introduce IOP. The fluid inside the cavity was described as incompressible 
so that the analysis would make sure the internal volume inside the ocular globe is 
maintained without change. Therefore, when the cornea is indented by the external load 
there will be a tendency to decrease the volume and increase the pressure. This pressure 
affects both cornea and sclera, adding to their surface tension and enlarging their size to 
accommodate the volume. This is compatible with the literature that the increase in IOP 
of biological eye globes would lead to the expansion of the sclera. 487 
 
In developing the new equation, several improvements were made, and some of them 
are presented here. (1) The numerical models were modified until full stability was 
achieved that enabled a 100% convergence rate. This was mainly achieved by modifying 
the element type, mesh density and constitutive material parameters from Ogden order 
three to order one. (2) The adjustments made in the model structure reduced the 
simulation time for every analysis to around 4 minutes. (3) The process of developing 
and analysing the numerical models, and exporting the data was entirely automated 
using a custom build software package allowing analysing several models in parallel and 
eliminating the time consumed by human interactions. (4) These points allowed 
expanding the size of the parametric study and looking at wider ranges of parameters. 
(5) In addition, more parameters were calculated and exported from the numerical 
simulations that enabled capturing more features from the corneal deformation under 
air puff.  
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(6) The strategy for developing the equation was improved where complex 
interconnected optimisation procedures were employed to automatically construct the 
most optimum equation. In contrast, in previous studies, the form of the equation was 
manually adjusted, and only the coefficients were optimised automatically.424 (7) A new 
innovative objective function was formed that enabled the development of the equation 
using numerical models while considering the noise and variations associated with 
clinical data. (8) In this project, a new methodology was developed to analyse and 
characterise KC cones for the first time. This led to the development of realistic 
asymmetric corneal models representing true conditions in clinical cases. Since this 
information has not been available until now, no FE model could be created with the 
precision as those in this thesis. (9) Asymmetric cone features and parameters were also 
varied in this study that included cone area, height and location in relation to Corvis ST 
monitoring line. (10) The stiffness in the cone area of FE models was reduced based on 
a recent study on KC microstructures of human corneas. 488  
 
(11) These new initiatives enabled a deeper understanding of corneal behaviour under 
air pressure that led to the development of an improved equation for bIOP2. The bIOP2 
relied purely on parameters collected from Corvis ST to estimate IOP values for eyes 
with various conditions. Further, a second equation was developed to incorporate 
geometrical changes by collecting information from topography devices in addition to 
Corvis ST parameters. This equation was introduced as bIOP2-KC and is dedicated to 
keratoconic and distorted corneas. Cone characteristics utilised in this equation are 
based on the methodology developed in this study.  
 
The improvements achieved in estimating IOP values were validated and verified 
through a large clinical study. This study expanded beyond exploring the effect only on 
healthy and keratoconic eyes as in previous studies. It evaluated the effect of surgical 
procedures, including refractive corrections and corneal crosslinking on the 
measurement of the IOP. It further evaluated the bIOP2 on glaucoma patients and in 
comparison with other tonometers including GAT, DCT and ORA. In addition to the 
clinical studies, experimental data were assessed where the true IOP was available and 
could be compared with the new IOP estimates. With this, a holistic view was provided 
on the performance of the new equations which is discussed next.  
 
An ex vivo study previously conducted in the Biomechanical Engineering Group at the 
University of Liverpool controlled the IOP in five donor intact human eye globes under 
strict laboratory conditions. 447 With access to the data of this study, the new bIOP2 was 
compared to bIOP and CVSIOP. Based on this, CVSIOP showed the largest differences 
compared to the true IOP with a mean of 6.1+5.6 (-0.5-17.3) mmHg. This was followed 
by bIOP with a mean of -0.2+2 (-3.6-4.2) mmHg and bIOP2 of 0.0 + 0.6 (-1.4-1.5) 
mmHg. In that study, for each eye, multiple readings were taken, and the cases used in 
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this thesis may be different from those presented in a previous study. 447 This led to 
minor changes in the means and standard deviations of values presented in the Results 
section. However, the message remained the same as bIOP was also recalculated for the 
cases used in this thesis. Based on these findings, bIOP2 improved on the prediction of 
true IOP in comparison to bIOP, slightly in mean values and significantly reduced the 
deviations that refer to the spread of estimations. Both bIOP2 (p=0.976) and bIOP 
(p=0.989) were not significantly different from the true IOP. Previous studies showed 
large errors with GAT when compared to actual IOP (1.7±1.8 to 5.2 ±1.6 mmHg). 489-491 
Inconsistent findings were reported when DCT errors were evaluated (0.58 ±0.70 to 
2.3±2.4 mmHg). 492,493  
 
The study on all clinical data, as explained in results section 4.5.1, clearly demonstrated 
that the bIOP2 is less influenced by corneal biomechanics compared to bIOP and other 
tonometry devices like DCT, ORA and GAT. This improvement in estimating IOP 
values for post-refractive surgeries post crosslinking, and in keratoconic eyes are 
significant. Also, the correlation with age in healthy datasets and with both CCT and 
age in KC datasets were reduced in bIOP2 measurements. However, bIOP2 showed 
some correlations with CCT in KC datasets and for this reason, a second equation was 
developed called bIOP2-KC. This equation can estimate improved IOP values if the 
topography information is available. In addition to all parameters used for bIOP2, in 
bIOP2-KC other parameters such as cone location, height and area were added.  
 
 
5.1.3 Stress-Strain Index 2 (SSI2)  
The last two decades experienced fast growth in interest in corneal biomechanics and 
its effect on the outcome of refractive surgery, measurement of intraocular pressure 
(IOP) and progression and management of keratoconus 494-497. This growth in interest 
has led to a few attempts to quantify corneal biomechanics in-vivo including, most 
notably, the Brillouin modulus, the Corneal Resistance Factor (CRF) and the Corneal 
Hysteresis (CH) provided by the Ocular Response Analyzer (ORA), and the Corvis ST 
deformation parameters including the Stiffness Parameter (SP) and the Integrated 
Inverse Radius (IntInvR) 441,446,498,499. A detailed discussion of these methods was provided 
in section 2.5. A more recent development is the Corvis Stress-Strain Index (SSI) which 
was designed to estimate the material stiffness of the cornea – rather than its overall 
stiffness – and seeks to determine the whole stress-strain behaviour rather than a 
particular value of the tangent modulus 107. This latter point is of particular importance 
since corneal tissue is known to have nonlinear pressure - deformation behaviour and 
stress-strain behaviour, and hence the tangent modulus (Et) does not maintain a 
constant value but increases gradually with load, stress, deformation and strain 500.  
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The cornea’s overall stiffness is defined as its resistance to deformation under both 
internal loads (primarily the IOP) and external loads (such as eyelid pressure and 
tonometric loading). Stiffness has two major components; the geometric stiffness and 
the material stiffness, Figure 5-1. The geometric element is affected by corneal curvature 
and diameter but is dominated by corneal thickness, and this justifies the emphasis 
placed on the central corneal thickness (CCT) in correcting IOP measurements for the 
effects of corneal stiffness variations 501. All these parameters can be measured accurately, 
making the geometric stiffness of the cornea easy to quantify. In contrast, the corneal 
material stiffness presented significant challenges and until recently, it was not possible 
to estimate the full stress-strain behaviour in-vivo. The introduction of the SSI was 
intended to address this challenge and could, if successful, help, to detect the 
progression of keratoconus (where there is a deterioration in material stiffness) and 
assess the effectiveness of the collagen crosslinking treatment (by detecting increases in 
material stiffness) 107. 
 
Figure 5-1 Components of overall stiffness 
 
As explained in section 2.5.1.3, corneal deformation under air puff is influenced by 
both IOP and material stiffness. On the other hand, material behaviour is non-linear, 
which results in different corneal stiffness under different IOP values. The SSI was the 
first parameter that attempted to address this issue. The report on the SSI presented 
evidence of its independence of both corneal thickness and the IOP, and this point was 
illustrated using clinical data and experimental results of ex-vivo human corneas tested 
under artificial IOP 107. The development of SSI was based on numerical models and 
used three main parameters of CCT, bIOP and SP. In the parametric study done for 
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developing this algorithm, it was found that when material properties of the cornea 
changes, CCT, bIOP and SP can form a 3D surface presenting that particular material 
stiffness. Further, when the material stiffness was changed, these 3D surfaces did not 
intersect. Hence the idea was developed that using these three parameters and with the 
knowledge of the position of 3D surfaces from numerical models, the material stiffness 
of the cornea could be estimated.  
 
Based on this logic, SSI became the first parameter that could provide insights into the 
actual material stiffness of the cornea. However, as it was shown in the previous section, 
bIOP was influenced by CCT and age (corneal biomechanics). Hence as this parameter 
was used in SSI, naturally there will be an adverse effect on the estimation of material 
properties of the cornea using this algorithm. Further, this equation could be susceptible 
to noise in clinical data as the 3D surfaces were developed purely based on numerical 
models. Hence upon application of the algorithm on more recent clinical data, there 
seemed to be a correlation with age and CCT to varying degrees. When it was tested on 
patients after refractive surgeries, changes in SSI was more than expected, and the value 
became lower than the pre SSI due to correlations with geometrical components. 428 
 
A second study attempted to develop a new equation to overcome these shortfalls by 
developing more complex models. This study relied on a multi-physics fluid-structure 
interaction model of the air-puff test and performed a parametric study on human eyes. 
The new equation (fSSI), employs similar parameters as SSI that were CCT, SP and fIOP 
as described in the previous section.415 The performance of fSSI was found to be close 
to SSI, and hence the new equation was not implemented into Corvis ST. This thesis 
attempted to overcome these challenges by following a new methodology. The numerical 
simulations and the procedure for generating models, analysing them and collecting the 
data were completely revised as described in chapter 3.  
 
Apart from that, this thesis did not try to build 3D surfaces and use a limited number 
of parameters to estimate material properties. Instead, the inter-connected blocks of 
optimisation algorithms that were developed for designing bIOP2 were given the 
flexibility to obtain the optimum equation for SSI2. This brought a number of advantage 
to the new equation in addition to the 11 points mentioned earlier in section 5.1.2. 
These include (12) reduced dependency of SSI2 to only three parameters as in SSI, (13) 
compensating for noise in clinical data, (14) ability to use a more accurate IOP 
measurement that was developed in this thesis (bIOP2) and (15) utilising geometrically 
more representative numerical models. Hence to evaluate the performance of SSI2 
equation, it was applied to clinical data of healthy and KC corneas and those who 
undergo surgeries such as refractive corrections and CXL. All values were compared with 
SSI to demonstrate the performance of the new equation and improvements brought 
by following the new methodology. 
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As another form of validation, correlations between SSI/SSI2 and age were compared 
with an earlier study involving inflation tests on ex-vivo human corneas 123,502. The study, 
which involved 57 corneas tested under inflation conditions with a posterior pressure 
simulating IOP, resulted in a stress-strain relationship of the form: 
 
𝜎 = 𝐴[𝑒𝐵𝜀 − 1] 
Equation 5-1 
where  = stress,  = strain, A = 1.26 × 10-3 and B = 0.0013 age2 + 0.013 age + 99. Both 
parameters of A and B are dimensionless. As another form of validation, Equation 5-1 





= 𝐴𝐵 𝑒𝐵𝜀 = 𝐵 (𝜎 + 𝐴) 
Equation 5-2 
where Et is the tangent modulus. At the specific case with age = 50 years (at which 
SSI = 1.0), B = 102.9. Since the ratio between Et at any age and Et at age = 50 equals the 
ratio between SSI at this age and SSI at age 50 years, which is 1.0, therefore SSI at any 









This value of SSI, based on ex-vivo results given in terms of age, has been compared to 
the values of SSI obtained from the analysis of the in vivo results, obtained from the two 
clinical datasets. After the development of SSI2 for healthy corneas, there was a need to 
consider further variations in specific clinical conditions. First, a new equation was 
developed for patients with KC eyes. As shown in the first part of this chapter, the 
majority of KC cones are located on the inferior side of the cornea. Corvis ST only 
monitors the horizontal meridian located in the centre of the cornea. Hence it is unable 
to capture information from the cone area in the majority of KC eyes. If the clinician is 
aware that this eye is KC or not, then there is an opportunity to utilise this new 
information and improve the accuracy of corneal material estimation, and for this 
reason, SSI2-KC was developed.  
 
In regards to refractive surgeries such as Femtosecond laser-assisted in situ 
keratomileuses (LASIK), Small incision lenticule extraction (SMILE) and 
Transepithelial Photorefractive keratectomy (PRK), there is a further complication. The 
three laser vision correction (LVC) procedures do affect corneal stiffness to different 
extents – while all three involve ablating tissue, only LASIK and SMILE also require 
tissue separation through the creation of a flap and a cap, respectively 503. The flap and 
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the cap also have different characteristics with the flap having an almost complete 
separation from the residual stroma, and the cap maintaining a connection with the 
surrounding stroma except at the location of a short incision 504. These differences in 
characteristics are expected to have different effects on corneal biomechanics in general, 
and corneal stiffness in particular 505. As a result of this, another equation was developed 
to compensate for geometrical changes induced through these surgeries that specifically 
applies to patient post LASIK and SMILE, and it is called SS2-PLS.  
 
The first validation started by comparing SSI and SSI2 of seven healthy clinical datasets 
with stiffness changes found experimentally using inflation tests of ex-vivo human 
corneas. 123 Both parameters showed a strong correlation with age and followed the same 
trend as ex vivo findings. The correlation between SSI and ex vivo results were weaker 
than the SSI2. SSI2 followed the ex vivo trend almost parallel to its linear regression 
line. The spread of the data in SSI2 was smaller than SSI. The mean values of SSI and 
SSI2 were slightly larger than ex vivo results. SSI2 maintained a significant correlation 
in all seven datasets while SSI showed insignificant correlations in two datasets with ex 
vivo findings. This validates SSI values and demonstrates improvements achieved by 
SSI2 in regards to correlations with age.  
 
On the other hand, LASIK and SMILE are significantly different from PRK. Both 
surgeries involve tissue loss, similar to that of PRK, but they additionally require the 
separation of a top flap or cap 506. While the cap is potentially more efficient than the 
flap in transmitting the surface tension caused by the IOP, they would behave similarly 
under the flexural action of the concentrated, external air puff 507. In this case, the 
separation of the tissue into a thin anterior component (flap or cap) and a thicker 
posterior component (residual stroma), means that, under flexural actions (air-puff 
pressure), the contribution of the posterior component becomes dominant with that of 
the anterior flap or cap becoming negligible. Therefore, the effect of LASIK and SMILE 
is a reduction in geometric stiffness (due to both tissue ablation and separation), and 
this causes a large effect on the cornea’s overall stiffness and more than PRK. 
Comparable observations were made in a series of publications in the literature 505,508-510.  
 
Nevertheless, the material stiffness should remain stable after LASIK and SMILE, 
similar to what has been found after PRK. However, assessing this hypothesis met a 
challenge caused by the fact that the current SSI did not consider the tissue separation 
experienced in LASIK and SMILE 107. Therefore, considering the CCT measured 
postoperatively, which includes the thickness of the flap and cap, wrongly overestimates 
the geometric stiffness used in the calculations, and hence underestimates the material 
stiffness. For this reason, a new SSI algorithm was developed based on numerical 
modelling of the ocular globe that considered this difference in the two surgeries. The 
new parameter, which is called SSI2-PLS, was applied to three different datasets of 
patients who undergo LASIK and SMILE with the expectation that the pre and post 
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values remain the same, and they were compared to SSI. It should be noted that SSI was 
not designed to be applied to these datasets, and as a result, a larger reduction in values 
postoperatively is expected.  
 
Based on the analysis presented in section 4.5.2, it is clear that SSI2 was able to 
significantly improve the estimation of corneal biomechanics more independent from 
geometrical changes and IOP values. This is a crucial step forward in enabling 
personalised medicine in the field of ophthalmology and the only available method for 
measuring in vivo corneal biomechanics at the moment. It is expected that the value of 
SSI2 will be used in software and devices used in ophthalmology to optimise procedures 
such as refractive corrections or crosslinking.  
 
5.2 Limitations of Study 
In this research, an attempt was made to minimise the influence of limitations associated 
with reaching the desired outcome of this study as much as possible. Although the goal 
of the study was well met, some limitations are mentioned below.  
 
• The analysis of corneal elevation data based on the methodology proposed in 
this thesis is influenced by the accuracy of topographers. For instance, in 
Pentactam, the error is estimated to be around 100 microns, and this would 
influence the accuracy of cone characteristics parameters obtained from the 
methodology developed in this study. 
• The reliance of the SSI2 and bIOP2 equations on a single meridian from 
horizontal corneal thickness profile obtained with the Corvis ST may introduce 
slightly higher variability than what could be achieved with other imaging 
techniques, such as the rotating scheimpflug tomographers.  
• Another limitation is that the differences between the three surgeries in ablation 
profiles and the width of ablated tissue could have further effects on the cornea’s 
geometric stiffness. However, these effects are unknown and expected to be small 
and had been ignored in this study to avoid introducing further complexity in 
the analysis.  
• Measurements taken from different Corvis ST devices may be subjected to small 
inherent variations which could influence the precision of equations developed 
in this study. 
• Readings taken from distorted eyes using Corvis ST may require manual 
triggering of air puff that could influence the behaviour of the cornea. This is 
because, in the simulations done in this study, the distance from the cornea to 
the nozzle was assumed 11 mm. Manual handling of the device would potentially 
change this distance and results in higher or lower pressure on the cornea. This 
is a potential source of error in keratoconic and crosslinked cornea.  
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• The data used for pre-surgery in CXL datasets must be collected on the day of 
the surgery. If the readings were taken a couple of months before the surgery 
date, corneal stiffness would potentially be higher in KC eyes and would result 
in errors when compared to postoperative data. The data presented in this study 
could not be confirmed to adhere to this protocol.  
• The effect of wound healing in refractive surgery data is unknown, and its effect 
could not be considered in the development of equations. If this information 
could be provided, the accuracy of equations could be improved. 
• The eye model did not include extracellular muscles and orbital fat. Hence the 
effect of whole eye movement was removed from Corvis ST readings to match 
the numerical models. A better understanding of the whole eye movement could 
improve the accuracy of equations.  
• Lack of proper understanding of corneal hysteresis limited the use of data 
collected from the return of cornea from the highest concavity point back to the 
neutral position. This is because numerical simulations could not adapt to 
hysteresis behaviour, and this factor could not be considered in equation 
development.  
• It is not known that if CXL would increase the flexural behaviour of the cornea. 
All studies conducted in this field, tested the cornea under tension and showed 
an increase in stiffness. One study that used ultrasound techniques should only 
5% increase in stiffness. Hence although the new SSI2 equations show stiffening 
after CXL in the majority of cases, it is not known if the increased value of 
stiffening is representative of true changes in corneal biomechanics.  
• Due to variations between geometrical and visual axes, Corvis ST does not always 
shoot perpendicular to the apex as it was simulated in this study. These 
variations could have affected the accuracy and spread of readings.  
• An ideal method for validating SSI2 would be to test fresh donor human eyes 
ex-vivo and compare the Corvis ST estimate of the material stiffness with results 
obtained from inflation. However, obtaining human eyes is extremely difficult 
and costly and was not feasible for this study.  
• Since Corvis ST captures the behaviour of the horizontal meridian of the central 
cornea, the estimation of material stiffness obtained from SSI or SSI2 is 
presenting overall corneal material stiffness separate from geometrical 
components. In diseases corneas, there is a localised variation in material 
stiffness, and this could not be measured in this study.  
• With the ability to collect more information from the eye, it may be possible to 
develop one single equation for SSI2 and bIOP2. However, at this time, this 
would not be possible and led to the development of multiple equations that 
deal with specific clinical conditions.   
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5.3 Concluding Remarks 
The aim of this study was to develop new methods to measure corneal biomechanics in 
vivo and estimate IOP independent of corneal biomechanics and geometric variations. 
Were this outcome to be achieved, personalised medicine would be possible in 
ophthalmology. Possible applications for SSI2 include optimising the strength of CXL, 
adjusting ablation thickness in refractive surgery based on corneal biomechanics, 
customising contact lenses by considering the mechanical interaction with the cornea, 
and improving glaucoma management. The new methods and equations were indeed 
achieved in this study, and validation using both experimental and clinical data was 
performed. In conclusion: 
• This study proposed a new method to explore the changes in anterior and 
posterior corneal surfaces in patients with keratoconus and to define the cone-
shaped area. The method is intended to help improve understanding of corneal 
shape as keratoconus progresses and customise treatment regimens such as 
collagen crosslinking and intracorneal ring implantation. Also, this information 
would now enable the development of numerical models representative of KC 
conditions in research. 
• A large parametric study was conducted that adapted realistic KC corneal 
geometry with reduced localised material stiffness enabled a better 
understanding of corneal behaviour under air puff and led to the development 
of new equations for estimating IOP and corneal material stiffness in vivo. 
• Three new equations were developed and validated for estimating corneal 
material stiffness in health eyes (SSI2), KC and CXL eyes (SSI2-KC), and those 
post LASIK and SMILE (SSI2-PLS).  
• bIOP2 and SSI2 were validated with experimental data and evaluated on a large 
set of clinical data while being compared with previously developed equations 
and compared with key parameters. 
• The bIOP2 equation has significantly reduced the correlation with CCT and age 
in comparison to bIOP. It was also less affected by biomechanical changes in 
keratoconus patients and crosslinked eyes and in eyes that underwent refractive 
surgeries.  
• The bIOP2-KC performed better in reducing the correlation with CCT in KC 
eyes compared to bIOP2 and bIOP. However, the estimation of IOP using 
bIOP2-KC did not change significantly compared to bIOP2 equation. 
• New SSI2 equations were superior to SSI in being less correlated with CCT and 
IOP while having a stronger correlation with age in line with earlier ex vivo 
experimental results.  
• SSI2-KC was able to capture the changes in KC eyes with disease progression 
better than the previous equations. Also, when SSI and SSI2-KC were compared 
in pre and post CXL data, SSI2-KC performed better by showing a fewer number 
of corneas softening after surgery.  
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• SSI-PLS showed better stability when pre and post LASIK and SMILE surgery 
data were compared. This analysis proved that the new methodology adapted for 
developing SSI2 was more suitable for estimating corneal biomechanics and is 
less affected by noise in clinical data.  
 
5.4 Recommendations for Future Studies  
Some recommendations are provided for future research to improve the performance 
of the equations developed in this study and further expand to new areas. These 
recommendations are as below:  
• Improving the Corvis ST fixation target to a more advanced adjustable method 
that ensures the air puff is shooting perpendicular to the corneal apex and 
aligned by geometrical axis instead of the visual axis. 
• Ex vivo studies on fresh donor human eyes could enable better evaluation of the 
performance of SSI2. To do this, Corvis ST should be used to estimate 
biomechanics and then compared with inflation tests results as a measure of true 
material stiffness.  
• A better understanding of corneal hysteresis could enable the improvement of 
numerical simulations and information obtained from the highest concavity of 
the cornea back to the neutral position could be utilised in the equations.  
• If the true distance from the Corvis ST nozzle to the cornea could be measured, 
this new information could be used in numerical simulations to adjust the 
pressure on the cornea and improve the accuracy of equations.  
• Ex vivo studies should be conducted on healthy and CXL corneas under flexural 
force to accurately measure the amount of stiffening with crosslinking under air 
puff loading.  
• A better understanding of the wound healing effect could lead to more accurate 
simulations of the cornea after refractive surgeries and improve the accuracy of 
equations  
• Reducing the errors induced by human interactions, including manual 
triggering of the air puff, could lead to improved repeatability of results. The 
influence of this on measurements is not known, and a clinical study could be 
conducted to evaluate this.  
• Capturing deformation of the cornea in more meridians could lead to a better 
understanding of corneal response at localised locations. Studies should be 
conducted to measure the suitable locations.  
• The application of a large pressure such as air puff eliminates the ability to 
estimate localised changes in corneal biomechanics. Hence combining air puff 
with other techniques such as Brilouine microscopy or videography could enable 
measurement of corneal stiffness with the ability to adjust for localised variations 
on the corneal surface.   
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Section A - Biomechanically Corrected IOP (bIOP2) 
 





Dataset 2 includes 329 healthy patients with mean age of 36.9 ±16.4 (7.0 -85.0) years 
and CCT of 545 ±34 (459 -681) microns. The IOP values obtained from CVSIOP, bIOP 
and bIOP2 were 15.5 ±2.2 (10.5 -24.5) mmHg, 14.3 ±2.0 (7.8 -21.7) mmHg and 
15.5 ± 1.2 (12.8 -21.0) mmHg respectively. bIOP2 was least correlated with CCT 
(p:0.985, R:-0.001) and age (p:0.637, R:-0.026). bIOP performed better in correlation 
with CCT (p:0.531, R:-0.035) than CVSIOP (p:0.000, R:0.391). CVSIOP showed 
weaker correlation (p:0.896, R:-0.007) with age in comparison to bIOP (p:0.000, R:-




Figure 6-1 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Dataset 2 
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Dataset 3 
Dataset 3 consist of 412 healthy patients with mean age of 34.4 ±9.9 (7.0 -62.0) years 
and CCT of 545 ±33 (441 -663) microns. The IOP values obtained from CVSIOP, bIOP 
and bIOP2 were 15.0 ±2.7 (6.0 -28.5) mmHg, 15.0 ±2.3 (9.4 -26.5) mmHg and 
15.4 ± 1.3 (12.6 -21.7) mmHg respectively. In terms of correlation with CCT, bIOP 
(p:0.853, R:0.009) and bIOP2 (p:0.757, R:-0.015) showed weak correlations and 
CVSIOP (p:0.000, R:0.348) was significantly correlated. Correlation with age was 
weakest in bIOP2 (p:0.715, R:0.018), followed by CVSIOP (p:0.620, R:0.024) and bIOP 
(p:0.600, R:-0.026). None of the devices showed significant correlations with age, Figure 




Figure 6-2 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Dataset 3 
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Dataset 4 
Dataset 4 consist of 212 healthy patients with mean age of 27.1 ±5.7 (15.0 -47.0) years 
and CCT of 550 ±30 (418 -634) microns. The IOP values obtained from CVSIOP, bIOP 
and bIOP2 were 16.7 ±2.3 (11.5 -24.0) mmHg, 16.0 ±2.4 (11.7 -22.7) mmHg and 
15.7 ± 1.4 (11.9 -19.4) mmHg respectively. The correlation with CCT was weakest for 
bIOP(p:0.719, R:0.025) followed by bIOP2 (p:0.063, R:-0.128) and CVSIOP (p:0.000, 
R:0.346). Correlation with age was not significant in CVSIOP (p:0.675, R:0.029), bIOP 
(p:0.800, R:0.017) and bIOP2 (p:0.574, R:0.039), Figure 6-3. 
 
 
Figure 6-3 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Dataset 4 
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Dataset 5 
Dataset 5 consist of 55 healthy patients with mean age of 34.6 ±9.4 (12.0 -66.0) years 
and CCT of 552 ±35 (459 -614) microns. The IOP values obtained from CVSIOP, bIOP 
and bIOP2 were 16.1 ±2.3 (12.5 -20.5) mmHg, 14.9 ±2.2 (10.5 -19.8) mmHg and 15.9 
±1.3 (12.8 -18.5) mmHg respectively. The correlation with CCT (p:0.524, R:0.088) and 
age (p:0.294, R:-0.144) was weakest in bIOP2. bIOP showed weaker correlation 
(p:0.382, R:0.120) with CCT compared to CVSIOP (p:0.002, R:0.410). In terms of 
correlation with age, CVSIOP (p:0.028, R:-0.296) performed better than bIOP (p:0.013, 
R:-0.333), Figure 6-4. 
 
 
Figure 6-4 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Dataset 5 
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Dataset 6 
Dataset 6 consist of 244 healthy patients with mean age of 32.9 ±13.0 (7.0 -80.0) years 
and CCT of 549 ±34 (435 -645) microns. The IOP values obtained from CVSIOP, bIOP 
and bIOP2 are 16.0 ±2.1 (9.5 -24.0) mmHg, 14.5 ±1.8 (9.8 -22.9) mmHg and 15.7 ±1.1 
(13.3 -19.5) mmHg respectively. The correlation with CCT (p:0.707, R:-0.024) and age 
(p:0.844, R:-0.013) was weakest in bIOP2. bIOP showed weaker correlation (p:0.241, 
R:-0.075) with CCT compared to CVSIOP (p:0.000, R:0.395). in terms of correlation 





Figure 6-5 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Dataset 6 
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Dataset 7 
Dataset 6 consist of 337 healthy patients with mean age of 25.7 ±7.9 (10.0 -81.0) years 
and CCT of 526 ±36 (424 -629) microns. The IOP values obtained from CVSIOP, bIOP 
and bIOP2 were 15.8 ±2.5 (9.5 -27.5) mmHg, 15.3 ±2.2 (9.9 -23.6) mmHg and 
15.5 ± 1.3 (12.2 -20.9) mmHg respectively. The correlation with CCT (p:0.117, 
R:0.086) and age (p:0.295, R:-0.057) was weakest in bIOP2. bIOP showed weaker 
correlation (p:0.029, R:0.119) with CCT compared to CVSIOP (p:0.000, R:0.447). In 
terms of correlation with age, CVSIOP (p:0.257, R:-0.062) performed better than bIOP 
(p:0.001, R:-0.173), Figure 6-6. 
 
 
Figure 6-6 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Dataset 7 
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Dataset 8 
Combining all data resulted in 2117 healthy patients with mean age of 33.9 ±13.9 
(7.0  - 91.0) years and CCT of 541 ±34 (418 -681) microns. The IOP values obtained 
from CVSIOP, bIOP and bIOP2 were 15.5 ±2.5 (6.0 -29.0) mmHg, 14.8 ±2.2 
(7.8 - 26.5) mmHg and 15.5 ±1.3 (11.9 -22.6) mmHg respectively. The correlation with 
CCT (p:0.986, R:-0.000) and age (p:0.981, R:-0.001) was weakest in bIOP2. bIOP 
showed weaker correlation (p:0.972, R:-0.001) with CCT compared to CVSIOP 
(p:0.000, R:0.367). in terms of correlation with age, CVSIOP (p:0.122, R:-0.034) 




Figure 6-7 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Dataset 8 
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Dataset 2 includes 38 patients who undergo PRK surgery with mean age of 38.1 ±10.7 
(21.0 - 79.0) years, CCT of 541±33 (458 -623) microns, CVSIOP of 15.8 ±2.8 
(10.5 - 24.5) mmHg, bIOP of 15.3±2.2 (10.4-21.7) mmHg and bIOP2 of 15.9 ±1.4 
(13.1-19.9). The correlation with age was weak for CVSIOP (R:0.119, P:0.477), bIOP 
(R:0.018, P:0.915) and bIOP2 (R:0.185, P:0.267). Correlation with CCT was the 
weakest for bIOP2 (R:-0.041, P:0.807) followed by bIOP (R:0.167, P:0.316) and 
CVSIOP (R:0.492, P:0.002), Figure 6-8. 
 
 
Figure 6-8 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in pre surgery LASIK Dataset 2 
Demographics for post operative data showed mean age of 39.8 ±10.7 (23.0 -80.0)  years, 
CCT of 414±37 (343-502) microns, CVSIOP of 12.9 ±2.3 (8.5-20.5) mmHg, bIOP of 
15.2 ±2.0 (11.2-19.6) mmHg and bIOP2 of 16.3 ±0.9 (14.8 -18.2) mmHg. The Wilcoxon 
signed-rank test showed no significant differences between pre and post surgery 
measurements of bIOP (p:0.632), whereas both bIOP2 (p=0.003) and CVSIOP 
(p=0.000) were significantly different. The correlation remained weak with age for 
CVSIOP (R:0.300, P:0.067), bIOP (R:0.063, P:0.708) and bIOP2 (R:-0.189, P:0.255). 
The correlation with CCT was weakest for bIOP (R:-0.010, P:0.952) followed by bIOP2 
(R:-0.167, P:0.318) and CVSIOP (R:0.019. P:0.908), Figure 6-9.  
 
Figure 6-9 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in post surgery LASIK Dataset 2 
To better evaluate the differences between pre and post-refractive surgery, Bland Altman 
plots were produced for each IOP measurement method, Figure 6-10. Among all data, 
bIOP had the least differences in mean IOP values between pre and post with only 
0.12 mmHg. This was followed by bIOP2 with differences of 0.47 mmHg and the 
CVSIOP       bIOP         bIOP2 
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smallest standard deviation among all three. CVSIOP had the mean differences of 
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Figure 6-10 The Bland Altman plots for (A) bIOP, (B) bIOP2 and (C) CVSIOP comparing the pre and 
post IOP values in LASIK Dataset 2 
Dataset 2 also includes 47 patients who undergo LASIK surgery with mean age of 
35.6±7.4 (21.0-47.0) years, CCT of 549±34 (476 - 632) microns, CVSIOP of 15.4 ±2.8 
(11.0 -25.0) mmHg, bIOP of 14.9 ±2.2 (11.2 -  22.5) mmHg and bIOP2 of 15.7 ±1.4 
(13.8-18.8) mmHg. The correlation with age was weak for CVSIOP (R:-0.002, P:0.988), 
bIOP (R:-0.146, P:0.327) and bIOP2 (R:0.000, P:0.998). CCT correlation was the 
weakest for bIOP2 (R:0.117, P:0.434) followed by bIOP (R:0.124, P:0.408) and CVSIOP 
(R:0.485, P:0.001), Figure 6-11. 
 
 
Figure 6-11 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in pre surgery LASIK Dataset 2 
Demographics for post operative data showed mean age of 36.1±7.4 (21.0-48.0) years, 
CCT of 475±51 (348-583) microns, CVSIOP of 12.0±2.0 (6.5-17.0) mmHg, bIOP of 
13.4±1.8 (8.8 -17.3) mmHg and bIOP2 of 15.4±0.9(13.8-17.2). The Wilcoxon signed-
rank test showed no significant differences between pre and post surgery measurements 
of bIOP2 (p:0.153), whereas both bIOP (p=0.000) and CVSIOP (p=0.000) were 
significantly different. The correlation remained weakest with age for bIOP2 (R-0.103, 
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P:0.4901), followed by CVSIOP (R:-0.185, P:0.2135) and bIOP (R:-0.295, P:0.0441). 
The correlation with CCT was weakest for bIOP (R:0.031, P:0.836) followed by bIOP2 
(R:0.117, P:0.434) and CVSIOP (R:0.319, P:0.029), Figure 6-12.  
 
 
Figure 6-12 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in post surgery LASIK Dataset 2 
To better evaluate the differences between pre and post-refractive surgery data, Bland 
Altman plots were produced for each IOP measurement method, Figure 6-13. Among 
all data, bIOP2 had the least differences in mean IOP values between pre and post with 
only 0.25 mmHg and the smallest standard deviation. This was followed by bIOP2 with 
the differences of 1.5 mmHg and CVSIOP with 3.5 mmHg, which had the largest 
standard deviation too.  
 
(A) 
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Figure 6-13 The Bland Altman plots for (A) bIOP, (B) bIOP2 and (C) CVSIOP comparing the pre and 
post IOP values in LASIK Dataset 2 
Dataset 2 also includes 17 patients who undergo SMILE surgery with mean age of 
24.1±4.5 (18.0-31.0) years, CCT of 548±22( 515-595) microns, CVSIOP of 
17.2±1.8(14.5-20.5) mmHg, 16.8±1.3(14.5-19.0) mmHg and bIOP2 of 16.6±0.8 
(15.2 - 18.1) mmHg. The correlation with age was weak for CVSIOP (R:-0.134, 
P:0.608), bIOP (R:-0.145, P:0.579) and bIOP2 (R:-0.058, P:0.824). CCT correlation was 
weak for bIOP2 (R:0.229, P:0.376) and bIOP (R:0.219, P:0.399) but significant for 
CVSIOP (R:0.562, P:0.019), Figure 6-14. 
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Figure 6-14 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in pre surgery LASIK Dataset 2 
 
Demographics for post operative data showed mean age of 24.8±4.3 (19.0 -32.0) years, 
CCT of 450± 26 (409 -499) microns, CVSIOP of 14.1±1.5(12.0-16.5) mmHg, bIOP of 
16.2±1.5(14.3-19.1) mmHg and bIOP2 of 16.6 ±1.0(15.1-19.3). The Wilcoxon signed-
rank test showed no significant differences between pre and post surgery measurements 
of bIOP2 (p:0.795), whereas both bIOP (p=0.000) and CVSIOP (p=0.000) were 
significantly different post-surgery. The correlation with age for bIOP2 (R:-0.335, 
P:0.189),  bIOP (R:-0.334, P:0.191) and CVSIOP (R:-0.244, P:0.346) remained weak. 
The correlation with CCT was weakest for bIOP (R:-0.007, P:0.979) followed by bIOP2 
(R:0.062, P:0.813) and CVSIOP (R:0.203, P:0.434), Figure 6-15.  
 
 
Figure 6-15 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in post surgery LASIK Dataset 2 
To better evaluate the differences between pre and post-refractive surgery data, Bland 
Altman plots were produced for each IOP measurement method, Figure 6-13. Among 
all data, bIOP2 had the least differences in mean IOP values between pre and post with 
only 0.02 mmHg and the smallest standard deviation. This was followed by bIOP2 with 
the value of 0.62 mmHg and CVSIOP with 3.1 mmHg, which had the largest standard 
deviation too.  
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Figure 6-16 The Bland Altman plots for (A) bIOP, (B) bIOP2 and (C) CVSIOP comparing the pre and 
post IOP values in LASIK Dataset 2 
Dataset 3 
Dataset 3 includes longitudinal refractive surgery data including SMILE (60 eyes), 
LASIK (80 eyes) and PRK (62 eyes) surgeries recorded at 1, 3 and 6 months 
postoperatively. Detailed demographics, including operational parameters, are provided 
in Table 6-1. The IOP values measured using three different methods and reported in 
CVSIOP, bIOP and bIOP2, Table 6-2. 
  
Table 6-1 Demographics and surgical parameters for LASIK, SMILE and PRK surgeries in Dataset 3 
 PRK LASIK SMILE 
Age (year) 
25.7+4.9 
(17 - 36) 
25.9+4.8 
(17 - 37) 
26.3+6 




(5.6 - 7.4) 
6.6+0.4 
(5.9 - 7.3) 
6.6+0.2 
(6 - 6.9) 
SE (diopter) 
-5.2+1.9 
(-9.7 - -1.5) 
-5.2+1.6 
(-9.5 - -1.8) 
-5.3+1.6 
(-8.8 - -2.4) 
S (diopter) 
-4.8+1.9 
(-9.2 - -1) 
-4.9+1.5 
(-9 - -1.5) 
-4.9+1.6 
(-8.3 - -2.1) 
C (diopter) 
-0.7+0.6 
(-2.5 - 0) 
-0.6+0.6 
(-2.5 - 0) 
-0.7+0.5 




(0 - 180) 
51.5+68.9 
(0 - 180) 
104.7+73.7 
(0 - 180) 
Op D (mm) 
6.6+0.4 
(5.6 - 7.4) 
6.6+0.4 
(5.9 - 7.3) 
6.6+0.2 
(6 - 6.9) 
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Cu D (mm) 
8.1+0.4 
(6.9 - 8.8) 
7.7+0.4 
(6.9 - 8.3) 
7.3+0.4 




(85 - 187) 
88.4+21.1 
(35 - 122) 
104.5+20.1 





(323 - 481) 
352.2+28.7 
(302 - 429) 
321+22 
(284 - 376) 
 
 
Table 6-2 IOP values measured using three different methods for LASIK, SMILE and PRK in 1,3 and 6 
months post operatively in Dataset 3 




(509 - 603.7) 
446.4+40.5 
(351 - 543) 
445.4+41.6 
(347 - 539.7) 
443.8+38.8 




(10.8 - 19.8) 
11.2+2.6 
(6.5 - 21.2) 
10.9+2.2 
(6.5 - 16.8) 
10.9+2 




(10.1 - 17.5) 
13.3+2.4 
(9.2 - 23.6) 
13.1+2 
(9.2 - 18.5) 
13+1.8 




(12.9 - 17.1) 
16.2+1.1 
(14.5 - 21.7) 
15.9+0.8 
(12.7 - 18) 
15.7+0.6 





(511.2 - 603) 
450.6+33.6 
(376.3 - 540.7) 
454.3+34.6 
(377.4 - 538.8) 
453.8+33.3 




(10.5 - 18.2) 
10+1.9 
(6 - 14) 
10.1+1.8 
(6.5 - 14.1) 
10.1+1.7 




(10.1 - 18.4) 
12.1+1.7 
(8.3 - 15.8) 
12.2+1.6 
(9.4 - 15.9) 
12.1+1.6 




(13.4 - 17.9) 
15.5+0.6 
(14.2 - 17.1) 
15.4+0.7 
(13.7 - 17.1) 
15.4+0.6 





(506 - 634.7) 
458.2+23.7 
(415 - 517.3) 
460.2+21.5 
(420.5 - 518) 
459.4+21 




(9.5 - 17.7) 
10.4+1.8 
(7.1 - 17.5) 
10.3+1.8 
(6.8 - 17.8) 
10.3+1.6 




(9.4 - 16.9) 
12.5+1.8 
(8.2 - 19.8) 
12.4+1.8 
(8.3 - 20.3) 
12.4+1.6 




(12.7 - 18.1) 
15.7+0.8 
(13.9 - 18.7) 
15.5+0.7 
(13.6 - 19.3) 
15.4+0.6 
(13.8 - 16.8) 
 
Statistical analysis showed significant differences between all three IOP values and CCT 
when compared with preoperative measurements, Table 6-3. However, looking closely 
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at the differences between these values, CVSIOP had the largest differences and 
standard deviation with the mean of 3.7+2.0(-5.7 - 9.0) mmHg for all three surgeries. 
This was followed by bIOP with differences of 1.4+1.8(-8.3 - 6.3) mmHg and bIOP2 of 
-0.5+0.9 (-5.4 - 3) mmHg. These results show that bIOP2 estimated postoperative IOP 
values more accurately than the other three while having the smallest standard deviation. 
It should be noted that on average the CVSIOP and bIOP underestimated IOP values, 
whereas bIOP2 slightly overestimated IOP by 0.5 mmHg in this dataset. This difference 
in IOP value is minimal and clinically has no impact on diagnosis.  
 
Table 6-3 The differences between IOP measurements postoperatively in comparison to preoperative values 
for LASIK, SMILE and PRK surgeries in Dataset 3 
PRK 1M Post (Diff) 3M Post (Diff) 6M Post (Diff) 
CCT (microns) 
109.7+30.6 
(21 - 175) 
110.6+32.2 
(24.3 - 179) 
112.3+29.9 
(44 - 175.4) 
CVSIOP (mmHg) 
3.1+2.7 
(-5.7 - 9) 
3.3+2 
(-1 - 8) 
3.4+1.8 
(-1.8 - 7.7) 
bIOP (mmHg) 
0.6+2.5 
(-8.3 - 6.3) 
0.9+1.8 
(-2.8 - 5.5) 
1+1.7 
(-3.1 - 5) 
bIOP2 (mmHg) 
-1+1.2 
(-5.4 - 2.1) 
-0.8+0.9 
(-2.8 - 1.1) 
-0.6+0.9 
(-2.8 - 2.2) 
LASIK    
CCT (microns) 
103.8+26.3 
(51.1 - 163.7) 
100.1+27.3 
(49.7 - 162.6) 
100.6+26.5 
(52.8 - 166.9) 
CVSIOP (mmHg) 
3.9+2 
(-0.2 - 8.7) 
3.8+2.1 
(-1 - 9) 
3.8+1.9 
(-1.9 - 8) 
bIOP (mmHg) 
1.6+1.8 
(-2.2 - 5.9) 
1.6+1.9 
(-2.4 - 6.1) 
1.6+1.7 
(-3.3 - 5.4) 
bIOP2 (mmHg) 
-0.5+0.9 
(-2.2 - 2.2) 
-0.4+1 
(-2 - 2.2) 
-0.3+0.9 
(-2.3 - 2) 
SMILE    
CCT (microns) 
98.7+21.3 
(62.3 - 151.7) 
96.7+20.3 
(58 - 158) 
97.6+19.3 
(54.3 - 152.7) 
CVSIOP (mmHg) 
3.7+1.7 
(-1 - 8) 
3.8+1.7 
(-1.3 - 7.5) 
3.8+1.6 
(0.8 - 7.8) 
bIOP (mmHg) 
1.3+1.5 
(-3 - 5) 
1.4+1.5 
(-3.5 - 5) 
1.4+1.5 
(-1.3 - 5.2) 
bIOP2 (mmHg) 
-0.6+0.9 
(-2.3 - 2.4) 
-0.4+0.9 
(-2.7 - 3) 
-0.3+0.9 
(-2 - 2.9) 
 
In PRK data CVSIOP found to be correlated with CCT at all time points. bIOP and 
bIOP2 were both uncorrelated with CCT in preoperative data. However, in 
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postoperative data bIOP was found to be least correlated with CCT followed by bIOP2 
and CVSIOP, Figure 6-17. The statistical comparison is provided in Table 6-4. 
 





Table 6-4 the R and p values for evaluating correlations of IOP values with CCT for preoperative and 1,3 
and 6 months postoperative in PRK data 



















0.363 0.004 0.419 0.001 0.464 0.000 0.506 0.000 
bIOP (mmHg) -0.038 0.767 0.188 0.143 0.205 0.109 0.277 0.029 
bIOP2 (mmHg) 0.007 0.956 -0.300 0.018 -0.327 0.009 -0.339 0.007 
 
In terms of PRK data, there was no significant correlation with age in all groups and all 
measurement methods, Figure 6-18. The difference between the three methods are small 
and detailed analysis is provided in Table 6-5. 
CVSIOP        
bIOP          
bIOP2 
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Figure 6-18 The correlation of IOP values with age in PRK data for preoperative and 1,3 and 6 months 
postoperative 
Table 6-5 the R and p values for evaluating correlations of IOP values with age for preoperative and 1,3 
and 6 months postoperative in PRK data 



















-0.043 0.738 -0.129 0.318 -0.148 0.252 -0.013 0.922 
bIOP (mmHg) -0.106 0.411 -0.174 0.177 -0.199 0.121 -0.051 0.695 
bIOP2 (mmHg) -0.154 0.232 -0.133 0.301 -0.168 0.191 -0.048 0.712 
 
In LASIK data, CVSIOP was correlated with CCT in all groups. bIOP was not correlated 
with CCT and bIOP2 was not correlated with CCT only in preoperative data. The 
postoperative CCT was negatively correlated with bIOP2, Figure 6-19. Detailed analysis 
provided in Table 6-6. 
CVSIOP 
bIOP          
bIOP2 
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Figure 6-19 The correlation of IOP values with CCT in LASIK data for preoperative and 1,3 and 6 
months postoperative 
Table 6-6 the R and p values for evaluating correlations of IOP values with CCT for preoperative and 1,3 
and 6 months postoperative in LASIK data 



















0.277 0.013 0.364 0.001 0.325 0.003 0.305 0.006 
bIOP (mmHg) -0.017 0.880 0.039 0.732 -0.036 0.754 -0.036 0.748 
bIOP2 (mmHg) -0.043 0.703 -0.370 0.001 -0.384 0.000 -0.412 0.000 
 
In LASIK data, there was no correlation with age in all groups and all measurements, 
Figure 6-20. The detailed analysis is provided in Table 6-7. Correlations remained weak 
in all and especially with bIOP and bIOP2.  
 
CVSIOP 
bIOP          
bIOP2 
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Figure 6-20 The correlation of IOP values with age in LASIK data for preoperative and 1,3 and 6 
months postoperative 
 
Table 6-7 the R and p values for evaluating correlations of IOP values with age for preoperative and 1,3 
and 6 months postoperative in LASIK data 





















-0.025 0.826 0.094 0.407 0.135 0.231 0.218 0.052 
bIOP (mmHg) 0.003 0.981 -0.025 0.824 0.009 0.937 0.090 0.427 
bIOP2 (mmHg) 0.125 0.270 -0.002 0.983 0.102 0.369 0.112 0.323 
 
In SMILE data, correlation with CCT was weak with bIOP in all cases. The bIOP 
correlation was not significant in pre-op and six months post-op, but it was significant 
in other groups. CVSIOP was also not significantly correlated with CCT in this case, 
Figure 6-21. Detailed analysis provided in Table 6-8 
CVSIOP 
bIOP          
bIOP2 
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Figure 6-21 The correlation of IOP values with CCT in SMILE data for preoperative and 1,3 and 6 
months postoperative 
Table 6-8 the R and p values for evaluating correlations of IOP values with CCT for preoperative and 1,3 
and 6 months postoperative in SMILE data 





















0.251 0.053 -0.055 0.674 0.018 0.892 0.229 0.079 
bIOP (mmHg) -0.079 0.548 -0.243 0.061 -0.197 0.131 0.027 0.835 
bIOP2 (mmHg) -0.169 0.196 -0.348 0.006 -0.426 0.001 -0.167 0.202 
 
The correlation with age in SMILE group, similar to others, remained not significant 




bIOP          
bIOP2 
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Figure 6-22 The correlation of IOP values with age in SMILE data for preoperative and 1,3 and 6 
months postoperative 
 
Table 6-9 the R and p values for evaluating correlations of IOP values with age for preoperative and 1,3 
and 6 months postoperative in SMILE data 





















-0.176 0.179 -0.032 0.806 -0.083 0.527 -0.098 0.456 
bIOP (mmHg) -0.173 0.187 -0.058 0.658 -0.126 0.337 -0.127 0.332 




bIOP          
bIOP2 
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Dataset 2 includes 37 KC patients who undergo CXL with mean age of 
22.0 ± 5.0 (14 - 31)and CCT of 482.5±30.5 (447 - 567) microns. The three mean IOP 
values for CVSIOP was 13.6±2.2 (10.5 - 20.0) mmHg, with bIOP of 15.1±2.0 
(12.5 - 21.1) mmHg and bIOP2 of 16.1±1.0 (14.5 - 18.8) mmHg. Correlation with age 
was not significant for CVSIOP (R: -0.1834 ,p: 0.2773), bIOP (R: -0.2587,p: 0.1221) 
and bIOP2 (R: - 0.1011, p: 0.5514). Correlation with CCT was significant for 
CVSIOP(R: 0.3938, p: 0.0159) and insignificant for bIOP (R: 0.0609, p: 0.7205) and 
bIOP2 (R: 0.0525, p: 0.7578), Figure 6-23.  
 
 
Figure 6-23 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Pre CXL Dataset 2 
 
In dataset 2 post CXL, mean CCT was 487 ±29 (444 - 569) microns with CVSIOP of 
14.0±2.4 (9.5 - 21.5) mmHg, bIOP of 15.5±2.1 (11.9 - 21.5) mmHg and bIOP2 of 
16.1±1(14.4 - 19.0) mmHg. The correlation with age was not significant for CVSIOP 
(R: -0.1952 ,p: 0.2469 ), bIOP (R: -0.2511 ,p: 0.1338 ) and bIOP2 (R: -0.0396 
,p:  0.8162 ). CCT was significantly correlated with CVSIOP (R: 0.3955, p: 0.0154) but 
not significant with bIOP (R: 0.1107, p: 0.5144) and bIOP2 (R: 0.1177, p: 0.4877), 
Figure 6-24.  
 
 
CVSIOP       bIOP         bIOP2 
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Figure 6-24 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Post CXL Dataset 2 
 
The mean differences of CVSIOP was -0.47±2.32 (-8.5 - 4.5) mmHg (p: 0.230), bIOP 
was -0.41±2.09(-7.4 - 4.1) mmHg (p:0.245 ), and bIOP2 -0.04±0.99(-2.86 -1.91) mmHg 
(p: 0.815 ). It clearly shows that bIOP2 improved on both standard deviations and mean 
differences in comparison to bIOP when pre and post-CXL data were compared.  
 
CVSIOP       bIOP         bIOP2 
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Dataset 3 
Dataset 3 includes 21 KC patients who undergo CXL with mean age of 29.2±7.2 
(18 - 41) years and CCT of 484±31 (421 - 544) microns. The mean measurements of 
CVSIOP was 13.1 ±2.9 (7.5 -18.5) mmHg, with bIOP of 14.4±2.6 (9.8 -19.9) mmHg 
and bIOP2 of 15.9±1.0 (14.4 -18.0) mmHg. The correlation with age was not significant 
for CVSIOP (R: -0.0704, p: 0.7616 ), bIOP (R: -0.1823, p: 0.4291) and bIOP2 
(R: - 0.0915, p: 0.6934). Correlations with CCT was significant for CVSIOP (R: 0.4417, 
p: 0.0450) but not significant for bIOP (R: 0.2212, p: 0.3353) and bIOP2 (R: 0.0639, p: 
0.7830 ), Figure 6-25. 
 
 
Figure 6-25 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Pre CXL Dataset 3 
 
In post CXL data, mean CCT was 455±43 (332 -523) microns, with CVSIOP of 
14.1±2.4(9.5 -19) mmHg, bIOP of 16.0 ±2.1 (11.2 -19.5) mmHg and bIOP2 of 16.5 
±1.2 (13.8 -18.6) mmHg. The correlation with age was not significant for CVSIOP 
(R: 0.1793, p: 0.4368 ), bIOP (R: 0.0436, p: 0.8513) and bIOP2 (R: 0.3455, p: 0.1251). 
Correlation with CCT was significant with CVSIOP (R: 0.4760, p: 0.0292) but not 
significant for bIOP (R: 0.1988, p: 0.3875) and bIOP2 (R: -0.1962, p: 0.3941), Figure 
6-26. 
 
CVSIOP       bIOP         bIOP2 
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Figure 6-26 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Post CXL Dataset 2 
The differences between pre and post for CVSIOP were -1.07±2.22(-6 -1.5) mmHg 
(p:0.64), with bIOP of -1.56±2.07(-6.3 -1.2) mmHg (p:0.004 ), and bIOP2 of 
- 0.59 ±1.18(-2.69 -1.9) mmHg (p:0.053). This clearly shows that EIOP improved on 
standard deviation and the mean differences in comparison to bIOP.  
 
CVSIOP       bIOP         bIOP2 
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Dataset 4 
This dataset includes 69 KC eyes undergo CXL with mean age of 26.1±8.8(13 -56) years, 
CCT of 481.5±37.8(404 -565) microns, CVSIOP of 11.8±2.5(6 -19) mmHg, bIOP 
was13.3±2.4(7.8 -21.1) mmHg and bIOP2 of 15±1.2(11.8 -18.5) mmHg. The 
correlation with CCT for Corvis ST IOP was significant (R:0.318, p:0.0077) while both 
bIOP2 (R:0.0393, p:0.7486) and bIOP (R:0.0133, p:0.9138) remained insignificant. 
The correlation with age for Corvis ST IOP (R:-0.0193, p:0.8752), bIOP2 (R:0.0064, 
p:0.9585) and bIOP (R:-0.0508, p:0.6782) was not significant, Figure 6-27.  
 
 
Figure 6-27 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Pre CXL Dataset 4 
One month post operative data demographics showed mean age of 26.3±8.8(13 -56) 
years, CCT of 466.8±42.3(358 -572) microns, CVSIOP of 14.1±2.8(5.5 -22) mmHg, 
bIOP of 15.8±2.9(8.4 -24.2) mmHg and bIOP2 of 16.1±1.6(13.5-21.3) mmHg. The 
correlation with CCT was not significant for CVSIOP (R:0.1001, p:0.413), bIOP2 
(R: - 0.15, p:0.2187) and bIOP (R:-0.1984, p:0.1022). The correlation with age for 
CVSIOP (R:0.122, p:0.318), bIOP2 (R:0.1393, p:0.2537) and bIOP (R:0.0424, 
p:0.7296) remained insignificant, Figure 6-28.  
CVSIOP       bIOP         bIOP2 
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Figure 6-28 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in Post CXL Dataset 4 
The differences between pre and post for CVSIOP were -2.3±3.1(-12.5 -2.5) mmHg 
(p<0.001), with bIOP of -2.5±3(-12.6 -2.9) mmHg (p<0.001), and bIOP2 of -1.2±1.6 
( - 5 - 2.6) mmHg (p<0.001). This clearly shows that EIOP improved on standard 
deviation and the mean differences in comparison to bIOP.  
CVSIOP       bIOP         bIOP2 
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Dataset 2 includes healthy, Normal Tension Glaucoma (NTG), HTG and OHT. 
Healthy group with 37 patients had mean age of 72.2 ±10.4 (51.0 -87.0) years, CCT of 
554 ±33 (487 -626) microns and IOP was measured using GAT and Corvis ST. The 
CVSIOP was 15.4 ±2.9 (10.5 -26.5) mmHg with bIOP of 13.4 ±2.8 (7.7 -23.6) mmHg, 
bIOP2 of 15.0 ±1.7 (12.3 -21.7) mmHg, GAT of 16.4 ±1.7 (12.3 -21.7) mmHg and 
adjusted GAT (AdjGAT) of 15.4 ±1.7 (12.3 -21.7) mmHg. CVSIOP (p:0.830, R:-0.036), 
GAT (p:0.350, R:0.165) and bIOP2 (p:0.116, R:-0.263) showed no significant 
correlations with CCT, whereas bIOP (p:0.035, R:-0.347) and AdjGAT (p:0.000, 
R: - 0.685) values were correlated. Correlation with age was not significant in CVSIOP 
(p:0.724, R:0.060), bIOP (p:0.981, R:0.004), bIOP2 (p:0.860, R:-0.030), GAT (p:0.109, 
R: - 0.280) and AdjGAT (p:0.903, R:0.022), Figure 6-29.  
 
Figure 6-29 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in healthy group of Dataset 2 
 
In NTG group with 33 patients had mean age of 75.7 ±9.7 (47.0 -87.0) years and CCT 
of 504 ±34 (430 -573) microns. Mena IOP measurements for CVSIOP was 13.4 ±2.4 
(8.5 - 17.5) mmHg, with bIOP of 12.9 ±2.3 (8.9 -18.3) mmHg, bIOP2 of 14.4 ±1.0 
(12.3 - 16.6) mmHg, GAT of 13.7 ±1.0 (12.3 -16.6) mmHg and AdjGAT of 16.3 ±1.0 
(12.3 - 16.6) mmHg. Correlation with CCT was significant for AdjGAT (p:0.000, R:-
0.650) and not significant in GAT (p:0.621, R:0.100), bIOP (p:0.172, R:-0.243), 
CVSIOP (p:0.319, R:0.179) and bIOP2 (p:0.230, R:-0.215). Age was not correlated 
significantly with bIOP (p:0.608, R:-0.093), CVSIOP (p:0.790, R:0.048), bIOP2 
(p:0.082, R:-0.308), GAT (p:0.187, R:-0.262) and AdjGAT (p:0.823, R:-0.045), Figure 
6-30. 
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Figure 6-30 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in NTG group of Dataset 2 
In HTG group with 41 cases, patients had mean age of 71.4 ±10.3 (38.0 -91.0) years and 
CCT of 523 ±31 (451 -597) microns. Mean IOP measurements showed bIOP of 
14.8 ±3.1 (10.8 -25.8) mmHg, CVSIOP of 15.8 ±3.6 (11.0 -27.5) mmHg, bIOP2 of 
15.8 ±1.9 (13.0 -22.6) mmHg, GAT of 17.2 ±1.9 (13.0 -22.6) mmHg and AdjGAT of 
18.6 ±1.9 (13.0 -22.6) mmHg. Correlation with CCT was significant with GAT (p:0.011, 
R: 0.437) and insignificant with bIOP (p:0.648, R:0.073), CVSIOP (p:0.052, R:0.306), 
bIOP2 (p:0.516, R:0.104) and AdjGAT (p:0.568, R:0.105). Age had no correlation with 
bIOP (p:0.835, R:-0.034), CVSIOP (p:0.949, R:0.010), bIOP2 (p:0.588, R:-0.087), GAT 
(p:0.780, R:-0.051) and AdjGAT (p:0.831, R:0.039), Figure 6-31. 
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Figure 6-31 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in HTG group of Dataset 2 
Patients with OHT were 45 cases with mean age of 60.3 ±12.1 (20.0 -85.0) years and 
CCT of 547 ±53 (352 -640) microns. IOP measurements showed mean bIOP of 
17.0 ± 4.1 (10.4 -29.1) mmHg, CVSIOP of 18.8 ±4.8 (8.5 -30.5) mmHg, bIOP2 of 
17.6 ± 2.4 (13.6 -23.8) mmHg, GAT of 22.0 ±2.4 (13.6 -23.8) mmHg and AdjGAT of 
20.7 ± 2.4 (13.6 -23.8) mmHg. There was significant correlations with CCT for 
CVSIOP (p:0.026, R:0.332) and AdjGAT (p:0.001, R:-0.521) and no correlation with 
bIOP (p:0.940, R:0.012), bIOP2 (p:0.811, R:-0.037) and GAT (p:0.809, R:-0.041). Age 
had significant correlation with CVSIOP (p:0.042, R:0.304) and no significant 
correlaiton with bIOP (p:0.249, R:0.176), bIOP2 (p:0.411, R:0.125), GAT (p:0.974, 
R: - 0.005) and AdjGAT (p:0.404, R:0.141), Figure 6-32.  
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Figure 6-32 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in OHT group of Dataset 2 
  
CVSIOP       bIOP         bIOP2        
 GAT       AdjGAT 
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This data includes 143 KC eyes with mean age of 33.9 ±14.9 (14.0 -80.0) years, CCT of 
495 ±40 (315 -597) microns, bIOP of 14.1 ±2.0 (9.6 -20.0) mmHg, CVSIOP of 13.1 
±2.3 (7.0 -20.5) mmHg, bIOP2 of 15.5 ±1.1 (12.5 -19.0) mmHg. Both bIOP (p:0.771, 
R:0.025) and bIOP2 (p:0.123, R:-0.130) were not correlated with CCT while CVSIOP 
(p:0.000, R:0.385) correlation was significant. Correlartin with age followed similar 
pattern were bIOP (p:0.317, R:0.084) and bIOP2 (p:0.309, R:0.086) were not correlated 
and CVSIOP (p:0.011, R:0.213) was significantly correlated, Figure 6-33.  
 
Figure 6-33 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in KC Dataset 2 
Comparison of IOP values with the healthy group (based on disease severity) showed no 
significant differences with FFKC (p: 0.1100), Mild (p: 0.3252), Moderate (p: 0.2390) 
and Severe (p: 0.7709) groups for bIOP2. However, bIOP was significantly different in 
all cases (p<0.001), Figure 6-34. 
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Figure 6-34 The changes in bIOP2 and bIOP in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 2 
 
Dataset 3 
This dataset consist of 363 KC eyes with mean age of 33.2 ±10.8 (13.0 -72.0) years, CCT 
of 492 ±40 (345 -590) microns, bIOP of 13.5 ±2.3 (7.4 -23.4) mmHg, CVSIOP of 
12.3 ± 2.5 (6.0 -23.5) mmHg, bIOP2 of 15.5 ±1.1 (11.5 -20.2) mmHg. The correlation 
with CCT was not significant in bIOP (p:0.549, R:-0.032) and it was significant with 
both bIOP2 (p:0.009, R:-0.137) and CVSIOP (p:0.000, R:0.311). Correlation with age 
was not significant with bIOP (p:0.111, R:-0.084), CVSIOP (p:0.874, R:0.008) and 
bIOP2 (p:0.891, R:-0.007), Figure 6-35. 
 
Figure 6-35 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in KC Dataset 3 
The comparison of IOP values with the healthy group (based on disease severity) showed 
significant differences with FFKC (p: 0.0083) group, and no significant differences with 
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Mild (p: 0.1553), Moderate (p: 0.7524) and Severe (P: 0.7698) KC cases for bIOP2. IOP 
was significantly different (p < 0.001) in all cases with bIOP values, Figure 6-36.  
 
 
Figure 6-36 The changes in bIOP2 and bIOP in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 3 
Dataset 4 
This dataset consist of 227 KC eyes with mean age of 27.6 ±7.5 (12.0 -58.0) years, CCT 
of 482 ±40 (374 -636) microns, bIOP of  15.6 ±1.9 (8.5 -23.3) mmHg, CVSIOP of 
14.2 ± 2.1 (6.5 -21.5) mmHg and bIOP2 of 15.9 ±1.1 (13.3 -19.9) mmHg. Correlation 
with CCT was not significant for bIOP (p:0.204, R:-0.085) and bIOP2 (p:0.533, 
R: - 0.042) but sificant with CVSIOP (p:0.000, R:0.339). Correlation with age was 
signfiicnat for bIOP (p:0.033, R:-0.142) and insignificant for CVSIOP (p:0.540, 
R: - 0.041) and bIOP2 (p:0.529, R:0.042), Figure 6-37. 
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Figure 6-37 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in KC Dataset 4 
The comparison of IOP values with the healthy group (based on disease severity) showed 
bIOP was not significantly different in FFKC (p: 0.9856 ), Mild (p: 0.3665 ), Moderate 
(p: 0.1882 ) and Severe (p: 0.0893) groups. similarly bIOP2 showed no significant 
differences with FFKC (p: 0.0829), Mild (p: 0. 3673), Moderate (p: 0.4374) and Severe 
(p: 0.1849) cases, Figure 6-38.  
 
Figure 6-38 The changes in bIOP2 and bIOP in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 4 
Dataset 5 
Consist of 14 KC eyes with mean age of 33.6 ±12.2 (20.0 -66.0) years, CCT of 484 ±22 
(451 - 529) microns, bIOP of 13.9 ±1.8 (11.8 -16.7) mmHg, CVSIOP of 12.6 ±2.0 
(10.0 - 15.5) mmHg and bIOP2 of 15.3 ±1.1 (13.4 -17.1) mmHg. Correlation with CCT 
was significant with CVSIOP (p:0.021, R:0.608) but not significant with bIOP2 
(p:0.145, R:0.410) and bIOP (p:0.148, R:0.407). There was no correlation with age in 
bIOP (p:0.233, R:-0.341), CVSIOP (p:0.618, R:-0.146) and bIOP2 (p:0.699, R:-0.114), 
Figure 6-39. 
CVSIOP       bIOP         bIOP2 
bIOP       bIOP2 
219 | Appendices | Ashkan Eliasy 
 
219 | P a g e  
 
 
Figure 6-39 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in KC Dataset 5 
The comparison of IOP values with the healthy group (based on disease severity) showed 
no significant differences with bIOP2 in FFKC (p: 0. 4398), Mild (p: 0. 1625), Moderate 
(p: 0. 6866) and Severe (p: 0. 5159) groups. Whereas the bIOP was significant in Mild 
(p: 0.0050) group and not significant in FFKC (p: 0.1723), Moderate (p: 0.0878 ) and 
Severe (p: 0.0969 ), Figure 6-40.   
 
 
Figure 6-40 The changes in bIOP2 and bIOP in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 5 
Dataset 6 
Dataset 6 consist of 143 KC eyes with mean age of 34.1 ±12.1 (12.0 -66.0) years, CCT 
of 490 ±38 (396 -602) mirons, bIOP of 13.7 ±2.4 (7.1 -21.1) mmHg, CVSIOP of 
12.5 ± 2.3 (6.0 -19.0) mmHg and bIOP2 of 15.1 ±1.3 (12.0 -19.1) mmHg. Correlation 
with CCT was not significant with CVSIOP (p:0.971, R:-0.003) and significant with 
bIOP (p:0.000, R:-0.369) and bIOP2 (p:0.001, R:-0.278). There was no significant 
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correlation with age and bIOP (p:0.052, R:-0.163), CVSIOP (p:0.492, R:-0.058) or 
bIOP2 (p:0.821, R:-0.019), Figure 6-41. 
 
 
Figure 6-41 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in KC Dataset 6 
The comparison with mean values between different groups (based on disease severity) 
showed bIOP was significantly different (p<0.001) in all cases. bIOP2 was not significant 
in FFKC (p: 0.0505) and significant in Mild (p: 0.0179), Moderate (p<0.01) and Severe 
(p: 0.0386), Figure 6-42.  
 
Figure 6-42 The changes in bIOP2 and bIOP in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 6 
Dataset 7 
Dataset 7 consist of 405 KC eyes with mean age of 27.1 ±10.5 (10.0 -81.0) years, CCT 
of 484 ±43 (297 -636) microns, bIOP of 15.0 ±2.1 (8.6 -22.0) mmHg, CVSIOP of 13.6 
±2.3 (6.0 -23.5) mmHg and bIOP2 of 15.5 ±1.1 (12.6 -20.1) mmHg. CCT was 
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significantly correlated with CVSIOP (p:0.000, R:0.323) and not significant with both 
bIOP (p:0.155, R:-0.07) and bIOP2 (p:0.774, R:-0.014). Age was significantly correlated 
with bIOP (p:0.000, R:-0.186) and not significant with CVSIOP (p:0.403, R:-0.042) and 
bIOP2 (p:0.082, R:-0.086), Figure 6-43.  
 
Figure 6-43 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in KC Dataset 7 
The comparison of patients at different stages of the disease with the healthy group 
showed no significant difference in bIOP2 with FFKC (p: 0.3692), Mild (p: 0.5531), 
Moderate (p: 0.8557) and Severe (p: 0.0903). On the other hand, bIOP was not 
significantly different in FFKC (p: 0.9718) and Mild (p: 0.1322) group, but the moderate 
(p: 0.0209) and severe (p: 0.0004) groups were significant, Figure 6-44.  
 
Figure 6-44 The changes in bIOP2 and bIOP in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 7 
Dataset 8 
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Combining all cases, 1522 KC eyes of patients with mean age of 31.1 ±11.7 (10.0 -83.0) 
years, CCT of 487 ±40 (297 -636) microns, bIOP of 14.3 ±2.3 (6.1 -23.4) mmHg, 
CVSIOP of 13.1 ±2.4 (4.5 -23.5) mmHg, bIOP2 of 15.5 ±1.1 (11.5 -20.2) mmHg. The 
correlation were significant with CCT for bIOP (p:0.000, R:-0.113), CVSIOP (p:0.000, 
R:0.246) and bIOP2 (p:0.000, R:-0.120). Age was not significantly correlated with 
bIOP2 (p:0.343, R:-0.024) and CVSIOP (p:0.075, R:-0.046) and it was significant in 
bIOP (p:0.000, R:-0.171), Figure 6-45. 
 
Figure 6-45 Correlation of IOP values from CVSIOP, bIOP and bIOP2 with CCT (left) and age (right) 
in KC Dataset 8 
The comparison between the healthy IOP values with disease stages showed no 
significant difference in bIOP2 with FFKC (p: 0.1052), Mild (p: 0.3909), Moderate (p: 
0.1051) and Severe (p: 0.0676) groups. This comparison was found significant (p< 0.01) 
between bIOP values in all groups, Figure 6-46.  
 
Figure 6-46 The changes in bIOP2 and bIOP in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 8 
CVSIOP       bIOP         bIOP2 
bIOP       bIOP2 
223 | Appendices | Ashkan Eliasy 
 




This dataset includes 143 KC eyes with a mean age of 33.9±14.9(14 -80) years, CCT of 
495.3±40.1(315 -597) microns, bIOP2 of 15.5±1.1(12.5 -19) mmHg and bIOP2KC of 
15.4±1.1(12.3 -19.4) mmHg. bIOP2-kc (p:0.8716, R:0.0137) correlation with CCT was 
weaker than bIOP2 (p:0.1229, R:-0.1296). The correlation with age slightly improved 
in bIOP2-kc (p:0.3768, R:0.0747). compared to bIOP2 (p:0.3088, R:0.0857). The 
differences between the IOP values of the two equations were not significant (p:0.5043), 
Figure 6-47.  
 
 
Figure 6-47 Correlation of IOP values from bIOP2 and bIOP2-KC with CCT (left) and age (right) in 
KC Dataset 2 
The differences between IOP values in each group separated based on disease severity 
were compared to healthy and remained close to the previously calculated values in 
section 4.5.1.1.7. Hence the numbers are not presented again for this section as the 
conclusion remained the same, Figure 6-48.   
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Figure 6-48 The changes in bIOP2 and bIOP2-KC in healthy, FFKC, Mild, Moderate and Severe 
keratoconic cases in Dataset 2 
 
Dataset 3 
This dataset includes 363 KC eyes with a mean age of 33.2±10.8(13 -72) years, CCT of 
492.2±40.5(345 -590) microns, bIOP2 of 15.5±1.1(11.5 -20.2) mmHg and bIOP2KC of 
15.5±1.1(11.4 -19.9) mmHg. The correlation with CCT improved in bIOP2kc 
(p:0.1116, R:-0.0842) compared to bIOP2 (p:0.009, R:-0.1369). Correlation with age 
remained the same for both bIOP2kc (p:0.745, R:-0.0172) and bIOP2 (p:0.8913, 
R: - 0.0072). The differences between the IOP values of the two equations were not 
significant (p:0. 3333), Figure 6-49. 
 
 
Figure 6-49 Correlation of IOP values from bIOP2 and bIOP2-KC with CCT (left) and age (right) in 
KC Dataset 3 
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The differences between IOP values in each group separated based on disease severity 
were compared to healthy and remained close to the previously calculated values in 
section 4.5.1.1.7. Hence the numbers are not presented again for this section as the 




Figure 6-50 The changes in bIOP2 and bIOP2-KC in healthy, FFKC, Mild, Moderate and Severe 
keratoconic cases in Dataset 3 
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Dataset 4 
This dataset includes 227 KC eyes with a mean age of 27.6±7.5(12 -58) years, CCT of 
482.1±39.7(374 -636) microns, bIOP2 of 15.9±1.1(13.3 -19.9) mmHg and bIOP2KC of 
15.9±1.1(13.3 -20.2) mmHg. The correlation with CCT remained insignificant while 
bIOP2 (p:0.5335, R:-0.0415) showed negative correlations and bIOP2KC (p:0.3577, 
R:0.0616) showed positive correlations. Correlations with age remained the same for 
both bIOP2 (p:0.5294, R:0.042) and bIOP2KC (p:0.5078, R:0.0444). The differences 
between the IOP values of the two equations were not significant (p:0. 5689), Figure 
6-51. 
 
Figure 6-51 Correlation of IOP values from bIOP2 and bIOP2-KC with CCT (left) and age (right) in 
KC Dataset 4 
The differences between IOP values in each group separated based on disease severity 
were compared to healthy and remained close to the previously calculated values in 
section 4.5.1.1.7. Hence the numbers are not presented again for this section as the 
conclusion remained the same, Figure 6-52.   
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Figure 6-52 The changes in bIOP2 and bIOP2-KC in healthy, FFKC, Mild, Moderate and Severe 
keratoconic cases in Dataset 4 
 
Dataset 5 
This dataset includes 14 KC eyes with a mean age of 33.6±12.2(20 -66) years, CCT of 
483.9±21.9(451 -529) microns, bIOP2 of 15.3±1.1(13.4 -17.1) mmHg and bIOP2KC of 
15.2±1.2(13 -17.2) mmHg. The correlation with CCT for bIOP2 (p:0.1449, R:0.4104) 
and for bIOP2KC (p:0.1159, R:0.4394) remained the same. Similarly, the correlations 
with age for bIOP2 (p:0.6986, R:-0.1138) and bIOP2KC (p:0.6415, R:-0.1366) did not 
change. The differences between the IOP values of the two equations were not 
significant (p:0. 8362), Figure 6-53. 
 
Figure 6-53 Correlation of IOP values from bIOP2 and bIOP2-KC with CCT (left) and age (right) in 
KC Dataset 5 
The differences between IOP values in each group separated based on disease severity 
were compared to healthy and remained close to the previously calculated values in 
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section 4.5.1.1.7. Hence the numbers are not presented again for this section as the 
conclusion remained the same, Figure 6-54.   
 
 
Figure 6-54 The changes in bIOP2 and bIOP2-KC in healthy, FFKC, Mild, Moderate and Severe 
keratoconic cases in Dataset 5 
Dataset6 
This dataset includes 143 KC eyes with a mean age of 34.1±12.1(12 -66) years, CCT of 
490±38.5(396 -602) microns, bIOP2 of 15.1±1.3(12 -19.1) mmHg and bIOP2KC of 
15.2±1.2(12.6 -19.2) mmHg. The correlation with CCT improved in bIOP2KC 
(p:0.042, R:-0.1715) compared to bIOP2 (p:0.0008, R:-0.2775). The correlations with 
age remained the same for both bIOP2 (p:0.8205, R:-0.0191) and bIOP2KC (p:0.7416, 
R:-0.028). The differences between the IOP values of the two equations were not 
significant (p:0. 2901), Figure 6-55. 
 
Figure 6-55 Correlation of IOP values from bIOP2 and bIOP2-KC with CCT (left) and age (right) in 
KC Dataset 6 
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The differences between IOP values in each group separated based on disease severity 
were compared to healthy and remained close to the previously calculated values in 
section 4.5.1.1.7. Hence the numbers are not presented again for this section as the 
conclusion remained the same, Figure 6-56.   
 
 
Figure 6-56 The changes in bIOP2 and bIOP2-KC in healthy, FFKC, Mild, Moderate and Severe 
keratoconic cases in Dataset 6 
Dataset 7 
This dataset includes 402 KC eyes with a mean age of 27.2±10.5(10 -81) years, CCT of 
484±42.6(297 -636) microns, bIOP2 of 15.5±1.1(12.6 -20.1) mmHg and bIOP2KC of 
15.5±1.1(12.8 -20.2) mmHg. The correlations remain insignificant while bIOP2 
(p:0.7629, R:-0.0151) showed negative correlation and bIOP2KC (p:0.071, R:0.0904) 
had a positive correlation with CCT. Correlations with age remained insignificant for 
bIOP2 (p:0.0818, R:-0.0869) and significant for bIOP2KC (p:0.0313, R:-0.1077) while 
they both have a similar correlation with age. The differences between the IOP values 
of the two equations were not significant (p:0. 4406), Figure 6-57. 
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Figure 6-57 Correlation of IOP values from bIOP2 and bIOP2-KC with CCT (left) and age (right) in 
KC Dataset 7 
The differences between IOP values in each group separated based on disease severity 
were compared to healthy and remained close to the previously calculated values in 
section 4.5.1.1.7. Hence the numbers are not presented again for this section as the 
conclusion remained the same, Figure 6-58.   
 
 
Figure 6-58 The changes in bIOP2 and bIOP2-KC in healthy, FFKC, Mild, Moderate and Severe 
keratoconic cases in Dataset 7 
Dataset 8 
Combining of KC datasets resulted in 1522 KC eyes with a mean age of 31.1±11.7 
(10 - 83) years, CCT of 486.9±40.4(297 -636) microns, bIOP2 of 15.5±1.1(11.5 -20.2) 
mmHg and bIOP2KC of 15.5±1.1(11.4 -20.2) mmHg. There was no correlation with 
CCT for bIOP2KC (p:0.4228, R:-0.0207) while bIOP2 (p:0.000, R:-0.1204) showed 
weak significant negative correlations. The correlation with age remained the same for 
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both bIOP2KC (p:0.4248, R:-0.0206) and bIOP2 (p:0.3432, R:-0.0243). The differences 




Figure 6-59 Correlation of IOP values from bIOP2 and bIOP2-KC with CCT (left) and age (right) in 
KC Dataset 8 
The differences between IOP values in each group separated based on disease severity 
were compared to healthy and remained close to the previously calculated values in 
section 4.5.1.1.7. Hence the numbers are not presented again for this section as the 
conclusion remained the same, Figure 6-60.   
 
Figure 6-60 The changes in bIOP2 and bIOP2-KC in healthy, FFKC, Mild, Moderate and Severe 
keratoconic cases in Dataset 8 
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Section B - Stress-Strain Index (SSI2) 
 





It included 239 patients with a mean age of 37.5±16.3(7-85) years, CCT of 547±32 
(464 - 644) microns, bIOP of 15.7±1.2(13.0-21.1) mmHg, bIOP2 of 15.1±2.0 (8.7-21.9) 
mmHg, SSI of 0.96±0.19(0.58-1.64) and SSI2-H of 1.00±0.20(0.45-1.72). Correlation 
with CCT for SSI was R:0.171 (p:0.008), and became weaker for SSI2-H, which was 
R:0.004 (p:0.955). Correlation with age for SSI was R:0.549 (p:0.000) and for SSI2-H 
was R:0.931 (p:0.000). Correlation with bIOP2 for SSI and SSI2-H was R:0.445 
(p:0.000) and R:-0.163 (p:0.012). The SSI2-H had a weaker negative correlation and 
SSI2-H  stringer positive correlation, Figure 6-61.  
 
Figure 6-61 The correlation of SSI and SSI2-H  with CCT (left), age (middle) and IOP (right) in 
Dataset 2 
Dataset 3 
It included 326 patients with a mean age of 34.5±9.8(7-62) years, CCT of 548±33 
(447 - 661) microns, bIOP of 15.6±1.2(12.6-21.8) mmHg, bIOP2 of 14.9±2.2 
(10.1 - 27.1) mmHg, SSI of 1.01±0.20(0.52-1.71) and SSI2-H of 1.02±0.14(0.59-1.48). 
The correlation with CCT for SSI was significant with R:0.145 (p:0.009), and for SSI2-
H  was insignificant with R:-0.007 (p:0.899). Correlation with age for SSI was R:0.174 
(p:0.002) and for SSI2-H was R:0.710 (p:0.000). Correlation with bIOP2 for SSI and 
SSI2-H was R:0.387 (p:0.000) and R:-0.048 (p:0.391). SSI showed significant 
correlations with IOP while SSI2-H remained insignificant and weaker, Figure 6-62.  
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Figure 6-62 The correlation of SSI and SSI2-H  with CCT (left), age (middle) and IOP (right) in 
Dataset 3 
Dataset 4 
It included 182 patients with a mean age of 27.1±5.3(19-47) years, CCT of 553±27 
(470 - 633) microns, bIOP of 15.8±1.3(12.2-19.4) mmHg, bIOP2 of 16.4±2(12.3-22.2) 
mmHg, SSI of 1.02±0.20(0.52-1.73) and SSI2-H  of 1.00±0.11(0.79-1.31). Correlation 
with CCT for SSI was R:-0.013 (p:0.864), and for SSI2-H  was R:0.018 (p:0.812) and 
both remained weak. Correlation with age for SSI was R:0.266 (p:0.000) and for SSI2- H 
was R:0.730 (p:0.000). Correlation with bIOP2 for SSI and SSI2-H was R:0.617 
(p:0.000) and R:0.026 (p:0.730). SSI showed a large positive correlation with IOP while 
there was no correlation with SSI2-H, Figure 6-63. 
 
 
Figure 6-63 The correlation of SSI and SSI2-H  with CCT (left), age (middle) and IOP (right) in 
Dataset 4 
Dataset 5 
It included 47 patients with a mean age of 33.6±8.6(12-54) years, CCT of 554±33 
(459 - 615) microns, bIOP of 15.9±1.3(12.9-18.6) mmHg, bIOP2 of 15.6±1.9 
(11.5 - 19.1) mmHg, SSI of 0.90±0.13(0.56-1.15) and SSI2-H of 0.96±0.09(0.68-1.17). 
Correlation with CCT for SSI was R:0.008 (p:0.958), and for SSI2-H was R:-0.231 
(p:0.118) and both remained insignificant. Correlation with age for SSI was R:0.209, 
(p:0.158) and for SSI2-H was R:0.749 (p:0.000). Correlation with bIOP2 for SSI and 
SSI2-H was R:0.745 (p:0.000) and R:0.008 (p:0.958). SSI showed significant positive 
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Figure 6-64 The correlation of SSI and SSI2-H  with CCT (left), age (middle) and IOP (right) in 
Dataset 5 
Dataset 6 
It included 122 patients with a mean age of 34.5±14.1(0-80) years, CCT of 552±32 
(473 - 645) microns, bIOP of 15.7±1.1(13.4-19.6) mmHg, bIOP2 of 15.6±1.9 
(10.1 - 22.8) mmHg, SSI of 0.93±0.19(0.53-1.79) and SSI2-H  of 1.00±0.16(0.65-1.62). 
Correlation with CCT for SSI was R:0.125 (p:0.169), and for SSI2-H was R:-0.056 
(p:0.529) and remained insignificant for both. Correlation with age for SSI was R:0.466 
(p:0.000) and for SSI2-H was R:0.911 (p:0.000). Correlation with bIOP2 for SSI and 
SSI2-H was R:0.506 (p:0.000) and R:0.097 (p:0.286). Significant positive correlations 
were observed in SSI while SSI2-H was not correlated, Figure 6-65.  
 
 
Figure 6-65 The correlation of SSI and SSI2-H  with CCT (left), age (middle) and IOP (right) in 
Dataset 6 
Dataset 7 
It included 78 patients with a mean age of 26.2±5.6(11-44) years, CCT of 523±28 
(456 - 617) microns, bIOP of 15.5±1.1(13.1-18.7) mmHg, bIOP2 of 16.8±1.8 
(12.1 - 22.5) mmHg, SSI of 0.9±0.25(0.52-1.66) and SSI2-H  of 1.0±0.13(0.81-1.55). 
Correlation with CCT was significant for both where for SSI was R:0.258 (p:0.023), and 
for SSI2-H was R:0.402 (p:0.000). Correlation with age for SSI was R:0.035 (p:0.763) 
and for SSI2-H  was R:0.463 (p:0.000). Correlation with bIOP2 for SSI and SSI2-H was 
R:0.429 (p:0.000) and R:-0.062 (p:0.590). SSI2-H was not correlated with IOP while 
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Figure 6-66 The correlation of SSI and SSI2-H  with CCT (left), age (middle) and IOP (right) in 
Dataset 7 
Dataset 8 
Combining all datasets resulted in 1410 patients with a mean age of 35.2±14(0-91) years, 
CCT of 545±32(447-661) microns, bIOP of 15.6±1.3(12.2-22.8) mmHg, bIOP2 of 
15.3±2.2(7.7-27.1) mmHg, SSI of 1±0.22(0.52-1.87) and SSI2-H  of 1.03±0.17 
(0.45 - 1.74). Correlation with CCT for SSI was significant with R:0.111 (p:0.000), while 
SSI2-H  was not correlated with R:-0.003 (p:0.899). Correlation with age for SSI was 
R:0.419 (p:0.000) and for SSI2-H  was R:0.841 (p:0.000). Correlation with bIOP2 for 
SSI and SSI2-H  was R:0.471 (p:0.000) and R:0.000 (p:0.999). This shows that SSI is 
highly correlated with IOP, while SSI2-H  has no correlation at all and is more 
representative of tissue’s material behaviour, Figure 6-67.  
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It includes 53 patients who undergo SMILE surgery with a mean CCT of 558±30 
(496 - 636) microns, age of 26.8±5.1(17-39) years, bIOP of 14.4±2.1(10.1-19.2) mmHg, 
bIOP2 of 15.4±1.2(12.7-18.5) mmHg, SSI of 0.98±0.14(0.75-1.46) and SSI2-H of 
0.86±0.12(0.54-1.16). After SMILE these values changed to a mean CCT of 
451±39(371-543) microns, age of 27.4±5.2(17-40) years, bIOP of 13.8±2 (9.4 - 17.7) 
mmHg, bIOP2 of 16±0.9(14.1-17.9) mmHg, SSI of 0.97±0.18(0.73-1.52) and SSI2-H 
of 0.84±0.08(0.66-1.03). To evaluate the performance of SSI values, 
(Pre SSI – Post SSI)/ Pre SSI was calculated. This value for SSI was 0.126±0.102  and 
for SSI2-H was 0.010±0.111. Bland Altman plots are provided to visualise these 
changes, Figure 6-68. 
 
 
Figure 6-68 Bland Altman plot for SSI2-H  (top) and SSI (bottom) comparing the pre and post PRK 
surgery results in Dataset 2 
SSI2-H  SSI 
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Further, the correlations between changes in CCT and SSI/SSI2-H  were evaluated. The 
correlation for SSI was R:-0.342 (p:0.011) and for SSI2-H was R:-0.007 (p:0.961). SSI, 
in this case, was significantly correlated with changes in CCT while SSI2-H did not 
correlate, Figure 6-69.  
 
Figure 6-69 The evaluation of correlation in changes in CCT with changes in SSI and SSI2-H  in PRK 
group of Dataset 2 
Correlations with CCT before surgery for SSI was R:-0.042 (p:0.765) and for SSI2-H 
was R:-0.116 (p:0.404) and insignificant in both cases. Age correlation with SSI was 
R:0.096 (p:0.490) and with SSI2-H was R:0.577 (p:0.000). Correlation of bIOP2 with 
SSI was strong and significant with R:0.345 (p:0.011) while SSI2-H had a similar 
correlation in the negative direction with R:-0.341 (p:0.012), Figure 6-70. 
 
Figure 6-70 The correlation of SSI and SSI2-H  with CCT (left), age (middle) and IOP (right) in pre-
surgery PRK group of Dataset 2 
 
Correlations with CCT before surgery for SSI was R:-0.070 (p:0.617) and for SSI2-H  
was R:-0.014 (p:0.920) and both remained insignificant. Age correlation with SSI was 
negative with R:-0.05 (p:0.972) and with SSI2-H was positive with R:0.633 (p:0.000). 
Correlation of bIOP2 with SSI was substantial and significant with R:0.590 (p:0.000) 
SSI SSI2-H 
SSI SSI2-H 
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Figure 6-71 The correlation of SSI and SSI2-H  with CCT (left), age (middle) and IOP (right) in post-
surgery PRK group of Dataset 2 
  
SSI SSI2-H 
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It included 143 patients with a mean age of 33.9±14.9(14-80) years, CCT of 
495±40(315-597) microns, bIOP of 14.1±2(9.6-20) mmHg, bIOP2 of 15.5±1.1(12.5-19) 
mmHg, SSI of 0.89±0.37(0.47-4.5) and SSI2-KC of 0.76±0.22(0.38-2). Correlation with 
CCT for SSI was high and significant with R:0.222 (p:0.008), while for SSI2-KC was it 
remained insignificant and weak with R:0.027 (p:0.750). Correlation with age for SSI 
was R:0.132 (p:0.117) and for SSI2-KC was R:0.747 (p:0.000). Correlation with bIOP2 
for SSI was large and significant with R:0.199 (p:0.017) while SS2 was not correlated 
and insignificant with R:0.008 (p:0.921), Figure 6-72. 
 
Figure 6-72 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in 
Dataset 2 
When comparing the changes in SSI and SSI2-KC with disease progression, it is clear 
that SSI2-KC followed a clear trend. In severe cases, corneal biomechanics changed and 
became softer than less severe or healthy patients. However, SSI changed were 
inconsistent and particularly in the Moderate group had a large standard deviation. 
SSI2-KC showed a more significant softening in Mild, Moderate and Severe cases, 
Figure 6-73. The detailed analysis for means, standard deviations and statistical 
comparison of SSI/ SSI2-KC values to the healthy group is provided in Table 6-10.   
 
SSI SSI2-KC 
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Figure 6-73 The changes in SSI2-KC and SSI in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 2 
 
Table 6-10 Showing the mean, standard deviation (SD) and statistical comparison with the healthy group 
for SSI / SSI2-KC in the same format as shown here in Dataset 2 
Mean 0.96/1 0.92/0.94 0.92/0.8 0.87/0.72 0.8/0.68 
SD 0.19/0.2 0.21/0.2 0.21/0.23 0.55/0.21 0.19/0.18 




It included 363 patients with a mean age of 33.2±10.8(13-72) years, CCT of 
492±40(345-590) microns, , bIOP of 13.5±2.3(7.4-23.4) mmHg, bIOP2 of 
15.5±1.1(11.5-20.2) mmHg, SSI of 0.9±0.24(0.43-2.19) and SSI2-KC of 
0.73±0.16(0.29-1.31). Correlation with CCT for SSI was R:0.328 (p:0.000), and for 
SSI2-KC was R:0.203 (p:0.000) where both are significant. Correlation with age for SSI 
was R:0.144 (p:0.006) and for SSI2-KC was R:0.699 (p:0.000). Correlation with bIOP2 
for SSI was large and significant with R:0.526 (p:0.000) while SSI2-KC remained 
insignificant and not correlated with R:0.043 (p:0.418), Figure 6-74. 
SSI SSI2-KC 
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Figure 6-74 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in 
Dataset 3 
When comparing the changes in SSI and SSI2-KC with disease progression, it is clear 
that both equations followed a clear trend. In severe cases, corneal biomechanics 
changed and became softer than less sever or healthy patients. SSI2-KC showed a more 
significant softening in Mild, Moderate and Severe cases, Figure 6-75. The detailed 
analysis for means, standard deviations and statistical comparison of SSI values to the 
healthy group is provided in Table 6-11.   
 
 
Figure 6-75 The changes in SSI2-KC and SSI in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 3 
 
Table 6-11 Showing the mean, standard deviation (SD) and statistical comparison with the healthy group 
for SSI / SSI2-KC in the same format as shown here in Dataset 3 
Mean 1.01/1.02 1.02/1 0.98/0.81 0.88/0.72 0.81/0.66 
SD 0.2/0.14 0.21/0.15 0.22/0.15 0.24/0.15 0.21/0.15 
SSI SSI2-KC 
SSI SSI2-KC 
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It included 227 patients with a mean age of 27.6±7.5(12-58) years, CCT of 482±40 
(374 -636) microns, bIOP of 15.6±1.9(8.5-23.3) mmHg, bIOP2 of 15.9±1.1(13.3-19.9) 
mmHg, SSI of 0.91±0.24(0.51-1.77) and SSI2-KC of 0.74±0.14(0.34-1.14). Correlation 
with CCT for SSI was large and significant with R:0.291 (p:0.000), while for SSI2, it 
remained weak and insignificant with R:0.054 (p:0.417). Correlation with age for SSI 
was R:0.238 (p:0.000) and for SSI2-KC was R:0.603 (p:0.000). Correlation with bIOP2 
for SSI was large and significant with R:0.637 (p:0.000) and for SSI2-KC it became weak 
and insignificant R:0.098 (p:0.141), Figure 6-76. 
 
Figure 6-76 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in 
Dataset 4 
When comparing the changes in SSI and SSI2-KC with disease progression, it is clear 
that SSI2-KC equation followed a clear trend. In severe cases, corneal biomechanics 
changed and became softer than less sever or healthy patients. SSI did not follow any 
trend, and it increased and decreased in various group. SSI2-KC showed a more 
significant softening in Mild, Moderate and Severe cases, Figure 6-77. The detailed 
analysis for means, standard deviations and statistical comparison of SSI values to the 
healthy group is provided in Table 6-12.   
 
SSI SSI2-KC 
243 | Appendices | Ashkan Eliasy 
 
243 | P a g e  
 
 
Figure 6-77 The changes in SSI2-KC and SSI in healthy, FFKC, Mild, Moderate and Severe keratoconic 






Table 6-12 Showing the mean, standard deviation (SD) and statistical comparison with the healthy group 
for SSI / SSI2-KC in the same format as shown here in Dataset 4 
Mean 1.02/1 1.16/0.95 0.97/0.79 0.84/0.71 0.88/0.7 
SD 0.2/0.11 0.26/0.18 0.23/0.14 0.19/0.13 0.29/0.13 




It included 14 patients with a mean age of 33.6±12.2(20-66) years, CCT of 484±22 
(451 -529) microns, bIOP of 13.9±1.8(11.8-16.7) mmHg, bIOP2 of 15.3±1.1 
(13.4 - 17.1) mmHg, SSI of 0.82±0.19(0.46-1.12) and SSI2-KC of 0.73±0.14(0.52-1.09). 
Correlation with CCT for SSI was strong with R:0.546 (p:0.044), and for SSI2-KC weak 
and insignificant with R:0.239 (p:0.410). Correlation with age for SSI was R:0.108 
(p:0.714) and for SSI2-KC was R:0.821 (p:0.000). Correlation with bIOP2 for SSI was 
large and significant with R:0.821 (p:0.000) while SSI2-KC remained not correlated 
with R:0.012 (p:0.968), Figure 6-78. 
SSI SSI2-KC 
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Figure 6-78 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in 
Dataset 5 
When comparing the changes in SSI and SSI2-KC with disease progression, it is clear 
that both equations followed a trend. They both reduced with disease severity; however, 
SSI changes are small. SSI2-KC showed a more significant softening in Mild, Moderate 
and Severe cases, Figure 6-79. The detailed analysis for means, standard deviations and 
statistical comparison of SSI values to the healthy group is provided in Table 6-13.   
 
 
Figure 6-79 The changes in SSI2-KC and SSI in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 5 
Table 6-13 Showing the mean, standard deviation (SD) and statistical comparison with the healthy group 
for SSI / SSI2-KC in the same format as shown here in Dataset 5 
Mean 0.9/0.96 0.86/0.98 0.82/0.75 0.84/0.76 0.73/0.52 
SD 0.13/0.09 0.1/0.2 0.21/0.09 0.2/0.2 0/0 
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Dataset 6 
It included 143 patients with a mean age of 34.1±12.1(12-66) years, CCT of 
490±38(396-602) microns, bIOP of 13.7±2.4(7.1-21.1), bIOP2 of 15.1±1.3(12-19.1), 
SSI of 0.73±0.18(0.42-1.36) and SSI2-KC of 0.68±0.15(0.33-1.15). Correlation with 
CCT for SSI was R:0.082 (p:0.330), and for SSI2-KC was R:0.049 (p:0.560) where both 
are small and insignificant. Correlation with age for SSI was R:0.116 (p:0.166) and for 
SSI2-KC was R:0.785 (p:0.000). Correlation with bIOP2 for SSI was strong and 
significant with R:0.667 (p:0.000) while SSI2-KC remained insignificant with R:0.125 
(p:0.125), Figure 6-80. 
 
Figure 6-80 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in 
Dataset 6 
When comparing the changes in SSI and SSI2-KC with disease progression, it is clear 
that both equations followed a clear trend. In severe cases, corneal biomechanics 
changed and became softer than less sever or healthy patients. SSI2-KC showed a more 
significant softening in Mild, Moderate and Severe cases, Figure 6-81. The detailed 
analysis for means, standard deviations and statistical comparison of SSI values to the 
healthy group is provided in Table 6-14.   
 
 
Figure 6-81 The changes in SSI2-KC and SSI in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 6 
SSI SSI2-KC 
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Table 6-14 Showing the mean, standard deviation (SD) and statistical comparison with the healthy group 
for SSI / SSI2-KC in the same format as shown here in Dataset 6 
Mean 0.93/1 0.90/0.94 0.81/0.71 0.72/0.69 0.68/0.65 
SD 0.19/0.16 0.17/0.19 0.17/0.12 0.18/0.18 0.17/0.13 
p value 1/1 0.647/0.039 0.000/0.000 0.000/0.000 0.000/0.000 
 
Dataset 7 
It included 402 patients with a mean age of 27.2±10.5(10-81) years, CCT of 
484±43(297-636) microns, bIOP of 15±2.1(8.6-22) mmHg, bIOP2 of 
15.5±1.1 (12.6 - 20.1) mmHg, SSI 0.82±0.19(0.39-1.66) and SSI2-KC of 0.7±0.14 
(0.34 - 1.35). Correlation with CCT for SSI was large and significant with R:0.321 
(p:0.000), and for SSI2-KC was weaker but still significant with R:0.176 (p:0.000). 
Correlation with age for SSI was R:0.134 (p:0.007) and for SSI2-KC was R:0.775 
(p:0.000). Correlation with bIOP2 for SSI was large and significant with R:0.580 
(p:0.000) while SSI remained not correlated with R:-0.042 (p:0.405), Figure 6-82. 
 
Figure 6-82 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in 
Dataset 7 
When comparing the changes in SSI and SSI2-KC with disease progression, it is clear 
that both equations followed a clear trend. In severe cases, corneal biomechanics 
changed and became softer than less severe or healthy patients. SSI2-KC showed a more 
significant softening in Mild, Moderate and Severe cases, Figure 6-83. The detailed 
analysis for means, standard deviations and statistical comparison of SSI values to the 
healthy group is provided in Table 6-15.   
 
SSI SSI2-KC 
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Figure 6-83 The changes in SSI2-KC and SSI in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 7 
 
Table 6-15 Showing the mean, standard deviation (SD) and statistical comparison with the healthy group 
for SSI / SSI2-KC in the same format as shown here in Dataset 7 
Mean 0.9/1 0.93/0.91 0.87/0.74 0.81/0.69 0.69/0.62 
SD 0.25/0.13 0.19/0.13 0.18/0.13 0.19/0.13 0.16/0.13 
p value 1/1 0.059/0.000 0.671/0.000 0.012/0.000 0.000/0.000 
 
Dataset 8 
Combining all datasets resulted in 1522 patients with a mean age of 31.1±11.7(10-83) 
years, CCT of 487±40(297-636) microns, bIOP of 14.3±2.3(6.1-23.4) mmHg, bIOP2 of 
15.5±1.1(11.5-20.2) mmHg, SSI of 0.86±0.25(0.1-4.5) and SSI2-KC of 0.73±0.16 
(0.29 - 2). Correlation with CCT for SSI was strong with R:0.257 (p:0.000), and for 
SSI2-KC weaker with R:0.131 (p:0.000). Correlation with age for SSI was R:0.164 
(p:0.000) and for SSI2-KC was R:0.716 (p:0.000). Correlation with bIOP2 for SSI was 
strong with R:0.516 (p:0.000) while SSI2-KC was weaker with R:0.068 (p:0.008) but still 
significant, Figure 6-84. 
SSI SSI2-KC 
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Figure 6-84 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in 
Dataset 8 
When comparing the changes in SSI and SSI2-KC with disease progression, it is clear 
that both equations followed a clear trend. In severe cases, corneal biomechanics 
changed and became softer than less sever or healthy patients. SSI2-KC showed a more 
significant softening in Mild, Moderate and Severe cases, Figure 6-85. The detailed 
analysis for means, standard deviations and statistical comparison of SSI values to the 
healthy group is provided in Table 6-16.   
 
 
Figure 6-85 The changes in SSI2-KC and SSI in healthy, FFKC, Mild, Moderate and Severe keratoconic 
cases in Dataset 8 
 
Table 6-16 Showing the mean, standard deviation (SD) and statistical comparison with the healthy group 
for SSI / SSI2-KC in the same format as shown here in Dataset 8 
Mean 1/1.03 0.97/0.95 0.87/0.74 0.81/0.69 0.69/0.62 
SD 0.22/0.17 0.21/0.16 0.18/0.13 0.19/0.13 0.16/0.13 
SSI SSI2-KC 
SSI SSI2-KC 
249 | Appendices | Ashkan Eliasy 
 
249 | P a g e  
 





Dataset 2  
Dataset 2 consists of 37 patients who undergo CXL with a mean CCT of 483±30 
(447 - 567) microns, age of 21.9±5(14-31) years, bIOP of 15±2(12.5-21.1) mmHg, 
bIOP2 of 16.1±1(14.5-18.8) mmHg, SSI of 0.87±0.14(0.61-1.22) and SSI2-KC of 
0.62±0.09(0.41-0.87). After crosslinking these values changed to a mean CCT of 
487±29(444-569) microns, bIOP of 15.5±2.1(11.9-21.5) mmHg, bIOP2 of 16.1±1 
(14.4-19) mmHg, SSI of 0.97±0.14(0.7-1.26) and SSI2-KC 0.7±0.08(0.55-0.88).In SSI, 
24.3% of patients showed softening after crosslinking, whereas with SSI2-KC 8.1% 
showed softening, Figure 6-86.  
 
 
Figure 6-86 The mean and standard deviation of pre-CXL and post-CXL data for SSI and SSI2-KC in 
the CXL Dataset 2 
Correlations with CCT before crosslinking for SSI was strong with R:0.415 (p:0.011) 
while SSI2-KC remained insignificant with R:0.269 (p:0.107). Age correlation with SSI 
was R:-0.070 (p:0.679) and with SSI2-KC was R:0.283 (p:0.090). The correlation of 
bIOP2 with SSI was strong with R:0.313 (p:0.059) while SSI2-KC remained 
uncorrelated with R:-0.037 (p:0.828), Figure 6-87.  
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Figure 6-87 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in the 
pre-surgery group of CXL Dataset 2 
Correlations with CCT after crosslinking for SSI was R:0.150 (p:0.377) and for SSI2-
KC was R:0.047 (p:0.782) where both remained insignificant. Age correlation with SSI 
was R:-0.242 (p:0.149) and with SSI2-KC was R:0.203 (p:0.228). Correlation of bIOP2 
with SSI and SSI2-KC were R:0.206 (p:0.222) and R:-0.263 (p:0.116). While both 
remained insignificant, SSI2-KC had a negative and SSI had a positive correlation, 
Figure 6-88.  
 
Figure 6-88 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in the 
post-surgery group of CXL Dataset 2 
 
Dataset 3  
Dataset 3 consist of 21 patients who undergo CXL with a mean CCT of 
484±31 (421 - 544) microns, age of 29.2±7.2(18-41) years, bIOP of 14.4±2.6(9.8-19.9) 
mmHg, bIOP2 of 15.9±1(14.4-17.9) mmHg, SSI of 0.77±0.11(0.6-1.09) and SSI2-KC 
of 0.62±0.11(0.42-0.83). After crosslinking these values changed to a mean CCT of 
455±43(332-523) microns, bIOP of 16±2.1(11.2-19.5) mmHg, bIOP2 of 16.5±1.1 
(13.8-18.6) mmHg, SSI of 0.83±0.22(0.57-1.43), SSI2-KC of 0.65±0.13(0.44-0.98). In 
SSI, 33.3% of patients showed softening after crosslinking, whereas with SSI2-KC 19% 
showed softening, Figure 6-89.  
SSI SSI2-KC 
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Figure 6-89 The mean and standard deviation of pre-CXL and post-CXL data for SSI and SSI2-KC in 
the CXL Dataset 3 
Correlations with CCT before crosslinking for SSI was R:0.196 (p:0.396) and for 
SSI2- KC was R:0.158 (p:0.494) where both remained insignificant. Age correlation 
with SSI was R:0.305 (p:0.180) and with SSI2-KC was R:0.784 (p:0.000). Correlation 
of bIOP2 with SSI was strong but insignificant with R:0.328 (p:0.146) while SSI2-KC 
was weaker and also insignificant with R:-0.124 (p:0.593), Figure 6-90. 
 
Figure 6-90 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in the 
pre-surgery group of CXL Dataset 3 
Correlations with CCT after crosslinking for SSI was R:0.265 (p:0.258) and for 
SSI2- KC was R:0.044 (p:0.851) where both are insignificant. Age correlation with SSI 
was R:0.530 (p:0.016) and with SSI2-KC was R:0.737 (p:0.000). Correlation of bIOP2 
with SSI and SSI2-KC were R:0.330 (p:0.156) and R:0.169 (p:0.464). SSI2-KC showed 
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Figure 6-91 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in post-
surgery group of CXL Dataset 3 
Dataset 4 
This dataset includes 69 CXL eyes with a mean age of 26.1 ± 8.8 (13 -56) years, CCT of 
481±38 (404 - 565) microns, bIOP of 13.3±2.4(7.8 -21.1) mmHg, bIOP2 of 14.9±1.2 
(11.7 -18.5) mmHg, SSI2-KC of 0.578±0.142(0.276 -0.97) and SSI of 
0.739±0.192(0.461 -1.296). After surgery these values changed to a mean age of 
26.3±8.8(13 -56) years, CCT of 467±42 (358 - 572) microns, bIOP of 
15.8±2.9 (8.4 - 24.2) mmHg, bIOP2 of 16.1±1.6(13.5 -21.3) mmHg, SSI2-KC of 
0.612±0.137(0.307 -0.993) and SSI of 0.855±0.278(0.508 -1.618). In SSI, 18.8% of 
patients showed softening after crosslinking, whereas with SSI2-KC 26.1% showed 
softening, Figure 6-92. 
 
 
Figure 6-92 The mean and standard deviation of pre-CXL and post-CXL data for SSI and SSI2-KC in 
the CXL Dataset 4 
In pre-surgery data, the correlation with CCT for SSI2-KC was R:0.204 (p:0.093), which 
is weaker than SSI with R:0.348 (p:0.003). Correlation with IOP for SSI2-KC was weak 
with R:0.150 (p:0.218) while SSI had strong correlations with R:0.652 (p:0.000). 
SSI SSI2-KC 
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Correlation with age for SSI2-KC was R:0.706 (p:0.000), and for SSI it was insignificant 
with R:0.070 (p:0.567), Figure 6-93. 
 
 
Figure 6-93 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in the 
pre-surgery group of CXL Dataset 4 
Correlation with CCT remained weaker after the surgery for SSI2-KC with R:0.216 
(p:0.075) than SSI with R:0.227 (p:0.061). Age correlation was stronger in SSI2-KC with 
R:0.720 (p:0.000) than SSI with R:0.138 (p:0.257). SSI2-KC was not significantly 
correlated with IOP with R:0.123 (p:0.312) while SSI had strong correlations with 




Figure 6-94 The correlation of SSI and SSI2-KC with CCT (left), age (middle) and IOP (right) in the 
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SSI-PLS for post LASIK and SMILE 
 
Dataset 2 
Dataset 2 consists of 47 patients who undergo LASIK with a mean CCT of 
549±34 (476 - 632) microns, age of 35.6±7.4(21-47) years, bIOP of 14.9±2.2(11.2-22.5) 
mmHg, bIOP2 of 15.7±1.4(13.8-18.8) mmHg, SSI of 1.04±0.25(0.56-1.67) and SSI2-H 
of 1.01±0.13(0.7-1.36). After LASIK these values changed to a mean CCT of 
475±51 (348 -583) microns, bIOP of 13.4±1.8(8.8-17.3) mmHg, bIOP2 of 
15.4±0.9(13.8-17.2) mmHg, SSI of 0.95±0.21(0.64-1.44) and SSI2-PLSof 
0.98±0.1(0.77-1.17). To evaluate the performance of SSI values, (Pre SSI – Post SSI)/ 
Pre SSI was calculated. This value for SSI was 0.066±0.161 and for SSI2 





Figure 6-95 Bland Altman plot for (top) SSI2 and (bottom) SSI comparing the pre and post LASIK 
surgery results in Dataset 2 
SSI2  SSI 
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Further, the correlations between changes in CCT and SSI/SSI2 were evaluated. The 
correlation for SSI was R:-0.349 (p:0.170) and for SSI2 was R:0.069 (p:0.792). This 
showed SSI2 changes were not significantly influenced by changes in CCT and this value 
was weaker than SSI, Figure 6-96.  
 
Figure 6-96 The evaluation of correlation in changes in CCT with changes in SSI and SSI2 in the 
LASIK group of Dataset 2 
 
Correlation with CCT before surgery for SSI was R:0.083 (p:0.579)and for SSI2-H was 
R:0.054 (p:0.719) where both were insignificant. Age correlation with SSI was R:0.298 
(p:0.422) and with SSI2-H was R:0.572 (p:0.000). The correlation of bIOP2 with SSI 
was significant and strong with R:0.504 (p:0.000) and SSI2-H was not correlated with 
R:0.029 (p:0.847), Figure 6-97. 
 
Figure 6-97 The correlation of SSI and SSI2-H with CCT (left), age (middle) and IOP (right) in the pre-
surgery LASIK group of Dataset 2 
 
Correlations with CCT after surgery for SSI became strong and significant with R:0.442 
(p:0.002) while SSI2-PLSremained insignificant with R:0.229 (p:0.121). Age correlation 
with SSI was R:0.222 (p:0.135) and with SSI2-PLSwas R:0.704 (p:0.000). Correlation of 
bIOP2 with SSI remained strong and significant with R:0.351 (p:0.016) while 
SSI2- PLSremained weak and insignificant with R:-0.097 (p:0.516), Figure 6-98. 
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Figure 6-98 The correlation of SSI and SSI2-PLSwith CCT (left), age (middle) and IOP (right) in the 
post-surgery LASIK group of Dataset 2 
 
Dataset 2 further includes 17 patients who undergo SMILE surgery with a mean CCT 
of 548±22(515-595) microns, age of 24.1±4.5(18-31) years, bIOP of 16.8±1.3 (14.5 - 19) 
mmHg, bIOP2 of 16.6±0.8(15.2-18.1) mmHg, SSI of 1.01±0.13(0.84-1.3) and SSI2-H 
of 0.84±0.07(0.7-0.97). After SMILE these values changed to a mean CCT of 
450±26(409-499) microns, age of 24.8±4.3(19-32) years, bIOP of 16.2±1.5(14.3-19.1) 
mmHg, bIOP2 of 16.6±1(15.1-19.3) mmHg, SSI of 0.86±0.11(0.68-1.07) and SSI2-PLS 
of 0.81±0.09(0.61-1). To evaluate the performance of SSI values, 
(Pre SSI – Post SSI) /  Pre SSI was calculated. This value for SSI was 0.137±0.136 and 
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Figure 6-99 Bland Altman plot for SSI2 (top) and SSI (bottom) comparing the pre and post SMILE 
surgery results in Dataset 2 
Further, the correlations between changes in CCT and SSI/SSI2 were evaluated. The 
correlation for SSI was R:0.069 (p:0.792) and for SSI2 was R:-0.349 (p:0.170). 
Both remained insignificant while SSI showed a weaker positive correlation and SSI2 
showed a stronger negative correlation, Figure 6-100. 
 
Figure 6-100 The evaluation of correlation in changes in CCT with changes in SSI and SSI2 in SMILE 
group of Dataset 2 
 
Correlations with CCT before surgery for SSI was R:0.187 (p:0.472) and for SSI2-H was 
weaker with R:0.024 (p:0.927) where both remained insignificant. Age correlation with 
SSI was negative with R:-0.059 (p:0.822) and with SSI2-H was R:0.583 (p:0.014). 
Correlation of bIOP2 with SSI was weak and positive with R:0.138 (p:0.598) and 
SSI2- H showed a stronger negative correlation with R:-0.415 (p:0.098) but 
insignificant, Figure 6-101. 
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Figure 6-101 The correlation of SSI and SSI2-H with CCT (left), age (middle) and IOP (right) in the 
pre-surgery SMILE group of Dataset 2 
 
Correlations with CCT after surgery for SSI was R:0.214 (p:0.409) and for SSI2-PLS 
was weaker and negative with R:-0.184 (p:0.480). Age correlation with SSI was negative 
with R:-0.239 (p:0.356) and SSI2-PLS remained positive with R:0.644 (p:0.005). 
Correlation of bIOP2 with SSI and SSI2-PLS were R:0.816 (p:0.000) and R:-0.534 
(p:0.027). Both were significant where SSI was positively correlated and SSI2-PLS 
negatively, Figure 6-102.  
 
 
Figure 6-102 The correlation of SSI and SSI2-PLS with CCT (left), age (middle) and IOP (right) in the 
post-surgery SMILE group of Dataset 2 
 
Dataset 3 
Dataset 3 consists of 43 patients who undergo LASIK with a mean CCT of 
560±27 (510- 605) microns, age of 25±5.2(17-36) years, bIOP of 13.8±1.6(11.2-18.8) 
mmHg, bIOP2 of 15.2±1(13.7-17.9) mmHg, SSI of 0.98±0.13(0.66-1.33) and SSI2-H 
of 0.83±0.09(0.54-1.03). After LASIK these values changed to a mean CCT of 
451±31(400-530) microns, age of 25.4±5.4(17-37) years, bIOP of 12.1±1.5(8.7-16.2) 
mmHg, bIOP2 of 15.3±0.6(14-17.2) mmHg, SSI of 0.85±0.08(0.72-1.11) and SSI2-PLS 
of 0.82±0.08(0.68-1.01). To evaluate the performance of SSI values, (Pre SSI – Post 
SSI)/ Pre SSI was calculated. This value for SSI was 0.126±0.102 and for SSI2 was 
0.010±0.111. Bland Altman plots are provided to visualise these changes, Figure 6-103. 
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Figure 6-103 Bland Altman plot for SSI2 (top) and SSI (bottom) comparing the pre and post LASIK 
surgery results in Dataset 3 
Further, the correlation between changes in CCT and SSI were evaluated. The 
correlation for SSI was R:0.245 (p:0.114) and for SSI2 R:0.222 (p:0.152). Both were 
insignificant and positively correlated with the reduction of CCT, Figure 6-104. 
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Figure 6-104 The evaluation of correlation in changes in CCT with changes in SSI and SSI2 in the 
LASIK group of Dataset 3 
 
Correlations with CCT before surgery for SSI was R:0.096 (p:0.541) and for SSI2-H was 
R:-0.131 (p:0.403) where both were insignificant. Age correlation with SSI was 
R:0.183 (p:0.240) and with SSI2-H was R:0.659 (p:0.000). Correlation of bIOP2 with 
SSI was strong and significant with R:0.784 (p:0.000) and for SSI2-H it remained 
insignificant and weakly correlated with R:0.070 (p:0.656), Figure 6-105. 
 
Figure 6-105 The correlation of SSI and SSI2-H with CCT (left), age (middle) and IOP (right) in the 
pre-surgery LASIK group of Dataset 3 
 
Correlations with CCT after surgery for SSI was R:0.218 (p:0.160) and for SSI2-PLS 
was R:0.1795 (p:0.250) where both remained insignificant. Age correlation with SSI was 
R:-0.028 (p:0.859) and with SSI2-PLS was R:0.558 (p:0.000). Correlation of bIOP2 with 
SSI remained significant with R:0.316 (p:0.039) and for SSI2-PLS remained 
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Figure 6-106 The correlation of SSI and SSI2-PLS with CCT (left), age (middle) and IOP (right) in the 
post-surgery LASIK group of Dataset 3 
 
Dataset 3 includes 52 patients who undergo SMILE surgery with a mean CCT of 
556±24(506-611) microns, age of 26.5±5.4(17-40) years, bIOP of 14.3±1.9 (10.3 - 18.4) 
mmHg, bIOP2 of 15.5±1.1(13.6-18) mmHg, SSI of 1.03±0.14(0.79-1.37) and SSI2-H 
of 0.86±0.09(0.66-1.01). After SMILE these values changed to a mean CCT of 
461±23(416-508) microns, bIOP of 13±1.7(9.2-17.4) mmHg, bIOP2 of 
15.7±0.7 (14.6 - 17.4) mmHg, SSI of 0.89±0.1(0.7-1.21) and SSI2-PLS of 
0.83±0.06(0.71-0.97). To evaluate the performance of SSI values, (Pre SSI – Post SSI)/ 
Pre SSI was calculated. This value for SSI was 0.127±0.111 and for SSI2 was 
0.033±0.081. Bland Altman plots are provided to visualise these changes, Figure 6-107. 
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Figure 6-107 Bland Altman plot for SSI2 (top) and SSI (bottom) comparing the pre and post SMILE 
surgery results in Dataset 3 
Further, the correlation between changes in CCT and SSI were evaluated. The 
correlation for SSI was R:-0.055 (p:0.696) and for SSI2 R:0.191 (p:0.175). Both changes 
in SSI and SSI2 were insignificant and weakly correlated with changes in CCT, Figure 
6-108. 
 
Figure 6-108 The evaluation of correlation in changes in CCT with changes in SSI and SSI2 in SMILE 
group of Dataset 3 
Correlation with CCT before surgery for SSI was R:0.061 (p:0.667) and for SSI2-H was 
R:-0.085 (p:0.547) and both showed insignificant correlations. Age correlation with SSI 
was negative with R:-0.239 (p:0.087) and with SSI2-H was R:0.594 (p:0.000). 
Correlation of bIOP2 with SSI was strong and significant with R:0.651 (p:0.000) and 
for SSI2-H it was weaker but still significant with R:-0.362 (p:0.008), Figure 6-109. 
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Figure 6-109 The correlation of SSI and SSI2-H with CCT (left), age (middle) and IOP (right) in the 
pre-surgery SMILE group of Dataset 3 
Correlation with CCT before surgery for SSI was strong and significant with R:0.489 
(p:0.000) and for SSI2-PLS it was weak and insignificant with R:-0.036 (p:0.799). Age 
correlation with SSI remained negative with R:-0.286 (p:0.040) and with SSI2-PLS was 
strong with R:0.628 (p:0.000). Correlation of bIOP2 with SSI remained strong and 
significant with R:0.453 (p:0.000) while SSI2-PLS became weakly correlated and 
insignificant with R:-0.148 (p:0.295), Figure 6-110. 
 
Figure 6-110 The correlation of SSI and SSI2-PLS with CCT (left), age (middle) and IOP (right) in the 
post-surgery SMILE group of Dataset 3 
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